# locus	type	ref	length	genotype	filter	pvalue	phred_qual_score	cnv_pvalue	coverage	allele_coverage	allele_ratio	allele_frequency_%	allele_frequency_%_corrected	zygosity	entry_count	maf	hrun	som_pval	gene	transcript	location	function	codon	exon	protein	coding	sift	polyphen	grantham	normalizedAlt	5000Exomes	FATHMM	NamedVariants	clinvar	cosmic	dbsnp	dgv	dra	drugbank	go	omim	pfam	phylop	dra_20170914	GRCh38_clinvar_20201226	GRCh38_cosmic_92	GRCh38_dbsnp_154	GRCh38_dgv_20200225	GRCh38_drugbank_20201029	GRCh38_esp6500_20151203	GRCh38_go_20201118	GRCh38_namedVariants_20151113	GRCh38_omim_20201202	GRCh38_pfam_33	GRCh38_phylop_20151118	GRCh38_refgene_201	gender	MyVariantDefaultDb_GRCh38
chr1:11790870	SNV	C	1	C/T	PASS	8.066776045948473e-82	810.933		400	C=210,T=190	C=0.525,T=0.475	47.50	52.5	heterozygous	1	0.074	2		MTHFR	NM_005957.5	MTHFR:exonic:NM_005957.5	missense	CAG	12	p.Arg594Gln	c.1781G>A	1.0	0.0	43.0	T	GMAF=0.0406:AMAF=0.0297:EMAF=0.0462	0.07		Benign, other	4986586	rs2274976		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		3.2														M	
chr1:11790946	SNV	G	1	G/C	PASS	1.432847598064586e-63	628.438		400	G=231,C=169	G=0.5775,C=0.4225	42.25	57.75	heterozygous	1	0.246	1		MTHFR	NM_005957.5	MTHFR:intronic:NM_005957.5	unknown			p.?	c.1753-48C>G				C	GMAF=0.2298:AMAF=0.1543:EMAF=0.2685					rs576853093:rs1332110504:rs3818762:rs1491370932		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		-2.26														M	
chr1:11791061	SNV	A	1	G/G	PASS	0.0	3578.63		360	A=0,G=360	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.098	1		MTHFR	NM_005957.5	MTHFR:intronic:NM_005957.5	unknown			p.?	c.1752+146T>C				G						rs7518348		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		0.08														M	
chr1:11791178	SNV	C	1	C/T	PASS	1.5156537556969718e-66	658.194		328	C=169,T=159	C=0.5152,T=0.4848	48.48	51.52	heterozygous	1	0.001	1		MTHFR	NM_005957.5	MTHFR:intronic:NM_005957.5	unknown			p.?	c.1752+29G>A				T	GMAF=0.0025:AMAF=9.0E-4:EMAF=0.0034					rs45483798		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		-0.33														M	
chr1:11792243	SNV	C	1	C/T	PASS	6.363557900409531e-99	981.963		400	C=192,T=208	C=0.48,T=0.52	52.00	48.0	heterozygous	1	0.251	2		MTHFR	NM_005957.5	MTHFR:intronic:NM_005957.5	unknown			p.?	c.1632+35G>A				T	GMAF=0.2229:AMAF=0.1491:EMAF=0.2607					rs1476413		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		-1.12														M	
chr1:11794400	SNV	G	1	A/A	PASS	0.0	3951.88		397	G=0,A=397	G=0.0,A=1.0	100.00	0.0	homozygous	1	0.097	1		MTHFR	NM_005957.5	MTHFR:exonic:NM_005957.5	synonymous	TTT	8	p.Phe435=	c.1305C>T				A	GMAF=0.1095:AMAF=0.3173:EMAF=0.003			Benign		rs756018487:rs4846051		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		0.65														M	
chr1:11794419	SNV	T	1	T/G	PASS	4.111497211045264e-104	1033.86		400	T=187,G=213	T=0.4675,G=0.5325	53.25	46.75	heterozygous	1	0.249	3		MTHFR	NM_005957.5	MTHFR:exonic:NM_005957.5	missense	GCA	8	p.Glu429Ala	c.1286A>C	0.06	0.021	107.0	G	GMAF=0.2596:AMAF=0.155:EMAF=0.3131	0.96		Conflicting interpretations of pathogenicity, other	3735923	rs1801131		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		3.76														M	
chr1:11794698	SNV	G	1	G/A	PASS	2.2646443075930064e-87	866.45		400	G=204,A=196	G=0.51,A=0.49	49.00	51.0	heterozygous	1	0.421	1		MTHFR	NM_005957.5	MTHFR:intronic:NM_005957.5	unknown			p.?	c.1166+31C>T				A	GMAF=0.4642:AMAF=0.4346:EMAF=0.4124					rs1994798		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		-4.42														M	
chr1:11794839	SNV	G	1	G/A	PASS	4.524806378555556e-93	923.444		400	G=198,A=202	G=0.495,A=0.505	50.50	49.5	heterozygous	1	0.103	1		MTHFR	NM_005957.5	MTHFR:exonic:NM_005957.5	synonymous	AGT	7	p.Ser352=	c.1056C>T				A	GMAF=0.094:AMAF=0.0878:EMAF=0.0971	0.2		Benign	5019033	rs2066462		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		-0.56														M	
chr1:11796321	SNV	G	1	G/A	PASS	4.248151535146525e-91	903.718		400	G=200,A=200	G=0.5,A=0.5	50.00	50.0	heterozygous	1	0.245	2		MTHFR	NM_005957.5	MTHFR:exonic:NM_005957.5	missense	GTC	5	p.Ala222Val	c.665C>T	0.0	0.998	64.0	A	GMAF=0.2706:AMAF=0.1217:EMAF=0.3469	0.98		drug response	146404	rs1801133		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		9.14														M	
chr1:11802707	INDEL	C	1	C/CT	PASS	2.241816183610028e-31	306.494		397	C=200,CT=197	C=0.5038,CT=0.4962	49.62	50.38	heterozygous	1	0.101	4		MTHFR	NM_005957.5	MTHFR:intronic:NM_005957.5	unknown			p.?	c.236+173_236+174insA				CT						rs55645287		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		0.8														M	
chr1:11802721	SNV	A	1	A/G	PASS	6.389987373482695e-100	991.945		400	A=191,G=209	A=0.4775,G=0.5225	52.25	47.75	heterozygous	1	0.129	1		MTHFR	NM_005957.5	MTHFR:intronic:NM_005957.5	unknown			p.?	c.236+160T>C				G						rs17367504		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		-1.03														M	
chr1:11803000	SNV	G	1	G/A	PASS	4.513360253409544e-98	973.455		397	G=191,A=206	G=0.4811,A=0.5189	51.89	48.11	heterozygous	1	0.102	4		MTHFR	NM_005957.5	MTHFR:exonic:NM_005957.5	synonymous	CCT	2	p.Pro39=	c.117C>T				A	GMAF=0.0897:AMAF=0.0783:EMAF=0.0956	0.01		Benign	5019072	rs2066470		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MTHFR)(dui:NBS2;dis:Core Conditions;g:MTHFR)(dui:NBS11;dis:Amino Acid Disorder;g:MTHFR)(dui:NBS57;dis:Homocystinuria;g:MTHFR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MTHFR)(dui:D002318;dis:Cardiovascular Diseases;g:MTHFR)(dui:D009422;dis:Nervous System Diseases;g:MTHFR)(dui:D014652;dis:Vascular Diseases;g:MTHFR)(dui:D009369;dis:Neoplasms;g:MTHFR)(dui:D000013;dis:Congenital Abnormalities;g:MTHFR)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:MTHFR)(dui:D030342;dis:Genetic Diseases, Inborn;g:MTHFR)(dui:D009371;dis:Neoplasms by Site;g:MTHFR)(dui:D002493;dis:Central Nervous System Diseases;g:MTHFR)(dui:D007154;dis:Immune System Diseases;g:MTHFR)(dui:D004066;dis:Digestive System Diseases;g:MTHFR)(dui:D001927;dis:Brain Diseases;g:MTHFR)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MTHFR)(dui:D009370;dis:Neoplasms by Histologic Type;g:MTHFR)(dui:D005767;dis:Gastrointestinal Diseases;g:MTHFR)(dui:D008659;dis:Metabolic Diseases;g:MTHFR)(dui:D006331;dis:Heart Diseases;g:MTHFR)(dui:D004067;dis:Digestive System Neoplasms;g:MTHFR)(dui:D001523;dis:Mental Disorders;g:MTHFR)(dui:D006402;dis:Hematologic Diseases;g:MTHFR)(dui:D009748;dis:Nutrition Disorders;g:MTHFR)(dui:D044342;dis:Malnutrition;g:MTHFR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:MTHFR)(dui:D007160;dis:Immunoproliferative Disorders;g:MTHFR)(dui:D008232;dis:Lymphoproliferative Disorders;g:MTHFR)(dui:D002561;dis:Cerebrovascular Disorders;g:MTHFR)(dui:D008206;dis:Lymphatic Diseases;g:MTHFR)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MTHFR)(dui:D008661;dis:Metabolism, Inborn Errors;g:MTHFR)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MTHFR)(dui:D020138;dis:Hyperhomocysteinemia;g:MTHFR)(dui:D017202;dis:Myocardial Ischemia;g:MTHFR)(dui:D003677;dis:Deficiency Diseases;g:MTHFR)(dui:D001361;dis:Avitaminosis;g:MTHFR)(dui:D014804;dis:Vitamin B Deficiency;g:MTHFR)(dui:D009421;dis:Nervous System Malformations;g:MTHFR)(dui:D009436;dis:Neural Tube Defects;g:MTHFR)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:MTHFR)(dui:D009140;dis:Musculoskeletal Diseases;g:MTHFR)(dui:D016769;dis:Embolism and Thrombosis;g:MTHFR)(dui:D009461;dis:Neurologic Manifestations;g:MTHFR)(dui:D003327;dis:Coronary Disease;g:MTHFR)(dui:D052776;dis:Female Urogenital Diseases;g:MTHFR)(dui:D052801;dis:Male Urogenital Diseases;g:MTHFR)(dui:D008286;dis:Malabsorption Syndromes;g:MTHFR)(dui:D007938;dis:Leukemia;g:MTHFR)(dui:D009057;dis:Stomatognathic Diseases;g:MTHFR)(dui:D007945;dis:Leukemia, Lymphoid;g:MTHFR)(dui:D007410;dis:Intestinal Diseases;g:MTHFR)(dui:D012871;dis:Skin Diseases;g:MTHFR)(dui:D009059;dis:Mouth Diseases;g:MTHFR)(dui:D004700;dis:Endocrine System Diseases;g:MTHFR)(dui:D003108;dis:Colonic Diseases;g:MTHFR)(dui:D007414;dis:Intestinal Neoplasms;g:MTHFR)(dui:D015179;dis:Colorectal Neoplasms;g:MTHFR)(dui:D014565;dis:Urogenital Neoplasms;g:MTHFR)(dui:D018640;dis:Stomatognathic System Abnormalities;g:MTHFR)(dui:D019967;dis:Schizophrenia Spectrum and Other Psychotic Disorders;g:MTHFR)(dui:D003240;dis:Connective Tissue Diseases;g:MTHFR)(dui:D014570;dis:Urologic Diseases;g:MTHFR)(dui:D013927;dis:Thrombosis;g:MTHFR)(dui:D020521;dis:Stroke;g:MTHFR)(dui:D008223;dis:Lymphoma;g:MTHFR)(dui:D005831;dis:Genital Diseases, Female;g:MTHFR)(dui:D008107;dis:Liver Diseases;g:MTHFR)(dui:D009056;dis:Mouth Abnormalities;g:MTHFR)(dui:D025063;dis:Chromosome Disorders;g:MTHFR)(dui:D019954;dis:Neurobehavioral Manifestations;g:MTHFR)(dui:D008607;dis:Intellectual Disability;g:MTHFR)(dui:D000015;dis:Abnormalities, Multiple;g:MTHFR)(dui:D004314;dis:Down Syndrome;g:MTHFR)(dui:D019851;dis:Thrombophilia;g:MTHFR)(dui:D054198;dis:Precursor Cell Lymphoblastic Leukemia-Lymphoma;g:MTHFR)(dui:D007674;dis:Kidney Diseases;g:MTHFR)(dui:D013272;dis:Stomach Diseases;g:MTHFR)(dui:D020246;dis:Venous Thrombosis;g:MTHFR)(dui:D003920;dis:Diabetes Mellitus;g:MTHFR)(dui:D013274;dis:Stomach Neoplasms;g:MTHFR)(dui:D009139;dis:Musculoskeletal Abnormalities;g:MTHFR)(dui:D005832;dis:Genital Diseases, Male;g:MTHFR)(dui:D001327;dis:Autoimmune Diseases;g:MTHFR)(dui:D012559;dis:Schizophrenia;g:MTHFR)(dui:D007246;dis:Infertility;g:MTHFR)(dui:D012140;dis:Respiratory Tract Diseases;g:MTHFR)(dui:D008171;dis:Lung Diseases;g:MTHFR)(dui:D002545;dis:Brain Ischemia;g:MTHFR)(dui:D012002;dis:Rectal Diseases;g:MTHFR)(dui:D007592;dis:Joint Diseases;g:MTHFR)(dui:D001168;dis:Arthritis;g:MTHFR)(dui:D008228;dis:Lymphoma, Non-Hodgkin;g:MTHFR)(dui:D019636;dis:Neurodegenerative Diseases;g:MTHFR)(dui:D012216;dis:Rheumatic Diseases;g:MTHFR)(dui:D001172;dis:Arthritis, Rheumatoid;g:MTHFR)(dui:D005833;dis:Genital Neoplasms, Female;g:MTHFR)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:MTHFR)(dui:D009008;dis:Abnormalities, Severe Teratoid;g:MTHFR)(dui:D000757;dis:Anencephaly;g:MTHFR)(dui:D003704;dis:Dementia;g:MTHFR)(dui:D019965;dis:Neurocognitive Disorders;g:MTHFR)(dui:D014591;dis:Uterine Diseases;g:MTHFR)(dui:D014594;dis:Uterine Neoplasms;g:MTHFR)(dui:D024801;dis:Tauopathies;g:MTHFR)(dui:D000544;dis:Alzheimer Disease;g:MTHFR)(dui:D007960;dis:Leukocyte Disorders;g:MTHFR)(dui:D007970;dis:Leukopenia;g:MTHFR)(dui:D013959;dis:Thyroid Diseases;g:MTHFR)(dui:D002277;dis:Carcinoma;g:MTHFR)(dui:D006967;dis:Hypersensitivity;g:MTHFR)(dui:D001157;dis:Arterial Occlusive Diseases;g:MTHFR)(dui:D008047;dis:Lip Diseases;g:MTHFR)(dui:D002971;dis:Cleft Lip;g:MTHFR)(dui:D019465;dis:Craniofacial Abnormalities;g:MTHFR)(dui:D019767;dis:Maxillofacial Abnormalities;g:MTHFR)(dui:D001161;dis:Arteriosclerosis;g:MTHFR)(dui:D018376;dis:Cardiovascular Abnormalities;g:MTHFR)(dui:D006330;dis:Heart Defects, Congenital;g:MTHFR)(dui:D013923;dis:Thromboembolism;g:MTHFR)(dui:D003110;dis:Colonic Neoplasms;g:MTHFR)(dui:D006980;dis:Hyperthyroidism;g:MTHFR)(dui:D048909;dis:Diabetes Complications;g:MTHFR)(dui:D001941;dis:Breast Diseases;g:MTHFR)(dui:D001943;dis:Breast Neoplasms;g:MTHFR)(dui:D001778;dis:Blood Coagulation Disorders;g:MTHFR)(dui:D007248;dis:Infertility, Male;g:MTHFR)(dui:D051437;dis:Renal Insufficiency;g:MTHFR)(dui:D025861;dis:Blood Coagulation Disorders, Inherited;g:MTHFR)(dui:D044882;dis:Glucose Metabolism Disorders;g:MTHFR)(dui:D000740;dis:Anemia;g:MTHFR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:MTHFR)(dui:D005759;dis:Gastroenteritis;g:MTHFR)(dui:D012678;dis:Sensation Disorders;g:MTHFR)(dui:D006086;dis:Graft vs Host Disease;g:MTHFR)(dui:D004427;dis:Ear Diseases;g:MTHFR)(dui:D006311;dis:Hearing Disorders;g:MTHFR)(dui:D034381;dis:Hearing Loss;g:MTHFR)(dui:D011248;dis:Pregnancy Complications;g:MTHFR)(dui:D000068105;dis:Bipolar and Related Disorders;g:MTHFR)(dui:D001714;dis:Bipolar Disorder;g:MTHFR)(dui:D011655;dis:Pulmonary Embolism;g:MTHFR)(dui:D004617;dis:Embolism;g:MTHFR)(dui:D003925;dis:Diabetic Angiopathies;g:MTHFR)(dui:D012142;dis:Respiratory Tract Neoplasms;g:MTHFR)(dui:D002577;dis:Uterine Cervical Diseases;g:MTHFR)(dui:D003639;dis:Hearing Loss, Sudden;g:MTHFR)(dui:D009385;dis:Neoplastic Processes;g:MTHFR)(dui:D002583;dis:Uterine Cervical Neoplasms;g:MTHFR)(dui:D013899;dis:Thoracic Neoplasms;g:MTHFR)(dui:D014571;dis:Urologic Neoplasms;g:MTHFR)(dui:D002278;dis:Carcinoma in Situ;g:MTHFR)(dui:D018290;dis:Cervical Intraepithelial Neoplasia;g:MTHFR)(dui:D005834;dis:Genital Neoplasms, Male;g:MTHFR)(dui:D011469;dis:Prostatic Diseases;g:MTHFR)(dui:D011471;dis:Prostatic Neoplasms;g:MTHFR)(dui:D008175;dis:Lung Neoplasms;g:MTHFR)(dui:D003324;dis:Coronary Artery Disease;g:MTHFR)(dui:D015448;dis:Leukemia, B-Cell;g:MTHFR)(dui:D015451;dis:Leukemia, Lymphocytic, Chronic, B-Cell;g:MTHFR)(dui:D001791;dis:Blood Platelet Disorders;g:MTHFR)(dui:D065886;dis:Neurodevelopmental Disorders;g:MTHFR)(dui:D001745;dis:Urinary Bladder Diseases;g:MTHFR)(dui:D001749;dis:Urinary Bladder Neoplasms;g:MTHFR)(dui:D056486;dis:Drug-Induced Liver Injury;g:MTHFR)(dui:D013921;dis:Thrombocytopenia;g:MTHFR)(dui:D002659;dis:Child Development Disorders, Pervasive;g:MTHFR)(dui:D002542;dis:Intracranial Embolism and Thrombosis;g:MTHFR)(dui:D020767;dis:Intracranial Thrombosis;g:MTHFR)(dui:D001321;dis:Autistic Disorder;g:MTHFR)(dui:D019964;dis:Mood Disorders;g:MTHFR)(dui:D003866;dis:Depressive Disorder;g:MTHFR)(dui:D000380;dis:Agranulocytosis;g:MTHFR)(dui:D009503;dis:Neutropenia;g:MTHFR)(dui:D023921;dis:Coronary Stenosis;g:MTHFR)(dui:D007247;dis:Infertility, Female;g:MTHFR)(dui:D012851;dis:Sinus Thrombosis, Intracranial;g:MTHFR)(dui:D001928;dis:Brain Diseases, Metabolic;g:MTHFR)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MTHFR)(dui:D018204;dis:Neoplasms, Connective and Soft Tissue;g:MTHFR)(dui:D008591;dis:Meningomyelocele;g:MTHFR)(dui:D008224;dis:Lymphoma, Follicular;g:MTHFR)(dui:D009372;dis:Neoplasms, Connective Tissue;g:MTHFR)(dui:D020258;dis:Neurotoxicity Syndromes;g:MTHFR)(dui:D052016;dis:Mucositis;g:MTHFR)(dui:D023903;dis:Coronary Restenosis;g:MTHFR)(dui:D009362;dis:Neoplasm Metastasis;g:MTHFR)(dui:D020879;dis:Neuromuscular Manifestations;g:MTHFR)(dui:D056784;dis:Leukoencephalopathies;g:MTHFR)(dui:D011618;dis:Psychotic Disorders;g:MTHFR)(dui:D009468;dis:Neuromuscular Diseases;g:MTHFR)(dui:D009135;dis:Muscular Diseases;g:MTHFR)(dui:D010523;dis:Peripheral Nervous System Diseases;g:MTHFR)(dui:D005530;dis:Foot Deformities;g:MTHFR)(dui:D005532;dis:Foot Deformities, Congenital;g:MTHFR)(dui:D006712;dis:Homocystinuria;g:MTHFR)(dui:D009128;dis:Muscle Spasticity;g:MTHFR)(dui:D017880;dis:Limb Deformities, Congenital;g:MTHFR)(dui:D000787;dis:Angina Pectoris;g:MTHFR)(dui:D003025;dis:Clubfoot;g:MTHFR)(dui:D009122;dis:Muscle Hypertonia;g:MTHFR)(dui:D038061;dis:Lower Extremity Deformities, Congenital;g:MTHFR)(dui:D017566;dis:Microvascular Angina;g:MTHFR)(dui:D001145;dis:Arrhythmias, Cardiac;g:MTHFR)(dui:D020260;dis:Heavy Metal Poisoning, Nervous System;g:MTHFR)(dui:D001281;dis:Atrial Fibrillation;g:MTHFR)(dui:D020261;dis:Arsenic Poisoning;g:MTHFR)(dui:D016889;dis:Endometrial Neoplasms;g:MTHFR)(dui:D013118;dis:Spinal Cord Diseases;g:MTHFR)(dui:D004342;dis:Drug Hypersensitivity;g:MTHFR)(dui:D007571;dis:Jaw Diseases;g:MTHFR)(dui:D007569;dis:Jaw Abnormalities;g:MTHFR)(dui:D002972;dis:Cleft Palate;g:MTHFR)(dui:D013971;dis:Thyrotoxicosis;g:MTHFR)(dui:D003872;dis:Dermatitis;g:MTHFR)(dui:D003875;dis:Drug Eruptions;g:MTHFR)(dui:D006201;dis:Hair Diseases;g:MTHFR)(dui:D007039;dis:Hypotrichosis;g:MTHFR)(dui:D046152;dis:Gastrointestinal Stromal Tumors;g:MTHFR)(dui:D000505;dis:Alopecia;g:MTHFR)(dui:D058186;dis:Acute Kidney Injury;g:MTHFR)(dui:D006973;dis:Hypertension;g:MTHFR)(dui:D008113;dis:Liver Neoplasms;g:MTHFR)	Tetrahydrofolic acid:Menadione:Methionine:Riboflavin:Benazepril:Methotrexate:Cyanocobalamin:Folic acid:Fluorouracil	GO:0031060:GO:0070829:GO:0043200:GO:0046655:GO:0045202:GO:0004489:GO:0044877:GO:0072341:GO:0001666:GO:0001843:GO:0005829:GO:0035999:GO:0009086:GO:0071949:GO:0033274:GO:0046500:GO:0006730:GO:0006555:GO:0050661:GO:0050660:GO:0042493:GO:0051593:GO:0070555:GO:0055114:GO:0050667	607093		-7.56														M	
chr1:23808231	SNV	T	1	C/C	PASS	0.0	4003.19		400	T=0,C=400	T=0.0,C=1.0	100.00	0.0	homozygous	1	0.113	1		HMGCL	NM_000191.3	HMGCL:exonic:NM_000191.3	synonymous	CTG	7	p.Leu218=	c.654A>G				C	GMAF=0.0737:AMAF=0.039:EMAF=0.0915			Benign		rs719400		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HMGCL)(dui:NBS2;dis:Core Conditions;g:HMGCL)(dui:NBS9;dis:Organic Acid Condition;g:HMGCL)(dui:NBS46;dis:3-Hydroxy-3-methylglutaric aciduria;g:HMGCL)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:HMGCL)(dui:D008659;dis:Metabolic Diseases;g:HMGCL)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HMGCL)(dui:D030342;dis:Genetic Diseases, Inborn;g:HMGCL)(dui:D008661;dis:Metabolism, Inborn Errors;g:HMGCL)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:HMGCL)	3-hydroxyglutaric acid	GO:0005198:GO:0006552:GO:0042594:GO:0007584:GO:0005782:GO:0046951:GO:0007005:GO:0000287:GO:0006637:GO:0031406:GO:0005777:GO:0006625:GO:0000062:GO:0005759:GO:0046872:GO:0001889:GO:0004419:GO:0005739:GO:0006629:GO:0005829:GO:0030145:GO:0032991:GO:0070542	613898	PF00682	1.23														M	
chr1:23817442	SNV	A	1	G/G	PASS	0.0	3858.27		400	A=1,G=399	A=0.0025,G=0.9975	99.75	0.25	homozygous	1	0.112	1		HMGCL	NM_000191.3	HMGCL:intronic:NM_000191.3	unknown			p.?	c.252+34T>C				G	GMAF=0.0735:AMAF=0.039:EMAF=0.0912			Benign		rs2076344		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HMGCL)(dui:NBS2;dis:Core Conditions;g:HMGCL)(dui:NBS9;dis:Organic Acid Condition;g:HMGCL)(dui:NBS46;dis:3-Hydroxy-3-methylglutaric aciduria;g:HMGCL)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:HMGCL)(dui:D008659;dis:Metabolic Diseases;g:HMGCL)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HMGCL)(dui:D030342;dis:Genetic Diseases, Inborn;g:HMGCL)(dui:D008661;dis:Metabolism, Inborn Errors;g:HMGCL)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:HMGCL)	3-hydroxyglutaric acid	GO:0005198:GO:0006552:GO:0042594:GO:0007584:GO:0005782:GO:0046951:GO:0007005:GO:0000287:GO:0006637:GO:0031406:GO:0005777:GO:0006625:GO:0000062:GO:0005759:GO:0046872:GO:0001889:GO:0004419:GO:0005739:GO:0006629:GO:0005829:GO:0030145:GO:0032991:GO:0070542	613898	PF00682	-1.17														M	
chr1:45508256	SNV	G	1	G/A	PASS	3.4166461281382797e-77	764.664		400	G=215,A=185	G=0.5375,A=0.4625	46.25	53.75	heterozygous	1	0.475	1		MMACHC	NM_015506.3	MMACHC:exonic:NM_015506.3	synonymous	GTA	3	p.Val107=	c.321G>A				A	GMAF=0.4162:AMAF=0.3723:EMAF=0.437	0.12		Benign	6288212	rs2275276		(dui:NBS9;dis:Organic Acid Condition;g:MMACHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMACHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMACHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMACHC)(dui:NBS2;dis:Core Conditions;g:MMACHC)(dui:NBS57;dis:Homocystinuria;g:MMACHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMACHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMACHC)(dui:D008659;dis:Metabolic Diseases;g:MMACHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMACHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMACHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMACHC)(dui:D009748;dis:Nutrition Disorders;g:MMACHC)(dui:D044342;dis:Malnutrition;g:MMACHC)(dui:D003677;dis:Deficiency Diseases;g:MMACHC)(dui:D020138;dis:Hyperhomocysteinemia;g:MMACHC)(dui:D001361;dis:Avitaminosis;g:MMACHC)(dui:D014804;dis:Vitamin B Deficiency;g:MMACHC)(dui:D009422;dis:Nervous System Diseases;g:MMACHC)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:MMACHC)(dui:D002493;dis:Central Nervous System Diseases;g:MMACHC)(dui:D003240;dis:Connective Tissue Diseases;g:MMACHC)(dui:D001927;dis:Brain Diseases;g:MMACHC)(dui:D001928;dis:Brain Diseases, Metabolic;g:MMACHC)(dui:D006712;dis:Homocystinuria;g:MMACHC)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MMACHC)(dui:D014806;dis:Vitamin B 12 Deficiency;g:MMACHC)(dui:D005128;dis:Eye Diseases;g:MMACHC)(dui:D012164;dis:Retinal Diseases;g:MMACHC)(dui:D012162;dis:Retinal Degeneration;g:MMACHC)(dui:D008268;dis:Macular Degeneration;g:MMACHC)	Hydroxocobalamin:Cyanocobalamin	GO:0071949:GO:0042803:GO:0032451:GO:0009235:GO:0005515:GO:0043295:GO:0005737:GO:0016491:GO:0006749:GO:0031419:GO:0005829:GO:0055114:GO:0016740:GO:0070988:GO:0033787	609831	PF16690	-0.88														M	
chr1:75728544	INDEL	GT	1	G/G	PASS	9.036494737223374e-258	2570.44		393	GT=0,G=393	GT=0.0,G=1.0	100.00	0.0	homozygous	1	0.0	4		ACADM	NM_000016.6	ACADM:intronic:NM_000016.6	unknown			p.?	c.118+57delT				G				Benign		rs1454388372:rs75993895:rs1173791164:rs796117827		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADM)(dui:NBS2;dis:Core Conditions;g:ACADM)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADM)(dui:NBS51;dis:Medium-chain acyl-CoA dehydrogenase deficiency;g:ACADM)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADM)(dui:D008659;dis:Metabolic Diseases;g:ACADM)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADM)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADM)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADM)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADM)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADM)(dui:D004066;dis:Digestive System Diseases;g:ACADM)(dui:D008107;dis:Liver Diseases;g:ACADM)(dui:D048550;dis:Hepatic Insufficiency;g:ACADM)(dui:D017093;dis:Liver Failure;g:ACADM)(dui:D005767;dis:Gastrointestinal Diseases;g:ACADM)(dui:D009748;dis:Nutrition Disorders;g:ACADM)(dui:D005759;dis:Gastroenteritis;g:ACADM)(dui:D007410;dis:Intestinal Diseases;g:ACADM)(dui:D044343;dis:Overnutrition;g:ACADM)(dui:D004760;dis:Enterocolitis;g:ACADM)(dui:D009765;dis:Obesity;g:ACADM)(dui:D020345;dis:Enterocolitis, Necrotizing;g:ACADM)	Octanoyl-Coenzyme A:3-thiaoctanoyl-CoA:Flavin adenine dinucleotide	GO:0042802:GO:0045329:GO:0003995:GO:0005634:GO:0006635:GO:0033539:GO:0031966:GO:0070991:GO:0005759:GO:0050660:GO:0051793:GO:0019254:GO:0005739:GO:0051791:GO:0055114:GO:0019216:GO:0030424	607008	PF02771:PF02770:PF00441:PF08028	0.2,0.0														M	
chr1:75728621	SNV	A	1	G/G	PASS	0.0	3874.19		400	A=4,G=396	A=0.01,G=0.99	99.00	1.0	homozygous	1	0.104	2		ACADM	NM_000016.6	ACADM:intronic:NM_000016.6	unknown			p.?	c.118+133A>G				G						rs1146572		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADM)(dui:NBS2;dis:Core Conditions;g:ACADM)(dui:NBS10;dis:Fatty Acid Oxidation Disorder;g:ACADM)(dui:NBS51;dis:Medium-chain acyl-CoA dehydrogenase deficiency;g:ACADM)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADM)(dui:D008659;dis:Metabolic Diseases;g:ACADM)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADM)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADM)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADM)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADM)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADM)(dui:D004066;dis:Digestive System Diseases;g:ACADM)(dui:D008107;dis:Liver Diseases;g:ACADM)(dui:D048550;dis:Hepatic Insufficiency;g:ACADM)(dui:D017093;dis:Liver Failure;g:ACADM)(dui:D005767;dis:Gastrointestinal Diseases;g:ACADM)(dui:D009748;dis:Nutrition Disorders;g:ACADM)(dui:D005759;dis:Gastroenteritis;g:ACADM)(dui:D007410;dis:Intestinal Diseases;g:ACADM)(dui:D044343;dis:Overnutrition;g:ACADM)(dui:D004760;dis:Enterocolitis;g:ACADM)(dui:D009765;dis:Obesity;g:ACADM)(dui:D020345;dis:Enterocolitis, Necrotizing;g:ACADM)	Octanoyl-Coenzyme A:3-thiaoctanoyl-CoA:Flavin adenine dinucleotide	GO:0042802:GO:0045329:GO:0003995:GO:0005634:GO:0006635:GO:0033539:GO:0031966:GO:0070991:GO:0005759:GO:0050660:GO:0051793:GO:0019254:GO:0005739:GO:0051791:GO:0055114:GO:0019216:GO:0030424	607008	PF02771:PF02770:PF00441:PF08028	-0.18														M	
chr1:100206504	SNV	T	1	C/C	PASS	0.0	3992.7		399	T=0,C=399	T=0.0,C=1.0	100.00	0.0	homozygous	1	0.108	1		DBT	NM_001918.5	DBT:exonic:NM_001918.5	missense	GGT	9	p.Ser384Gly	c.1150A>G	1.0	0.0	56.0	C	GMAF=0.1408:AMAF=0.2251:EMAF=0.0976			Benign		rs12021720		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:DBT)(dui:NBS2;dis:Core Conditions;g:DBT)(dui:NBS11;dis:Amino Acid Disorder;g:DBT)(dui:NBS56;dis:Maple syrup urine disease;g:DBT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:DBT)(dui:D009422;dis:Nervous System Diseases;g:DBT)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:DBT)(dui:D002493;dis:Central Nervous System Diseases;g:DBT)(dui:D008659;dis:Metabolic Diseases;g:DBT)(dui:D030342;dis:Genetic Diseases, Inborn;g:DBT)(dui:D001927;dis:Brain Diseases;g:DBT)(dui:D001928;dis:Brain Diseases, Metabolic;g:DBT)(dui:D008661;dis:Metabolism, Inborn Errors;g:DBT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:DBT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:DBT)(dui:D008375;dis:Maple Syrup Urine Disease;g:DBT)		GO:0009083:GO:0031405:GO:0031625:GO:0005947:GO:0016407:GO:0005737:GO:0005759:GO:0005739:GO:0043754:GO:0042645	248610	PF02817:PF00198:PF00364	1.94														M	
chr1:115033402	SNV	A	1	G/G	PASS	0.0	3967.59		400	A=1,G=399	A=0.0025,G=0.9975	99.75	0.25	homozygous	1	0.016	1		TSHB	NM_000549.5	TSHB:exonic:NM_000549.5	missense	GCA	2	p.Thr14Ala	c.40A>G	0.32	0.0	58.0	G	GMAF=0.0248:AMAF=0.0057:EMAF=0.0345			Benign		rs10776792		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TSHB)(dui:NBS2;dis:Core Conditions;g:TSHB)(dui:NBS12;dis:Endocrine Disorder;g:TSHB)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TSHB)(dui:D004700;dis:Endocrine System Diseases;g:TSHB)(dui:D013959;dis:Thyroid Diseases;g:TSHB)(dui:D007037;dis:Hypothyroidism;g:TSHB)(dui:D009140;dis:Musculoskeletal Diseases;g:TSHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TSHB)(dui:D001847;dis:Bone Diseases;g:TSHB)(dui:D001849;dis:Bone Diseases, Endocrine;g:TSHB)(dui:D004392;dis:Dwarfism;g:TSHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:TSHB)(dui:D001848;dis:Bone Diseases, Developmental;g:TSHB)(dui:D003409;dis:Congenital Hypothyroidism;g:TSHB)(dui:D009422;dis:Nervous System Diseases;g:TSHB)(dui:D001523;dis:Mental Disorders;g:TSHB)(dui:D000068105;dis:Bipolar and Related Disorders;g:TSHB)(dui:D009461;dis:Neurologic Manifestations;g:TSHB)(dui:D001714;dis:Bipolar Disorder;g:TSHB)(dui:D019954;dis:Neurobehavioral Manifestations;g:TSHB)(dui:D003244;dis:Consciousness Disorders;g:TSHB)(dui:D014474;dis:Unconsciousness;g:TSHB)(dui:D003128;dis:Coma;g:TSHB)		GO:0005615:GO:0043627:GO:0007186:GO:0005737:GO:0051592:GO:0007267:GO:0009653:GO:0016486:GO:0033189:GO:0005576:GO:0005179:GO:0009755	188540		0.21														M	
chr2:1433638	SNV	C	1	T/T	PASS	0.0	3965.16		400	C=1,T=399	C=0.0025,T=0.9975	99.75	0.25	homozygous	1	0.437	1		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.349+31C>T				T	GMAF=0.4955:AMAF=0.2935:EMAF=0.4009					rs4927578		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-0.12														M	
chr2:1456034	SNV	A	1	G/G	PASS	0.0	3979.54		400	A=0,G=400	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.065	1		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.613-42A>G				G	GMAF=0.0716:AMAF=0.104:EMAF=0.055					rs4927610:rs1036271161		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-0.86														M	
chr2:1456232	SNV	G	1	G/T	PASS	1.821377637104797e-83	827.396		397	G=206,T=191	G=0.5189,T=0.4811	48.11	51.89	heterozygous	1	0.365	4		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	TCT	7	p.Ala257Ser	c.769G>T	0.13	0.056	99.0	T	GMAF=0.3813:AMAF=0.3761:EMAF=0.384	0.1		Benign	7302182	rs4927611		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.75														M	
chr2:1456368	SNV	A	1	A/G	PASS	1.1814082519208925e-66	659.276		400	A=227,G=173	A=0.5675,G=0.4325	43.25	56.75	heterozygous	1	0.363	3		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.819+86A>G				G	GMAF=0.3765:AMAF=0.3656:EMAF=0.3812					rs4927612		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.09														M	
chr2:1477383	SNV	G	1	G/T	PASS	5.2820194976998775e-95	942.772		400	G=196,T=204	G=0.49,T=0.51	51.00	49.0	heterozygous	1	0.408	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	TCG	8	p.Ala373Ser	c.1117G>T	1.0	0.005	99.0	T	GMAF=0.4069:AMAF=0.3165:EMAF=0.4479	0.03		Benign	3749597	rs2280132		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.12														M	
chr2:1477459	SNV	G	1	G/C	PASS	6.025595860743593e-94	932.2		400	G=197,C=203	G=0.4925,C=0.5075	50.75	49.25	heterozygous	1	0.29	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	ACC	8	p.Ser398Thr	c.1193G>C	0.05	0.999	58.0	C	GMAF=0.2184:AMAF=0.1362:EMAF=0.2602	0.89		Benign	1579950	rs2175977		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	1.05														M	
chr2:1484896	SNV	T	1	T/C	PASS	3.7368012538212015e-89	884.275		400	T=202,C=198	T=0.505,C=0.495	49.50	50.5	heterozygous	1	0.403	2		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.1597+42T>C				C	GMAF=0.4494:AMAF=0.3093:EMAF=0.4789					rs6715129		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.34														M	
chr2:1494031	SNV	C	1	C/T	PASS	6.251726927756951e-83	822.04		399	C=208,T=191	C=0.5213,T=0.4787	47.87	52.13	heterozygous	1	0.359	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	synonymous	GAT	11	p.Asp666=	c.1998C>T				T	GMAF=0.3505:AMAF=0.3221:EMAF=0.3651	0.01		Benign	3757660	rs780537993:rs1126797		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-5.14														M	
chr2:1495956	SNV	C	1	C/T	PASS	1.01859138805414e-73	729.92		400	C=219,T=181	C=0.5475,T=0.4525	45.25	54.75	heterozygous	1	0.273	1		TPO	NM_000547.5	TPO:intronic:NM_000547.5	unknown			p.?	c.2007-33C>T				T	GMAF=0.2825:AMAF=0.2245:EMAF=0.3123					rs2276704		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-0.1														M	
chr2:1496127	SNV	C	1	C/T	PASS	1.8005284996988501e-59	587.446		336	C=187,T=149	C=0.5565,T=0.4435	44.35	55.65	heterozygous	1	0.439	4		TPO	NM_000547.5	TPO:exonic:NM_000547.5	synonymous	CCT	12	p.Pro715=	c.2145C>T				T	GMAF=0.413:AMAF=0.4414:EMAF=0.3985	0.04		Benign	1685440	rs732608		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-2.72														M	
chr2:1496155	SNV	A	1	A/C	PASS	7.077827926090111e-71	701.501		330	A=170,C=160	A=0.5152,C=0.4848	48.48	51.52	heterozygous	1	0.498	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	CCT	12	p.Thr725Pro	c.2173A>C	1.0	0.0	38.0	C	GMAF=0.4703:AMAF=0.3926:EMAF=0.4001	0.03		Benign	3812428	rs732609		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	2.92														M	
chr2:1516904	SNV	T	1	T/C	PASS	3.3189445755261096e-70	694.79		400	T=223,C=177	T=0.5575,C=0.4425	44.25	55.75	heterozygous	1	0.336	1		TPO	NM_000547.5	TPO:exonic:NM_000547.5	missense	GCG	15	p.Val847Ala	c.2540T>C	1.0	0.0	64.0	C	GMAF=0.3867:AMAF=0.2288:EMAF=0.4677	0		Benign	148793	rs1126799		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	0.63														M	
chr2:1542555	SNV	C	1	C/G	PASS	3.1174536130312157e-78	775.062		400	C=214,G=186	C=0.535,G=0.465	46.50	53.5	heterozygous	1	0.353	2		TPO	NM_000547.5	TPO:utr_3:NM_000547.5	unknown		17	p.?	c.*81C>G				G	GMAF=0.3815:AMAF=0.2384:EMAF=0.4437	0		Benign	4001255	rs1042589		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TPO)(dui:NBS2;dis:Core Conditions;g:TPO)(dui:NBS12;dis:Endocrine Disorder;g:TPO)(dui:NBS61;dis:Primary Congenital Hypothyroidism;g:TPO)(dui:D004700;dis:Endocrine System Diseases;g:TPO)(dui:D013959;dis:Thyroid Diseases;g:TPO)(dui:D007037;dis:Hypothyroidism;g:TPO)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TPO)(dui:D030342;dis:Genetic Diseases, Inborn;g:TPO)(dui:D009140;dis:Musculoskeletal Diseases;g:TPO)(dui:D001847;dis:Bone Diseases;g:TPO)(dui:D001848;dis:Bone Diseases, Developmental;g:TPO)(dui:D001849;dis:Bone Diseases, Endocrine;g:TPO)(dui:D004392;dis:Dwarfism;g:TPO)(dui:D003409;dis:Congenital Hypothyroidism;g:TPO)(dui:D006042;dis:Goiter;g:TPO)(dui:D009422;dis:Nervous System Diseases;g:TPO)(dui:D009468;dis:Neuromuscular Diseases;g:TPO)(dui:D010523;dis:Peripheral Nervous System Diseases;g:TPO)	Methimazole:Carbimazole:Propylthiouracil:2-mercaptobenzothiazole:Triclosan:Dextrothyroxine:Iodine:Resorcinol	GO:0035162:GO:0006590:GO:0005886:GO:0042446:GO:0009986:GO:0020037:GO:0042744:GO:0004447:GO:0004601:GO:0005887:GO:0006979:GO:0005615:GO:0005509:GO:0098869:GO:0055114	606765:600044	PF03098:PF00084:PF07645	-1.2														M	
chr2:149576462	SNV	C	1	T/T	PASS	0.0	3923.37		400	C=2,T=398	C=0.005,T=0.995	99.50	0.5	homozygous	1	0.24	1		MMADHC	NM_015702.3	MMADHC:exonic:NM_015702.3	synonymous	CAA	5	p.Gln151=	c.453G>A				T	GMAF=0.2261:AMAF=0.4839:EMAF=0.094	0.38		Benign	7128893	rs11545261		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-0.09														M	
chr2:149587175	SNV	C	1	G/G	PASS	0.0	4001.85		400	C=0,G=400	C=0.0,G=1.0	100.00	0.0	homozygous	1	0.311	1		MMADHC|MMADHC-DT	NM_015702.3|NR_110240.1	MMADHC:intronic:NM_015702.3|MMADHC-DT:upstream:NR_110240.1	unknown|	|	|	p.?|	c.-52-26G>C|	|	|	|	G|	GMAF=0.2632:AMAF=0.3497:EMAF=0.0949					rs4667420		(dui:NBS9;dis:Organic Acid Condition;g:MMADHC)(dui:NBS11;dis:Amino Acid Disorder;g:MMADHC)(dui:NBS43;dis:Methylmalonic acidemia;g:MMADHC)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MMADHC)(dui:NBS2;dis:Core Conditions;g:MMADHC)(dui:NBS57;dis:Homocystinuria;g:MMADHC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MMADHC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MMADHC)(dui:D008659;dis:Metabolic Diseases;g:MMADHC)(dui:D030342;dis:Genetic Diseases, Inborn;g:MMADHC)(dui:D008661;dis:Metabolism, Inborn Errors;g:MMADHC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MMADHC)		GO:0005515:GO:0005737:GO:0005739:GO:0005829:GO:0009235	611935	PF10229	-0.12														M	
chr3:49421681	SNV	A	1	A/C	PASS	2.1642129928688194e-87	866.647		400	A=204,C=196	A=0.51,C=0.49	49.00	51.0	heterozygous	1	0.417	3		AMT|NICN1	NR_028435.2|NM_032316.3	AMT:intronic_nc:NR_028435.2|NICN1:downstream:NM_032316.3	|unknown	|	|	|p.?	|c.*3152T>G	|	|	|	|C						rs4855873		(dui:D009750;dis:Nutritional and Metabolic Diseases;g:AMT)(dui:D008659;dis:Metabolic Diseases;g:AMT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:AMT)(dui:D009422;dis:Nervous System Diseases;g:AMT)(dui:D030342;dis:Genetic Diseases, Inborn;g:AMT)(dui:D008661;dis:Metabolism, Inborn Errors;g:AMT)(dui:D002493;dis:Central Nervous System Diseases;g:AMT)(dui:D001927;dis:Brain Diseases;g:AMT)(dui:D001928;dis:Brain Diseases, Metabolic;g:AMT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:AMT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:AMT)(dui:D020158;dis:Hyperglycinemia, Nonketotic;g:AMT)	Tetrahydrofolic acid:NADH:5-methyltetrahydrofolic acid:Glycine	GO:0005515:GO:0005654:GO:0005874	238310:611516		1.08														M	
chr3:183017394	SNV	C	1	A/A	PASS	0.0	3993.62		399	C=0,A=399	C=0.0,A=1.0	100.00	0.0	homozygous	1	0.047	1		MCCC1	NM_020166.5	MCCC1:intronic:NM_020166.5	unknown			p.?	c.1978-57G>T				A	GMAF=0.0675:AMAF=0.065:EMAF=0.0685					rs6786878		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC1)(dui:NBS2;dis:Core Conditions;g:MCCC1)(dui:NBS9;dis:Organic Acid Condition;g:MCCC1)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC1)(dui:D009422;dis:Nervous System Diseases;g:MCCC1)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC1)(dui:D001927;dis:Brain Diseases;g:MCCC1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC1)(dui:D008659;dis:Metabolic Diseases;g:MCCC1)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC1)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC1)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC1)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC1)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC1)(dui:D019636;dis:Neurodegenerative Diseases;g:MCCC1)(dui:D009069;dis:Movement Disorders;g:MCCC1)(dui:D010300;dis:Parkinson Disease;g:MCCC1)(dui:D001480;dis:Basal Ganglia Diseases;g:MCCC1)(dui:D020734;dis:Parkinsonian Disorders;g:MCCC1)	Biotin	GO:0009083:GO:0009374:GO:1905202:GO:0006552:GO:0004075:GO:0004485:GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0005759:GO:0046872:GO:0005739:GO:0005829:GO:0016421	609010	PF08443:PF07478:PF02222:PF00364:PF02786:PF02785:PF00289:PF02655	-0.36														M	
chr3:183017423	SNV	T	1	G/G	PASS	0.0	3993.17		399	T=0,G=399	T=0.0,G=1.0	100.00	0.0	homozygous	1	0.303	1		MCCC1	NM_020166.5	MCCC1:intronic:NM_020166.5	unknown			p.?	c.1978-86A>C				G						rs2292056		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC1)(dui:NBS2;dis:Core Conditions;g:MCCC1)(dui:NBS9;dis:Organic Acid Condition;g:MCCC1)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC1)(dui:D009422;dis:Nervous System Diseases;g:MCCC1)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC1)(dui:D001927;dis:Brain Diseases;g:MCCC1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC1)(dui:D008659;dis:Metabolic Diseases;g:MCCC1)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC1)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC1)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC1)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC1)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC1)(dui:D019636;dis:Neurodegenerative Diseases;g:MCCC1)(dui:D009069;dis:Movement Disorders;g:MCCC1)(dui:D010300;dis:Parkinson Disease;g:MCCC1)(dui:D001480;dis:Basal Ganglia Diseases;g:MCCC1)(dui:D020734;dis:Parkinsonian Disorders;g:MCCC1)	Biotin	GO:0009083:GO:0009374:GO:1905202:GO:0006552:GO:0004075:GO:0004485:GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0005759:GO:0046872:GO:0005739:GO:0005829:GO:0016421	609010	PF08443:PF07478:PF02222:PF00364:PF02786:PF02785:PF00289:PF02655	-0.45														M	
chr3:183072461	SNV	G	1	A/A	PASS	0.0	3966.93		400	G=1,A=399	G=0.0025,A=0.9975	99.75	0.25	homozygous	1	0.084	1		MCCC1	NM_020166.5	MCCC1:exonic:NM_020166.5	synonymous	CTT	5	p.Leu132=	c.396C>T				A	GMAF=0.1147:AMAF=0.2034:EMAF=0.0692			Benign		rs7622479		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC1)(dui:NBS2;dis:Core Conditions;g:MCCC1)(dui:NBS9;dis:Organic Acid Condition;g:MCCC1)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC1)(dui:D009422;dis:Nervous System Diseases;g:MCCC1)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC1)(dui:D001927;dis:Brain Diseases;g:MCCC1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC1)(dui:D008659;dis:Metabolic Diseases;g:MCCC1)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC1)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC1)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC1)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC1)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC1)(dui:D019636;dis:Neurodegenerative Diseases;g:MCCC1)(dui:D009069;dis:Movement Disorders;g:MCCC1)(dui:D010300;dis:Parkinson Disease;g:MCCC1)(dui:D001480;dis:Basal Ganglia Diseases;g:MCCC1)(dui:D020734;dis:Parkinsonian Disorders;g:MCCC1)	Biotin	GO:0009083:GO:0009374:GO:1905202:GO:0006552:GO:0004075:GO:0004485:GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0005759:GO:0046872:GO:0005739:GO:0005829:GO:0016421	609010	PF08443:PF07478:PF02222:PF00364:PF02786:PF02785:PF00289:PF02655	0.89														M	
chr4:158680524	SNV	C	1	T/T	PASS	0.0	3880.26		400	C=3,T=397	C=0.0075,T=0.9925	99.25	0.75	homozygous	1	0.327	1		ETFDH	NM_004453.4	ETFDH:exonic:NM_004453.4	missense	ATA	2	p.Thr31Ile	c.92C>T	0.1	0.0	89.0	T	GMAF=0.3434:AMAF=0.2596:EMAF=0.14	0.84		Benign	4158888	rs11559290		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFDH)(dui:NBS3;dis:Secondary Conditions;g:ETFDH)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFDH)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFDH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFDH)(dui:D008659;dis:Metabolic Diseases;g:ETFDH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFDH)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFDH)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFDH)(dui:D028361;dis:Mitochondrial Diseases;g:ETFDH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFDH)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFDH)(dui:D009748;dis:Nutrition Disorders;g:ETFDH)(dui:D044343;dis:Overnutrition;g:ETFDH)(dui:D009765;dis:Obesity;g:ETFDH)	Metformin:2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol	GO:0009055:GO:0022904:GO:0043783:GO:0004174:GO:0022900:GO:0048039:GO:0006979:GO:0031305:GO:0033539:GO:0005515:GO:0031966:GO:0048038:GO:0005759:GO:0016491:GO:0046872:GO:0050660:GO:0051539	231675	PF01946:PF13450:PF05187:PF00890	1.1														M	
chr5:71626789	SNV	G	1	G/A	PASS	1.4635245097784238e-88	878.346		399	G=202,A=197	G=0.5063,A=0.4937	49.37	50.63	heterozygous	1	0.186	1		MCCC2	NM_022132.5	MCCC2:intronic:NM_022132.5	unknown			p.?	c.738+36G>A				A	GMAF=0.2032:AMAF=0.2797:EMAF=0.164			Benign		rs12516456		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC2)(dui:NBS2;dis:Core Conditions;g:MCCC2)(dui:NBS9;dis:Organic Acid Condition;g:MCCC2)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC2)(dui:D009422;dis:Nervous System Diseases;g:MCCC2)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC2)(dui:D001927;dis:Brain Diseases;g:MCCC2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC2)(dui:D008659;dis:Metabolic Diseases;g:MCCC2)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC2)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC2)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC2)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC2)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC2)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC2)	Biotin	GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0009083:GO:0005759:GO:1905202:GO:0005739:GO:0006552:GO:0005829:GO:0015936:GO:0004485	609014	PF01039	-0.73														M	
chr5:71635139	SNV	A	1	A/G	PASS	7.919540789912748e-63	621.013		400	A=232,G=168	A=0.58,G=0.42	42.00	58.0	heterozygous	1	0.33	1		MCCC2	NM_022132.5	MCCC2:intronic:NM_022132.5	unknown			p.?	c.904-12A>G				G	GMAF=0.2889:AMAF=0.1416:EMAF=0.3643			Benign		rs277984		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC2)(dui:NBS2;dis:Core Conditions;g:MCCC2)(dui:NBS9;dis:Organic Acid Condition;g:MCCC2)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC2)(dui:D009422;dis:Nervous System Diseases;g:MCCC2)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC2)(dui:D001927;dis:Brain Diseases;g:MCCC2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC2)(dui:D008659;dis:Metabolic Diseases;g:MCCC2)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC2)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC2)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC2)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC2)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC2)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC2)	Biotin	GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0009083:GO:0005759:GO:1905202:GO:0005739:GO:0006552:GO:0005829:GO:0015936:GO:0004485	609014	PF01039	-1.82														M	
chr5:71649248	SNV	A	1	A/G	PASS	3.5318316979195846e-113	1124.52		400	A=178,G=222	A=0.445,G=0.555	55.50	44.5	heterozygous	1	0.149	1		MCCC2	NM_022132.5	MCCC2:exonic:NM_022132.5	synonymous	GCG	14	p.Ala456=	c.1368A>G				G	GMAF=0.1868:AMAF=0.2935:EMAF=0.1321	0.07		Benign	4407210	rs10064079		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC2)(dui:NBS2;dis:Core Conditions;g:MCCC2)(dui:NBS9;dis:Organic Acid Condition;g:MCCC2)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC2)(dui:D009422;dis:Nervous System Diseases;g:MCCC2)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC2)(dui:D001927;dis:Brain Diseases;g:MCCC2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC2)(dui:D008659;dis:Metabolic Diseases;g:MCCC2)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC2)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC2)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC2)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC2)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC2)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC2)	Biotin	GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0009083:GO:0005759:GO:1905202:GO:0005739:GO:0006552:GO:0005829:GO:0015936:GO:0004485	609014	PF01039	-1.2														M	
chr5:71652827	SNV	G	1	G/A	PASS	2.341531475169316e-77	766.305		399	G=214,A=185	G=0.5363,A=0.4637	46.37	53.63	heterozygous	1	0.186	1		MCCC2	NM_022132.5	MCCC2:intronic:NM_022132.5	unknown			p.?	c.1574+73G>A				A						rs2242372		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:MCCC2)(dui:NBS2;dis:Core Conditions;g:MCCC2)(dui:NBS9;dis:Organic Acid Condition;g:MCCC2)(dui:NBS45;dis:3-Methylcrotonyl-CoA carboxylase deficiency;g:MCCC2)(dui:D009422;dis:Nervous System Diseases;g:MCCC2)(dui:D002493;dis:Central Nervous System Diseases;g:MCCC2)(dui:D001927;dis:Brain Diseases;g:MCCC2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MCCC2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MCCC2)(dui:D008659;dis:Metabolic Diseases;g:MCCC2)(dui:D030342;dis:Genetic Diseases, Inborn;g:MCCC2)(dui:D008661;dis:Metabolism, Inborn Errors;g:MCCC2)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:MCCC2)(dui:D001928;dis:Brain Diseases, Metabolic;g:MCCC2)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:MCCC2)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:MCCC2)	Biotin	GO:0002169:GO:0005524:GO:0005515:GO:0006768:GO:0009083:GO:0005759:GO:1905202:GO:0005739:GO:0006552:GO:0005829:GO:0015936:GO:0004485	609014	PF01039	0.28														M	
chr6:32038450	INDEL	CTGC	3	C/C	PASS	0.0	3889.33		396	CTGC=0,C=396	CTGC=0.0,C=1.0	100.00	0.0	homozygous	1		1		CYP21A2	NM_000500.9	CYP21A2:exonic:NM_000500.9	nonframeshiftDeletion		1	p.Leu10del	c.29_31delTGC				C	GMAF=0.1888:AMAF=0.0762:EMAF=0.2467					rs1554304337:rs28381641:rs1401750531:rs1424110213:rs1170743134:rs764653902		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	0.35,0.73,1.19,-1.31														M	
chr6:32038540	SNV	C	1	T/T	PASS	8e-323	3221.1		342	C=6,T=336	C=0.0175,T=0.9825	98.25	1.75	homozygous	1		2		CYP21A2	NM_000500.9	CYP21A2:exonic:NM_000500.9	synonymous	TTG	1	p.Leu40=	c.118C>T				T		0.61		Benign	4160891	rs6468		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	0.09														M	
chr6:32038560	SNV	C	1	A/A	PASS	2.582260190634464e-257	2565.88		292	C=9,A=283	C=0.0308,A=0.9692	96.92	3.0799999999999983	homozygous	1		4		CYP21A2	NM_000500.9	CYP21A2:exonic:NM_000500.9	synonymous	CCA	1	p.Pro46=	c.138C>A				A		0.05		Benign	4160892	rs6464		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	0.44														M	
chr6:32038820	SNV	C	1	T/T	PASS	1.4487718535447189e-109	1088.39		121	C=4,T=117	C=0.0331,T=0.9669	96.69	3.3100000000000023	homozygous	1	0.288	2		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.292+9C>T				T				Benign		rs6462		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-1.82														M	
chr6:32038844	SNV	A	1	C/C	PASS	2.9013491821233654e-99	985.374		125	A=11,C=114	A=0.088,C=0.912	91.20	8.799999999999997	homozygous	1	0.218	7		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.292+33A>C				C	GMAF=0.2224:AMAF=0.0745:EMAF=0.2975					rs755425808:rs6463		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	1.04														M	
chr6:32038878	SNV	C	1	T/T	PASS	6.280583588133205e-131	1302.02		132	C=0,T=132	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.218	1		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.292+67C>T				T						rs6449		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-2.74														M	
chr6:32039081	SNV	C	1	A/A	PASS	9.354056741475598e-171	1700.29		212	C=17,A=195	C=0.0802,A=0.9198	91.98	8.019999999999996	homozygous	1	0.348	2		CYP21A2	NM_000500.9	CYP21A2:intronic:NM_000500.9	unknown			p.?	c.293-13C>A				A	GMAF=0.3707:AMAF=0.3445:EMAF=0.384			Conflicting interpretations of pathogenicity		rs6467:rs1267808195		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-0.23														M	
chr6:32039109	SNV	G	1	A/A	PASS	3.1117163371059817e-168	1675.07		212	G=18,A=194	G=0.0849,A=0.9151	91.51	8.489999999999995	homozygous	1	0.215	2		CYP21A2	NM_000500.9	CYP21A2:exonic:NM_000500.9	missense	AAG	3	p.Arg103Lys	c.308G>A	0.48	0.0	26.0	A	GMAF=0.2315:AMAF=0.0693:EMAF=0.3145	0		Benign	1319109	rs6474		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	-0.6														M	
chr6:32040013	SNV	C	1	C/G	PASS	1.6492633189611037e-06	57.8271		269	C=217,G=52	C=0.8067,G=0.1933	19.33	80.67	heterozygous	1	0.214	1		CYP21A2	NM_000500.9	CYP21A2:exonic:NM_000500.9	synonymous	CTG	7	p.Leu249=	c.747C>G				G		0.01		Benign	4003960	rs6477		(dui:D004700;dis:Endocrine System Diseases;g:CYP21A2)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP21A2)(dui:D006058;dis:Gonadal Disorders;g:CYP21A2)(dui:D052776;dis:Female Urogenital Diseases;g:CYP21A2)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP21A2)(dui:D000013;dis:Congenital Abnormalities;g:CYP21A2)(dui:D052801;dis:Male Urogenital Diseases;g:CYP21A2)(dui:D014564;dis:Urogenital Abnormalities;g:CYP21A2)(dui:D012734;dis:Disorders of Sex Development;g:CYP21A2)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP21A2)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP21A2)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP21A2)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP21A2)(dui:D008659;dis:Metabolic Diseases;g:CYP21A2)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP21A2)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP21A2)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP21A2)(dui:D058489;dis:46, XX Disorders of Sex Development;g:CYP21A2)(dui:D017588;dis:Hyperandrogenism;g:CYP21A2)	Ketoconazole	GO:0016705:GO:0008395:GO:0008202:GO:0005496:GO:0006694:GO:0004497:GO:0020037:GO:0005789:GO:0006704:GO:0005506:GO:0006705:GO:0004509:GO:0055114:GO:0016125	613815	PF00067	0.02														M	
chr6:39909177	INDEL	A	1	A/AC	PASS	0.016654055207776	17.7848		5	A=2,AC=3	A=0.4,AC=0.6	60.00	40.0	heterozygous	1		0		MOCS1	NM_001358530.2	MOCS1:intronic:NM_001358530.2	unknown			p.?	c.1103-76_1103-75insG				AC						rs1582803997		(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MOCS1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MOCS1)(dui:D008659;dis:Metabolic Diseases;g:MOCS1)(dui:D030342;dis:Genetic Diseases, Inborn;g:MOCS1)(dui:D008661;dis:Metabolism, Inborn Errors;g:MOCS1)(dui:D008664;dis:Metal Metabolism, Inborn Errors;g:MOCS1)			603707	PF01967:PF04055:PF06463:PF13353	-0.62														M	
chr6:39927671	SNV	T	1	T/C	PASS	1.3458603540559197e-142	1418.71		338	T=110,C=228	T=0.3254,C=0.6746	67.46	32.540000000000006	heterozygous	1	0.377	2		MOCS1	NM_001358530.2	MOCS1:intronic:NM_001358530.2	unknown			p.?	c.124-216A>G				C				Benign		rs3008822		(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:MOCS1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:MOCS1)(dui:D008659;dis:Metabolic Diseases;g:MOCS1)(dui:D030342;dis:Genetic Diseases, Inborn;g:MOCS1)(dui:D008661;dis:Metabolism, Inborn Errors;g:MOCS1)(dui:D008664;dis:Metal Metabolism, Inborn Errors;g:MOCS1)			603707	PF01967:PF04055:PF06463:PF13353	-0.93														M	
chr6:49435569	SNV	T	1	T/C	PASS	2.4609341899525536e-79	786.089		399	T=212,C=187	T=0.5313,C=0.4687	46.87	53.13	heterozygous	1	0.451	1		MMUT	NM_000255.4	MMUT:exonic:NM_000255.4	missense	GTA	12	p.Ile671Val	c.2011A>G	1.0	0.0	29.0	C	GMAF=0.393:AMAF=0.4122:EMAF=0.3833	0.25		Benign	4004063	rs8589		.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	3.9														M	
chr6:49440256	SNV	T	1	T/C	PASS	6.283476569844692e-100	992.018		400	T=191,C=209	T=0.4775,C=0.5225	52.25	47.75	heterozygous	1	0.0	1		MMUT	NM_000255.4	MMUT:exonic:NM_000255.4	missense	GCA	11	p.Thr636Ala	c.1906A>G	0.0	0.887	58.0	C						rs569669261		.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	7.67														M	
chr6:49441774	SNV	G	1	G/C	PASS	1.312199899019231e-121	1208.82		400	G=170,C=230	G=0.425,C=0.575	57.50	42.5	heterozygous	1	0.329	1		MMUT	NM_000255.4	MMUT:intronic:NM_000255.4	unknown			p.?	c.1808+66C>G				C						rs9473555		.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	0.46														M	
chr6:49444720	SNV	C	1	C/T	PASS	2.963466348548627e-89	885.282		400	C=202,T=198	C=0.505,T=0.495	49.50	50.5	heterozygous	1	0.266	1		MMUT	NM_000255.4	MMUT:exonic:NM_000255.4	missense	CAT	9	p.Arg532His	c.1595G>A	0.0	0.225	29.0	T	GMAF=0.3135:AMAF=0.2108:EMAF=0.366	0.03		Benign	5001998	rs1141321		.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	-0.01														M	
chr6:49457733	SNV	T	1	T/C	PASS	1.9493956831325725e-86	857.101		400	T=205,C=195	T=0.5125,C=0.4875	48.75	51.25	heterozygous	1	0.011	1		MMUT	NM_000255.4	MMUT:exonic:NM_000255.4	synonymous	CCG	3	p.Pro237=	c.711A>G				C	GMAF=0.0106:AMAF=0.0052:EMAF=0.0134			Benign		rs138085432		.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	0.87														M	
chr6:49457808	SNV	C	1	C/T	PASS	2.585830180421042e-87	865.874		400	C=204,T=196	C=0.51,T=0.49	49.00	51.0	heterozygous	1	0.449	1		MMUT	NM_000255.4	MMUT:exonic:NM_000255.4	synonymous	AAA	3	p.Lys212=	c.636G>A				T	GMAF=0.3984:AMAF=0.4274:EMAF=0.3836	0.39		Benign	6350580	rs2229384		.		GO:0019626:GO:0042802:GO:0042803:GO:0009791:GO:0004494:GO:0009235:GO:0043547:GO:0072341:GO:0005515:GO:0005737:GO:0005759:GO:0046872:GO:0003924:GO:0031419:GO:0005739:GO:0050667	609058	PF02310:PF01642	0.67														M	
chr6:80107031	SNV	T	1	C/C	PASS	0.0	3996.93		400	T=0,C=400	T=0.0,C=1.0	100.00	0.0	homozygous	1	0.388	1		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.196+142T>C				C						rs35447745		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	-1.0														M	
chr6:80127522	SNV	A	1	G/G	PASS	0.0	3647.02		400	A=12,G=388	A=0.03,G=0.97	97.00	3.0	homozygous	1	0.388	3		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.197-25A>G				G	GMAF=0.323:AMAF=0.1148:EMAF=0.4297			Benign		rs9448893		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	0.45														M	
chr6:80272984	SNV	G	1	A/A	PASS	0.0	4003.2		400	G=0,A=400	G=0.0,A=1.0	100.00	0.0	homozygous	1	0.403	1		BCKDHB	NM_000056.4	BCKDHB:intronic:NM_000056.4	unknown			p.?	c.952-151G>A				A						rs9341811		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHB)(dui:NBS2;dis:Core Conditions;g:BCKDHB)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHB)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHB)(dui:D008659;dis:Metabolic Diseases;g:BCKDHB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHB)(dui:D009422;dis:Nervous System Diseases;g:BCKDHB)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHB)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHB)(dui:D001927;dis:Brain Diseases;g:BCKDHB)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHB)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHB)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHB)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHB)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0005739:GO:0003826:GO:0007584:GO:0055114:GO:0005730	248611	PF02779:PF02780	-0.85														M	
chr7:117531068	SNV	T	1	T/C	PASS	4.602565735813676e-108	1073.37		400	T=183,C=217	T=0.4575,C=0.5425	54.25	45.75	heterozygous	1	0.001	2		CFTR	NM_000492.4	CFTR:exonic:NM_000492.4	missense	ACT	4	p.Ile148Thr	c.443T>C	0.0	0.29	89.0	C	GMAF=5.0E-4:AMAF=0.0:EMAF=8.0E-4		I148T	Conflicting interpretations of pathogenicity		rs35516286		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		7.61														M	
chr7:117536538	INDEL	TGATT	4	TGATT/T	PASS	3.457004938868652e-87	864.613		383	TGATT=189,T=194	TGATT=0.4935,T=0.5065	50.65	49.35	heterozygous	1		1		CFTR	NM_000492.4	CFTR:intronic:NM_000492.4	unknown			p.?	c.744-9_744-6delGATT				T						rs1584787644:rs397508793:rs387906367:rs1584787639:rs1554380751:rs878854022		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		0.15,0.0,0.0,-0.48,2.25														M	
chr7:117548607	INDEL	TG	1	TG/T	PASS	9.473271845042451e-19	180.235		209	TG=142,T=67	TG=0.6794,T=0.3206	32.06	67.94	heterozygous	1	0.017	1		CFTR|CFTR-AS1	NM_000492.4|NR_149084.1	CFTR:intronic:NM_000492.4|CFTR-AS1:intronic_nc:NR_149084.1	unknown|	|	|	p.?|	c.1210-33delG|	|	|	|	T|						rs1584793309:rs3832534		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		0.07,0.07														M	
chr7:117548625	INDEL	TG	1	TG/T	PASS	1.9310788175580915e-46	457.142		290	TG=140,T=150	TG=0.4828,T=0.5172	51.72	48.28	heterozygous	1		1		CFTR|CFTR-AS1	NM_000492.4|NR_149084.1	CFTR:intronic:NM_000492.4|CFTR-AS1:intronic_nc:NR_149084.1	unknown|	|	|	p.?|	c.1210-15delG|	|	|	|	T|				Likely benign		rs1230197379:rs947648829:rs775751830:rs371831442:rs1584793324:rs1584793326:rs765376630:rs1399483116		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		-0.38,-1.27														M	
chr7:117559403	SNV	A	1	A/G	PASS	4.5972698853086615e-93	923.375		400	A=197,G=203	A=0.4925,G=0.5075	50.75	49.25	heterozygous	1	0.337	1		CFTR|CFTR-AS1	NM_000492.4|NR_149084.1	CFTR:intronic:NM_000492.4|CFTR-AS1:intronic_nc:NR_149084.1	unknown|	|	|	p.?|	c.1393-61A>G|	|	|	|	G|				Benign		rs34855237		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		0.3														M	
chr7:117559479	SNV	G	1	A/A	PASS	0.0	3967.23		400	G=1,A=399	G=0.0025,A=0.9975	99.75	0.25	homozygous	1	0.418	2		CFTR|CFTR-AS1	NM_000492.4|NR_149084.1	CFTR:exonic:NM_000492.4|CFTR-AS1:intronic_nc:NR_149084.1	missense|	ATG|	11|	p.Val470Met|	c.1408G>A|	1.0|	0.0|	21.0|	A|	GMAF=0.4024:AMAF=0.1496:EMAF=0.4681	0.39	M470V	Benign/Likely benign	3762337	rs397508204:rs213950		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		2.57														M	
chr7:117595001	SNV	T	1	G/G	PASS	0.0	3993.24		399	T=0,G=399	T=0.0,G=1.0	100.00	0.0	homozygous	1	0.479	1		CFTR	NM_000492.4	CFTR:exonic:NM_000492.4	synonymous	ACG	15	p.Thr854=	c.2562T>G				G	GMAF=0.4028:AMAF=0.3813:EMAF=0.2922	0.13		Benign/Likely benign	4161733	rs1584813846:rs1554389814:rs397508396:rs1042077		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		0.28														M	
chr7:117606582	SNV	G	1	G/A	PASS	2.963466348548627e-89	885.282		400	G=202,A=198	G=0.505,A=0.495	49.50	50.5	heterozygous	1	0.119	1		CFTR	NM_000492.4	CFTR:intronic:NM_000492.4	unknown			p.?	c.2909-92G>A				A				Benign		rs35050470		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		-0.23														M	
chr7:117627457	SNV	C	1	C/A	PASS	2.897343587701345e-99	985.38		399	C=191,A=208	C=0.4787,A=0.5213	52.13	47.87	heterozygous	1	0.144	1		CFTR	NM_000492.4	CFTR:intronic:NM_000492.4	unknown			p.?	c.3469-65C>A				A				Benign		rs213989		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		-0.12														M	
chr7:117667054	SNV	G	1	G/A	PASS	2.0710949036603802e-85	846.838		400	G=206,A=194	G=0.515,A=0.485	48.50	51.5	heterozygous	1	0.186	1		CFTR	NM_000492.4	CFTR:exonic:NM_000492.4	synonymous	CAA	27	p.Gln1463=	c.4389G>A				A	GMAF=0.2259:AMAF=0.2444:EMAF=0.2164	0.11		Benign/Likely benign	3762339	rs1800136:rs1584850283		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CFTR)(dui:NBS2;dis:Core Conditions;g:CFTR)(dui:NBS14;dis:Other Disorder;g:CFTR)(dui:D004066;dis:Digestive System Diseases;g:CFTR)(dui:NBS72;dis:Cystic fibrosis;g:CFTR)(dui:D010182;dis:Pancreatic Diseases;g:CFTR)(dui:D012140;dis:Respiratory Tract Diseases;g:CFTR)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CFTR)(dui:D030342;dis:Genetic Diseases, Inborn;g:CFTR)(dui:D008171;dis:Lung Diseases;g:CFTR)(dui:D007232;dis:Infant, Newborn, Diseases;g:CFTR)(dui:D003550;dis:Cystic Fibrosis;g:CFTR)(dui:D052801;dis:Male Urogenital Diseases;g:CFTR)(dui:D010195;dis:Pancreatitis;g:CFTR)(dui:D005832;dis:Genital Diseases, Male;g:CFTR)(dui:D007246;dis:Infertility;g:CFTR)(dui:D007248;dis:Infertility, Male;g:CFTR)(dui:D010038;dis:Otorhinolaryngologic Diseases;g:CFTR)(dui:D009668;dis:Nose Diseases;g:CFTR)(dui:D012141;dis:Respiratory Tract Infections;g:CFTR)(dui:D050500;dis:Pancreatitis, Chronic;g:CFTR)(dui:D005767;dis:Gastrointestinal Diseases;g:CFTR)(dui:D007410;dis:Intestinal Diseases;g:CFTR)(dui:D001982;dis:Bronchial Diseases;g:CFTR)(dui:D053713;dis:Azoospermia;g:CFTR)(dui:D001987;dis:Bronchiectasis;g:CFTR)(dui:D010254;dis:Paranasal Sinus Diseases;g:CFTR)(dui:D009369;dis:Neoplasms;g:CFTR)(dui:D012852;dis:Sinusitis;g:CFTR)(dui:D012220;dis:Rhinitis;g:CFTR)(dui:D009371;dis:Neoplasms by Site;g:CFTR)(dui:D004067;dis:Digestive System Neoplasms;g:CFTR)(dui:D001523;dis:Mental Disorders;g:CFTR)(dui:D019966;dis:Substance-Related Disorders;g:CFTR)(dui:D003108;dis:Colonic Diseases;g:CFTR)(dui:D005770;dis:Gastrointestinal Neoplasms;g:CFTR)(dui:D007414;dis:Intestinal Neoplasms;g:CFTR)(dui:D012002;dis:Rectal Diseases;g:CFTR)(dui:D015179;dis:Colorectal Neoplasms;g:CFTR)	Ivacaftor:Colforsin:Crofelemer:Elexacaftor:Dexibuprofen:Lumacaftor:Glyburide:Ibuprofen:Lonidamine:Phosphoaminophosphonic Acid-Adenylate Ester:Bumetanide:Tezacaftor:ATP:Dexfosfoserine	GO:0016887:GO:1902476:GO:0045921:GO:0005789:GO:0034707:GO:0048240:GO:0051087:GO:0030660:GO:0005829:GO:0106138:GO:0015108:GO:0030301:GO:0015701:GO:0015106:GO:0016853:GO:0030665:GO:0019869:GO:0042626:GO:1902161:GO:0006695:GO:0005765:GO:0005886:GO:0031901:GO:0005634:GO:0005515:GO:0051454:GO:0071320:GO:0060081:GO:0032991:GO:0016324:GO:0034976:GO:0005254:GO:0005524:GO:0005887:GO:0017081:GO:0005769:GO:0050891:GO:0030165:GO:0035774:GO:0016579:GO:0061024:GO:0035377:GO:0055085:GO:0005260:GO:1904322:GO:1902943:GO:0009986:GO:0005737:GO:0006904:GO:0016020:GO:0016021:GO:0010008:GO:0055037:GO:0055038:GO:0019899	602421		0.01														M	
chr8:142875392	SNV	A	1	C/C	PASS	2.0323570109361877e-303	3026.92		398	A=39,C=359	A=0.098,C=0.902	90.20	9.799999999999997	homozygous	1	0.259	2		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.1122-80T>G				C						rs6395		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-2.29														M	
chr8:142875509	SNV	T	1	C/C	PASS	0.0	3975.79		398	T=0,C=398	T=0.0,C=1.0	100.00	0.0	homozygous	1	0.24	1		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.1122-197A>G				C						rs6392		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-2.07														M	
chr8:142876440	SNV	G	1	A/A	PASS	0.0	3967.06		400	G=1,A=399	G=0.0025,A=0.9975	99.75	0.25	homozygous	1	0.315	1		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.800-45C>T				A	GMAF=0.4197:AMAF=0.3926:EMAF=0.4336					rs7822986		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-1.98														M	
chr8:142876563	SNV	A	1	C/C	PASS	8.77000821143659e-178	1770.57		211	A=13,C=198	A=0.0616,C=0.9384	93.84	6.159999999999997	homozygous	1	0.382	2		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.799+119T>G				C						rs10956991		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-3.19														M	
chr8:142877011	SNV	C	1	T/T	PASS	0.0	3967.13		400	C=1,T=399	C=0.0025,T=0.9975	99.75	0.25	homozygous	1	0.436	1		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.595+12G>A				T	GMAF=0.4845:AMAF=0.3736:EMAF=0.4587			Benign		rs6387		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-3.01														M	
chr8:142877264	SNV	G	1	G/A	PASS	1.7567097026646111e-68	677.553		400	G=224,A=176	G=0.56,A=0.44	44.00	56.0	heterozygous	1	0.012	1		CYP11B1	NM_000497.4	CYP11B1:intronic:NM_000497.4	unknown			p.?	c.396-42C>T				A	GMAF=0.0213:AMAF=0.0052:EMAF=0.0296					rs61751146		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-2.37														M	
chr8:142879181	SNV	G	1	A/A	PASS	0.0	3856.14		389	G=0,A=389	G=0.0,A=1.0	100.00	0.0	homozygous	1	0.303	1		CYP11B1	NM_000497.4	CYP11B1:exonic:NM_000497.4	synonymous	GAT	2	p.Asp82=	c.246C>T				A	GMAF=0.3283:AMAF=0.1117:EMAF=0.4393	0.01		Benign	4162721	rs5283		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-0.46														M	
chr8:142879589	SNV	T	1	C/C	PASS	0.0	4002.81		400	T=0,C=400	T=0.0,C=1.0	100.00	0.0	homozygous	1	0.416	1		CYP11B1	NM_000497.4	CYP11B1:exonic:NM_000497.4	synonymous	CTG	1	p.Leu75=	c.225A>G				C	GMAF=0.4923:AMAF=0.4424:EMAF=0.4588	0.05		Benign	6338105	rs6410		(dui:D004700;dis:Endocrine System Diseases;g:CYP11B1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP11B1)(dui:D006058;dis:Gonadal Disorders;g:CYP11B1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP11B1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP11B1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP11B1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP11B1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP11B1)(dui:D000013;dis:Congenital Abnormalities;g:CYP11B1)(dui:D008659;dis:Metabolic Diseases;g:CYP11B1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP11B1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP11B1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP11B1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP11B1)(dui:D012734;dis:Disorders of Sex Development;g:CYP11B1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP11B1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP11B1)(dui:D000308;dis:Adrenocortical Hyperfunction;g:CYP11B1)(dui:D006929;dis:Hyperaldosteronism;g:CYP11B1)	Hydrocortisone acetate:Mibefradil:Dexamethasone:Ketoconazole:Cimetidine:Metyrapone:Hydrocortisone butyrate:Hydrocortisone:Hydrocortisone valerate:Aldosterone:Etomidate:Levoketoconazole:Spironolactone:Osilodrostat:Mitotane:Dexamethasone acetate:Hydrocortisone succinate:Miconazole:Phenytoin:Hydrocortisone probutate	GO:0034651:GO:0034650:GO:0008203:GO:0006700:GO:0008217:GO:0005743:GO:0020037:GO:0006704:GO:0006955:GO:0005506:GO:0047783:GO:0004507:GO:0005739:GO:0042593:GO:0071375:GO:0032342:GO:0032870:GO:0055114:GO:0016125:GO:0035865	610613		-0.64														M	
chr10:102831079	INDEL	AGGGAACCCTGATCTGAGGATGTAGCCTTATTATGG	35	AGGGAACCCTGATCTGAGGATGTAGCCTTATTATGG/A	PASS	1e-05	50.0		693	AGGGAACCCTGATCTGAGGATGTAGCCTTATTATGG=364,A=329	AGGGAACCCTGATCTGAGGATGTAGCCTTATTATGG=0.5253,A=0.4747	47.47	52.53	heterozygous	1	0.0:0.004:0.169			CYP17A1	NM_000102.4	CYP17A1:intronic:NM_000102.4	unknown			p.?	c.1244-129_1244-95delCCATAATAAGGCTACATCCTCAGATCAGGGTTCCC				A						rs869228446:rs1406908533:rs562963192:rs1276663458:rs915546176:rs908055791:rs1284547910:rs139275291:rs1590202473:rs1279313673:rs561699026:rs1399856034:rs1590202460		(dui:D004700;dis:Endocrine System Diseases;g:CYP17A1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP17A1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP17A1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP17A1)(dui:D006058;dis:Gonadal Disorders;g:CYP17A1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP17A1)(dui:D008659;dis:Metabolic Diseases;g:CYP17A1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP17A1)(dui:D000013;dis:Congenital Abnormalities;g:CYP17A1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP17A1)(dui:D012734;dis:Disorders of Sex Development;g:CYP17A1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP17A1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP17A1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP17A1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP17A1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP17A1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP17A1)(dui:D009369;dis:Neoplasms;g:CYP17A1)(dui:D009371;dis:Neoplasms by Site;g:CYP17A1)(dui:D004066;dis:Digestive System Diseases;g:CYP17A1)(dui:D008107;dis:Liver Diseases;g:CYP17A1)(dui:D009422;dis:Nervous System Diseases;g:CYP17A1)(dui:D005831;dis:Genital Diseases, Female;g:CYP17A1)(dui:D005832;dis:Genital Diseases, Male;g:CYP17A1)(dui:D002493;dis:Central Nervous System Diseases;g:CYP17A1)(dui:D001927;dis:Brain Diseases;g:CYP17A1)(dui:D007246;dis:Infertility;g:CYP17A1)(dui:D014565;dis:Urogenital Neoplasms;g:CYP17A1)(dui:D010049;dis:Ovarian Diseases;g:CYP17A1)(dui:D000291;dis:Adnexal Diseases;g:CYP17A1)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CYP17A1)(dui:D011469;dis:Prostatic Diseases;g:CYP17A1)(dui:D012871;dis:Skin Diseases;g:CYP17A1)(dui:D001941;dis:Breast Diseases;g:CYP17A1)(dui:D003560;dis:Cysts;g:CYP17A1)(dui:D010048;dis:Ovarian Cysts;g:CYP17A1)(dui:D001943;dis:Breast Neoplasms;g:CYP17A1)(dui:D005834;dis:Genital Neoplasms, Male;g:CYP17A1)(dui:D009370;dis:Neoplasms by Histologic Type;g:CYP17A1)(dui:D011471;dis:Prostatic Neoplasms;g:CYP17A1)(dui:D002318;dis:Cardiovascular Diseases;g:CYP17A1)(dui:D004067;dis:Digestive System Neoplasms;g:CYP17A1)(dui:D014652;dis:Vascular Diseases;g:CYP17A1)(dui:D019636;dis:Neurodegenerative Diseases;g:CYP17A1)(dui:D006973;dis:Hypertension;g:CYP17A1)(dui:D009069;dis:Movement Disorders;g:CYP17A1)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:CYP17A1)(dui:D001523;dis:Mental Disorders;g:CYP17A1)(dui:D002277;dis:Carcinoma;g:CYP17A1)(dui:D010300;dis:Parkinson Disease;g:CYP17A1)(dui:D001480;dis:Basal Ganglia Diseases;g:CYP17A1)(dui:D020734;dis:Parkinsonian Disorders;g:CYP17A1)(dui:D000230;dis:Adenocarcinoma;g:CYP17A1)(dui:D008113;dis:Liver Neoplasms;g:CYP17A1)(dui:D007247;dis:Infertility, Female;g:CYP17A1)(dui:D020018;dis:Sexual Dysfunctions, Psychological;g:CYP17A1)(dui:D006528;dis:Carcinoma, Hepatocellular;g:CYP17A1)(dui:D007006;dis:Hypogonadism;g:CYP17A1)(dui:D007248;dis:Infertility, Male;g:CYP17A1)(dui:D010900;dis:Pituitary Diseases;g:CYP17A1)(dui:D005234;dis:Fatty Liver;g:CYP17A1)(dui:D007018;dis:Hypopituitarism;g:CYP17A1)(dui:D008103;dis:Liver Cirrhosis;g:CYP17A1)(dui:D014883;dis:Water-Electrolyte Imbalance;g:CYP17A1)(dui:D006947;dis:Hyperkalemia;g:CYP17A1)(dui:D006974;dis:Hypertension, Malignant;g:CYP17A1)(dui:D007027;dis:Hypothalamic Diseases;g:CYP17A1)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:CYP17A1)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:CYP17A1)	Stanolone:Dexamethasone:Ketoconazole:Nabiximols:Abiraterone:Medical Cannabis:Cannabidiol:Clomifene:Aldosterone:NADH:Spironolactone:Aminophenazone:Dexamethasone acetate:Progesterone:Prasterone	GO:0019825:GO:0042448:GO:0008202:GO:0005783:GO:0006694:GO:0043025:GO:0042446:GO:0020037:GO:0005789:GO:0006704:GO:0007548:GO:0006702:GO:0005506:GO:0004508:GO:0047442:GO:0055114:GO:0030424	609300	PF00067	-2.03,-0.36,0.4,0.19,-0.39,-0.53,-0.41,1.02,1.7,-0.55,-3.0,-0.28,-1.25,-0.01,0.01,-0.04,-1.26,-0.03,-0.55,0.06,-0.54,-0.01,-0.19,0.08,0.12,0.93,-0.69,0.6,-0.73,-0.35,-0.94,-0.21,-0.35,0.53,0.81,0.02														M	
chr10:102831395	SNV	T	1	T/A	PASS	2.9040226544645045e-113	1125.37		400	T=178,A=222	T=0.445,A=0.555	55.50	44.5	heterozygous	1	0.187	2		CYP17A1	NM_000102.4	CYP17A1:intronic:NM_000102.4	unknown			p.?	c.1243+113A>T				A						rs10883783		(dui:D004700;dis:Endocrine System Diseases;g:CYP17A1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP17A1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP17A1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP17A1)(dui:D006058;dis:Gonadal Disorders;g:CYP17A1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP17A1)(dui:D008659;dis:Metabolic Diseases;g:CYP17A1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP17A1)(dui:D000013;dis:Congenital Abnormalities;g:CYP17A1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP17A1)(dui:D012734;dis:Disorders of Sex Development;g:CYP17A1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP17A1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP17A1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP17A1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP17A1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP17A1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP17A1)(dui:D009369;dis:Neoplasms;g:CYP17A1)(dui:D009371;dis:Neoplasms by Site;g:CYP17A1)(dui:D004066;dis:Digestive System Diseases;g:CYP17A1)(dui:D008107;dis:Liver Diseases;g:CYP17A1)(dui:D009422;dis:Nervous System Diseases;g:CYP17A1)(dui:D005831;dis:Genital Diseases, Female;g:CYP17A1)(dui:D005832;dis:Genital Diseases, Male;g:CYP17A1)(dui:D002493;dis:Central Nervous System Diseases;g:CYP17A1)(dui:D001927;dis:Brain Diseases;g:CYP17A1)(dui:D007246;dis:Infertility;g:CYP17A1)(dui:D014565;dis:Urogenital Neoplasms;g:CYP17A1)(dui:D010049;dis:Ovarian Diseases;g:CYP17A1)(dui:D000291;dis:Adnexal Diseases;g:CYP17A1)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CYP17A1)(dui:D011469;dis:Prostatic Diseases;g:CYP17A1)(dui:D012871;dis:Skin Diseases;g:CYP17A1)(dui:D001941;dis:Breast Diseases;g:CYP17A1)(dui:D003560;dis:Cysts;g:CYP17A1)(dui:D010048;dis:Ovarian Cysts;g:CYP17A1)(dui:D001943;dis:Breast Neoplasms;g:CYP17A1)(dui:D005834;dis:Genital Neoplasms, Male;g:CYP17A1)(dui:D009370;dis:Neoplasms by Histologic Type;g:CYP17A1)(dui:D011471;dis:Prostatic Neoplasms;g:CYP17A1)(dui:D002318;dis:Cardiovascular Diseases;g:CYP17A1)(dui:D004067;dis:Digestive System Neoplasms;g:CYP17A1)(dui:D014652;dis:Vascular Diseases;g:CYP17A1)(dui:D019636;dis:Neurodegenerative Diseases;g:CYP17A1)(dui:D006973;dis:Hypertension;g:CYP17A1)(dui:D009069;dis:Movement Disorders;g:CYP17A1)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:CYP17A1)(dui:D001523;dis:Mental Disorders;g:CYP17A1)(dui:D002277;dis:Carcinoma;g:CYP17A1)(dui:D010300;dis:Parkinson Disease;g:CYP17A1)(dui:D001480;dis:Basal Ganglia Diseases;g:CYP17A1)(dui:D020734;dis:Parkinsonian Disorders;g:CYP17A1)(dui:D000230;dis:Adenocarcinoma;g:CYP17A1)(dui:D008113;dis:Liver Neoplasms;g:CYP17A1)(dui:D007247;dis:Infertility, Female;g:CYP17A1)(dui:D020018;dis:Sexual Dysfunctions, Psychological;g:CYP17A1)(dui:D006528;dis:Carcinoma, Hepatocellular;g:CYP17A1)(dui:D007006;dis:Hypogonadism;g:CYP17A1)(dui:D007248;dis:Infertility, Male;g:CYP17A1)(dui:D010900;dis:Pituitary Diseases;g:CYP17A1)(dui:D005234;dis:Fatty Liver;g:CYP17A1)(dui:D007018;dis:Hypopituitarism;g:CYP17A1)(dui:D008103;dis:Liver Cirrhosis;g:CYP17A1)(dui:D014883;dis:Water-Electrolyte Imbalance;g:CYP17A1)(dui:D006947;dis:Hyperkalemia;g:CYP17A1)(dui:D006974;dis:Hypertension, Malignant;g:CYP17A1)(dui:D007027;dis:Hypothalamic Diseases;g:CYP17A1)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:CYP17A1)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:CYP17A1)	Stanolone:Dexamethasone:Ketoconazole:Nabiximols:Abiraterone:Medical Cannabis:Cannabidiol:Clomifene:Aldosterone:NADH:Spironolactone:Aminophenazone:Dexamethasone acetate:Progesterone:Prasterone	GO:0019825:GO:0042448:GO:0008202:GO:0005783:GO:0006694:GO:0043025:GO:0042446:GO:0020037:GO:0005789:GO:0006704:GO:0007548:GO:0006702:GO:0005506:GO:0004508:GO:0047442:GO:0055114:GO:0030424	609300	PF00067	0.44														M	
chr10:102831425	SNV	G	1	G/T	PASS	1.6908302148684018e-78	777.719		400	G=213,T=187	G=0.5325,T=0.4675	46.75	53.25	heterozygous	1	0.142	2		CYP17A1	NM_000102.4	CYP17A1:intronic:NM_000102.4	unknown			p.?	c.1243+83C>A				T						rs284849		(dui:D004700;dis:Endocrine System Diseases;g:CYP17A1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP17A1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP17A1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP17A1)(dui:D006058;dis:Gonadal Disorders;g:CYP17A1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP17A1)(dui:D008659;dis:Metabolic Diseases;g:CYP17A1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP17A1)(dui:D000013;dis:Congenital Abnormalities;g:CYP17A1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP17A1)(dui:D012734;dis:Disorders of Sex Development;g:CYP17A1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP17A1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP17A1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP17A1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP17A1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP17A1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP17A1)(dui:D009369;dis:Neoplasms;g:CYP17A1)(dui:D009371;dis:Neoplasms by Site;g:CYP17A1)(dui:D004066;dis:Digestive System Diseases;g:CYP17A1)(dui:D008107;dis:Liver Diseases;g:CYP17A1)(dui:D009422;dis:Nervous System Diseases;g:CYP17A1)(dui:D005831;dis:Genital Diseases, Female;g:CYP17A1)(dui:D005832;dis:Genital Diseases, Male;g:CYP17A1)(dui:D002493;dis:Central Nervous System Diseases;g:CYP17A1)(dui:D001927;dis:Brain Diseases;g:CYP17A1)(dui:D007246;dis:Infertility;g:CYP17A1)(dui:D014565;dis:Urogenital Neoplasms;g:CYP17A1)(dui:D010049;dis:Ovarian Diseases;g:CYP17A1)(dui:D000291;dis:Adnexal Diseases;g:CYP17A1)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CYP17A1)(dui:D011469;dis:Prostatic Diseases;g:CYP17A1)(dui:D012871;dis:Skin Diseases;g:CYP17A1)(dui:D001941;dis:Breast Diseases;g:CYP17A1)(dui:D003560;dis:Cysts;g:CYP17A1)(dui:D010048;dis:Ovarian Cysts;g:CYP17A1)(dui:D001943;dis:Breast Neoplasms;g:CYP17A1)(dui:D005834;dis:Genital Neoplasms, Male;g:CYP17A1)(dui:D009370;dis:Neoplasms by Histologic Type;g:CYP17A1)(dui:D011471;dis:Prostatic Neoplasms;g:CYP17A1)(dui:D002318;dis:Cardiovascular Diseases;g:CYP17A1)(dui:D004067;dis:Digestive System Neoplasms;g:CYP17A1)(dui:D014652;dis:Vascular Diseases;g:CYP17A1)(dui:D019636;dis:Neurodegenerative Diseases;g:CYP17A1)(dui:D006973;dis:Hypertension;g:CYP17A1)(dui:D009069;dis:Movement Disorders;g:CYP17A1)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:CYP17A1)(dui:D001523;dis:Mental Disorders;g:CYP17A1)(dui:D002277;dis:Carcinoma;g:CYP17A1)(dui:D010300;dis:Parkinson Disease;g:CYP17A1)(dui:D001480;dis:Basal Ganglia Diseases;g:CYP17A1)(dui:D020734;dis:Parkinsonian Disorders;g:CYP17A1)(dui:D000230;dis:Adenocarcinoma;g:CYP17A1)(dui:D008113;dis:Liver Neoplasms;g:CYP17A1)(dui:D007247;dis:Infertility, Female;g:CYP17A1)(dui:D020018;dis:Sexual Dysfunctions, Psychological;g:CYP17A1)(dui:D006528;dis:Carcinoma, Hepatocellular;g:CYP17A1)(dui:D007006;dis:Hypogonadism;g:CYP17A1)(dui:D007248;dis:Infertility, Male;g:CYP17A1)(dui:D010900;dis:Pituitary Diseases;g:CYP17A1)(dui:D005234;dis:Fatty Liver;g:CYP17A1)(dui:D007018;dis:Hypopituitarism;g:CYP17A1)(dui:D008103;dis:Liver Cirrhosis;g:CYP17A1)(dui:D014883;dis:Water-Electrolyte Imbalance;g:CYP17A1)(dui:D006947;dis:Hyperkalemia;g:CYP17A1)(dui:D006974;dis:Hypertension, Malignant;g:CYP17A1)(dui:D007027;dis:Hypothalamic Diseases;g:CYP17A1)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:CYP17A1)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:CYP17A1)	Stanolone:Dexamethasone:Ketoconazole:Nabiximols:Abiraterone:Medical Cannabis:Cannabidiol:Clomifene:Aldosterone:NADH:Spironolactone:Aminophenazone:Dexamethasone acetate:Progesterone:Prasterone	GO:0019825:GO:0042448:GO:0008202:GO:0005783:GO:0006694:GO:0043025:GO:0042446:GO:0020037:GO:0005789:GO:0006704:GO:0007548:GO:0006702:GO:0005506:GO:0004508:GO:0047442:GO:0055114:GO:0030424	609300	PF00067	-0.16														M	
chr10:102832492	SNV	A	1	A/C	PASS	8.36565595755809e-99	980.775		400	A=192,C=208	A=0.48,C=0.52	52.00	48.0	heterozygous	1	0.139	1		CYP17A1	NM_000102.4	CYP17A1:intronic:NM_000102.4	unknown			p.?	c.1139+19T>G				C	GMAF=0.2204:AMAF=0.0744:EMAF=0.2952			Benign		rs4919686		(dui:D004700;dis:Endocrine System Diseases;g:CYP17A1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP17A1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP17A1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP17A1)(dui:D006058;dis:Gonadal Disorders;g:CYP17A1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP17A1)(dui:D008659;dis:Metabolic Diseases;g:CYP17A1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP17A1)(dui:D000013;dis:Congenital Abnormalities;g:CYP17A1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP17A1)(dui:D012734;dis:Disorders of Sex Development;g:CYP17A1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP17A1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP17A1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP17A1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP17A1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP17A1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP17A1)(dui:D009369;dis:Neoplasms;g:CYP17A1)(dui:D009371;dis:Neoplasms by Site;g:CYP17A1)(dui:D004066;dis:Digestive System Diseases;g:CYP17A1)(dui:D008107;dis:Liver Diseases;g:CYP17A1)(dui:D009422;dis:Nervous System Diseases;g:CYP17A1)(dui:D005831;dis:Genital Diseases, Female;g:CYP17A1)(dui:D005832;dis:Genital Diseases, Male;g:CYP17A1)(dui:D002493;dis:Central Nervous System Diseases;g:CYP17A1)(dui:D001927;dis:Brain Diseases;g:CYP17A1)(dui:D007246;dis:Infertility;g:CYP17A1)(dui:D014565;dis:Urogenital Neoplasms;g:CYP17A1)(dui:D010049;dis:Ovarian Diseases;g:CYP17A1)(dui:D000291;dis:Adnexal Diseases;g:CYP17A1)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CYP17A1)(dui:D011469;dis:Prostatic Diseases;g:CYP17A1)(dui:D012871;dis:Skin Diseases;g:CYP17A1)(dui:D001941;dis:Breast Diseases;g:CYP17A1)(dui:D003560;dis:Cysts;g:CYP17A1)(dui:D010048;dis:Ovarian Cysts;g:CYP17A1)(dui:D001943;dis:Breast Neoplasms;g:CYP17A1)(dui:D005834;dis:Genital Neoplasms, Male;g:CYP17A1)(dui:D009370;dis:Neoplasms by Histologic Type;g:CYP17A1)(dui:D011471;dis:Prostatic Neoplasms;g:CYP17A1)(dui:D002318;dis:Cardiovascular Diseases;g:CYP17A1)(dui:D004067;dis:Digestive System Neoplasms;g:CYP17A1)(dui:D014652;dis:Vascular Diseases;g:CYP17A1)(dui:D019636;dis:Neurodegenerative Diseases;g:CYP17A1)(dui:D006973;dis:Hypertension;g:CYP17A1)(dui:D009069;dis:Movement Disorders;g:CYP17A1)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:CYP17A1)(dui:D001523;dis:Mental Disorders;g:CYP17A1)(dui:D002277;dis:Carcinoma;g:CYP17A1)(dui:D010300;dis:Parkinson Disease;g:CYP17A1)(dui:D001480;dis:Basal Ganglia Diseases;g:CYP17A1)(dui:D020734;dis:Parkinsonian Disorders;g:CYP17A1)(dui:D000230;dis:Adenocarcinoma;g:CYP17A1)(dui:D008113;dis:Liver Neoplasms;g:CYP17A1)(dui:D007247;dis:Infertility, Female;g:CYP17A1)(dui:D020018;dis:Sexual Dysfunctions, Psychological;g:CYP17A1)(dui:D006528;dis:Carcinoma, Hepatocellular;g:CYP17A1)(dui:D007006;dis:Hypogonadism;g:CYP17A1)(dui:D007248;dis:Infertility, Male;g:CYP17A1)(dui:D010900;dis:Pituitary Diseases;g:CYP17A1)(dui:D005234;dis:Fatty Liver;g:CYP17A1)(dui:D007018;dis:Hypopituitarism;g:CYP17A1)(dui:D008103;dis:Liver Cirrhosis;g:CYP17A1)(dui:D014883;dis:Water-Electrolyte Imbalance;g:CYP17A1)(dui:D006947;dis:Hyperkalemia;g:CYP17A1)(dui:D006974;dis:Hypertension, Malignant;g:CYP17A1)(dui:D007027;dis:Hypothalamic Diseases;g:CYP17A1)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:CYP17A1)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:CYP17A1)	Stanolone:Dexamethasone:Ketoconazole:Nabiximols:Abiraterone:Medical Cannabis:Cannabidiol:Clomifene:Aldosterone:NADH:Spironolactone:Aminophenazone:Dexamethasone acetate:Progesterone:Prasterone	GO:0019825:GO:0042448:GO:0008202:GO:0005783:GO:0006694:GO:0043025:GO:0042446:GO:0020037:GO:0005789:GO:0006704:GO:0007548:GO:0006702:GO:0005506:GO:0004508:GO:0047442:GO:0055114:GO:0030424	609300	PF00067	-1.55														M	
chr10:102832918	SNV	G	1	G/C	PASS	3.9192232245497306e-66	654.068		396	G=225,C=171	G=0.5682,C=0.4318	43.18	56.82	heterozygous	1	0.35	1		CYP17A1	NM_000102.4	CYP17A1:intronic:NM_000102.4	unknown			p.?	c.969+75C>G				C						rs3740397		(dui:D004700;dis:Endocrine System Diseases;g:CYP17A1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP17A1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP17A1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP17A1)(dui:D006058;dis:Gonadal Disorders;g:CYP17A1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP17A1)(dui:D008659;dis:Metabolic Diseases;g:CYP17A1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP17A1)(dui:D000013;dis:Congenital Abnormalities;g:CYP17A1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP17A1)(dui:D012734;dis:Disorders of Sex Development;g:CYP17A1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP17A1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP17A1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP17A1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP17A1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP17A1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP17A1)(dui:D009369;dis:Neoplasms;g:CYP17A1)(dui:D009371;dis:Neoplasms by Site;g:CYP17A1)(dui:D004066;dis:Digestive System Diseases;g:CYP17A1)(dui:D008107;dis:Liver Diseases;g:CYP17A1)(dui:D009422;dis:Nervous System Diseases;g:CYP17A1)(dui:D005831;dis:Genital Diseases, Female;g:CYP17A1)(dui:D005832;dis:Genital Diseases, Male;g:CYP17A1)(dui:D002493;dis:Central Nervous System Diseases;g:CYP17A1)(dui:D001927;dis:Brain Diseases;g:CYP17A1)(dui:D007246;dis:Infertility;g:CYP17A1)(dui:D014565;dis:Urogenital Neoplasms;g:CYP17A1)(dui:D010049;dis:Ovarian Diseases;g:CYP17A1)(dui:D000291;dis:Adnexal Diseases;g:CYP17A1)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CYP17A1)(dui:D011469;dis:Prostatic Diseases;g:CYP17A1)(dui:D012871;dis:Skin Diseases;g:CYP17A1)(dui:D001941;dis:Breast Diseases;g:CYP17A1)(dui:D003560;dis:Cysts;g:CYP17A1)(dui:D010048;dis:Ovarian Cysts;g:CYP17A1)(dui:D001943;dis:Breast Neoplasms;g:CYP17A1)(dui:D005834;dis:Genital Neoplasms, Male;g:CYP17A1)(dui:D009370;dis:Neoplasms by Histologic Type;g:CYP17A1)(dui:D011471;dis:Prostatic Neoplasms;g:CYP17A1)(dui:D002318;dis:Cardiovascular Diseases;g:CYP17A1)(dui:D004067;dis:Digestive System Neoplasms;g:CYP17A1)(dui:D014652;dis:Vascular Diseases;g:CYP17A1)(dui:D019636;dis:Neurodegenerative Diseases;g:CYP17A1)(dui:D006973;dis:Hypertension;g:CYP17A1)(dui:D009069;dis:Movement Disorders;g:CYP17A1)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:CYP17A1)(dui:D001523;dis:Mental Disorders;g:CYP17A1)(dui:D002277;dis:Carcinoma;g:CYP17A1)(dui:D010300;dis:Parkinson Disease;g:CYP17A1)(dui:D001480;dis:Basal Ganglia Diseases;g:CYP17A1)(dui:D020734;dis:Parkinsonian Disorders;g:CYP17A1)(dui:D000230;dis:Adenocarcinoma;g:CYP17A1)(dui:D008113;dis:Liver Neoplasms;g:CYP17A1)(dui:D007247;dis:Infertility, Female;g:CYP17A1)(dui:D020018;dis:Sexual Dysfunctions, Psychological;g:CYP17A1)(dui:D006528;dis:Carcinoma, Hepatocellular;g:CYP17A1)(dui:D007006;dis:Hypogonadism;g:CYP17A1)(dui:D007248;dis:Infertility, Male;g:CYP17A1)(dui:D010900;dis:Pituitary Diseases;g:CYP17A1)(dui:D005234;dis:Fatty Liver;g:CYP17A1)(dui:D007018;dis:Hypopituitarism;g:CYP17A1)(dui:D008103;dis:Liver Cirrhosis;g:CYP17A1)(dui:D014883;dis:Water-Electrolyte Imbalance;g:CYP17A1)(dui:D006947;dis:Hyperkalemia;g:CYP17A1)(dui:D006974;dis:Hypertension, Malignant;g:CYP17A1)(dui:D007027;dis:Hypothalamic Diseases;g:CYP17A1)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:CYP17A1)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:CYP17A1)	Stanolone:Dexamethasone:Ketoconazole:Nabiximols:Abiraterone:Medical Cannabis:Cannabidiol:Clomifene:Aldosterone:NADH:Spironolactone:Aminophenazone:Dexamethasone acetate:Progesterone:Prasterone	GO:0019825:GO:0042448:GO:0008202:GO:0005783:GO:0006694:GO:0043025:GO:0042446:GO:0020037:GO:0005789:GO:0006704:GO:0007548:GO:0006702:GO:0005506:GO:0004508:GO:0047442:GO:0055114:GO:0030424	609300	PF00067	0.26														M	
chr10:102835491	SNV	G	1	G/A	PASS	7.798301105232513e-103	1021.08		400	G=188,A=212	G=0.47,A=0.53	53.00	47.0	heterozygous	1	0.187	2		CYP17A1	NM_000102.4	CYP17A1:intronic:NM_000102.4	unknown			p.?	c.298-99C>T				A						rs4919687		(dui:D004700;dis:Endocrine System Diseases;g:CYP17A1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP17A1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP17A1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP17A1)(dui:D006058;dis:Gonadal Disorders;g:CYP17A1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP17A1)(dui:D008659;dis:Metabolic Diseases;g:CYP17A1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP17A1)(dui:D000013;dis:Congenital Abnormalities;g:CYP17A1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP17A1)(dui:D012734;dis:Disorders of Sex Development;g:CYP17A1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP17A1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP17A1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP17A1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP17A1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP17A1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP17A1)(dui:D009369;dis:Neoplasms;g:CYP17A1)(dui:D009371;dis:Neoplasms by Site;g:CYP17A1)(dui:D004066;dis:Digestive System Diseases;g:CYP17A1)(dui:D008107;dis:Liver Diseases;g:CYP17A1)(dui:D009422;dis:Nervous System Diseases;g:CYP17A1)(dui:D005831;dis:Genital Diseases, Female;g:CYP17A1)(dui:D005832;dis:Genital Diseases, Male;g:CYP17A1)(dui:D002493;dis:Central Nervous System Diseases;g:CYP17A1)(dui:D001927;dis:Brain Diseases;g:CYP17A1)(dui:D007246;dis:Infertility;g:CYP17A1)(dui:D014565;dis:Urogenital Neoplasms;g:CYP17A1)(dui:D010049;dis:Ovarian Diseases;g:CYP17A1)(dui:D000291;dis:Adnexal Diseases;g:CYP17A1)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CYP17A1)(dui:D011469;dis:Prostatic Diseases;g:CYP17A1)(dui:D012871;dis:Skin Diseases;g:CYP17A1)(dui:D001941;dis:Breast Diseases;g:CYP17A1)(dui:D003560;dis:Cysts;g:CYP17A1)(dui:D010048;dis:Ovarian Cysts;g:CYP17A1)(dui:D001943;dis:Breast Neoplasms;g:CYP17A1)(dui:D005834;dis:Genital Neoplasms, Male;g:CYP17A1)(dui:D009370;dis:Neoplasms by Histologic Type;g:CYP17A1)(dui:D011471;dis:Prostatic Neoplasms;g:CYP17A1)(dui:D002318;dis:Cardiovascular Diseases;g:CYP17A1)(dui:D004067;dis:Digestive System Neoplasms;g:CYP17A1)(dui:D014652;dis:Vascular Diseases;g:CYP17A1)(dui:D019636;dis:Neurodegenerative Diseases;g:CYP17A1)(dui:D006973;dis:Hypertension;g:CYP17A1)(dui:D009069;dis:Movement Disorders;g:CYP17A1)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:CYP17A1)(dui:D001523;dis:Mental Disorders;g:CYP17A1)(dui:D002277;dis:Carcinoma;g:CYP17A1)(dui:D010300;dis:Parkinson Disease;g:CYP17A1)(dui:D001480;dis:Basal Ganglia Diseases;g:CYP17A1)(dui:D020734;dis:Parkinsonian Disorders;g:CYP17A1)(dui:D000230;dis:Adenocarcinoma;g:CYP17A1)(dui:D008113;dis:Liver Neoplasms;g:CYP17A1)(dui:D007247;dis:Infertility, Female;g:CYP17A1)(dui:D020018;dis:Sexual Dysfunctions, Psychological;g:CYP17A1)(dui:D006528;dis:Carcinoma, Hepatocellular;g:CYP17A1)(dui:D007006;dis:Hypogonadism;g:CYP17A1)(dui:D007248;dis:Infertility, Male;g:CYP17A1)(dui:D010900;dis:Pituitary Diseases;g:CYP17A1)(dui:D005234;dis:Fatty Liver;g:CYP17A1)(dui:D007018;dis:Hypopituitarism;g:CYP17A1)(dui:D008103;dis:Liver Cirrhosis;g:CYP17A1)(dui:D014883;dis:Water-Electrolyte Imbalance;g:CYP17A1)(dui:D006947;dis:Hyperkalemia;g:CYP17A1)(dui:D006974;dis:Hypertension, Malignant;g:CYP17A1)(dui:D007027;dis:Hypothalamic Diseases;g:CYP17A1)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:CYP17A1)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:CYP17A1)	Stanolone:Dexamethasone:Ketoconazole:Nabiximols:Abiraterone:Medical Cannabis:Cannabidiol:Clomifene:Aldosterone:NADH:Spironolactone:Aminophenazone:Dexamethasone acetate:Progesterone:Prasterone	GO:0019825:GO:0042448:GO:0008202:GO:0005783:GO:0006694:GO:0043025:GO:0042446:GO:0020037:GO:0005789:GO:0006704:GO:0007548:GO:0006702:GO:0005506:GO:0004508:GO:0047442:GO:0055114:GO:0030424	609300	PF00067	0.95														M	
chr10:102837167	SNV	C	1	C/A	PASS	5.731918411587516e-73	722.417		294	C=141,A=153	C=0.4796,A=0.5204	52.04	47.96	heterozygous	1	0.41	2		CYP17A1	NM_000102.4	CYP17A1:exonic:NM_000102.4	synonymous	TCT	1	p.Ser65=	c.195G>T				A	GMAF=0.3833:AMAF=0.3616:EMAF=0.3944	0.17		Benign	3751499	rs6163		(dui:D004700;dis:Endocrine System Diseases;g:CYP17A1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP17A1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP17A1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP17A1)(dui:D006058;dis:Gonadal Disorders;g:CYP17A1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP17A1)(dui:D008659;dis:Metabolic Diseases;g:CYP17A1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP17A1)(dui:D000013;dis:Congenital Abnormalities;g:CYP17A1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP17A1)(dui:D012734;dis:Disorders of Sex Development;g:CYP17A1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP17A1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP17A1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP17A1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP17A1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP17A1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP17A1)(dui:D009369;dis:Neoplasms;g:CYP17A1)(dui:D009371;dis:Neoplasms by Site;g:CYP17A1)(dui:D004066;dis:Digestive System Diseases;g:CYP17A1)(dui:D008107;dis:Liver Diseases;g:CYP17A1)(dui:D009422;dis:Nervous System Diseases;g:CYP17A1)(dui:D005831;dis:Genital Diseases, Female;g:CYP17A1)(dui:D005832;dis:Genital Diseases, Male;g:CYP17A1)(dui:D002493;dis:Central Nervous System Diseases;g:CYP17A1)(dui:D001927;dis:Brain Diseases;g:CYP17A1)(dui:D007246;dis:Infertility;g:CYP17A1)(dui:D014565;dis:Urogenital Neoplasms;g:CYP17A1)(dui:D010049;dis:Ovarian Diseases;g:CYP17A1)(dui:D000291;dis:Adnexal Diseases;g:CYP17A1)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CYP17A1)(dui:D011469;dis:Prostatic Diseases;g:CYP17A1)(dui:D012871;dis:Skin Diseases;g:CYP17A1)(dui:D001941;dis:Breast Diseases;g:CYP17A1)(dui:D003560;dis:Cysts;g:CYP17A1)(dui:D010048;dis:Ovarian Cysts;g:CYP17A1)(dui:D001943;dis:Breast Neoplasms;g:CYP17A1)(dui:D005834;dis:Genital Neoplasms, Male;g:CYP17A1)(dui:D009370;dis:Neoplasms by Histologic Type;g:CYP17A1)(dui:D011471;dis:Prostatic Neoplasms;g:CYP17A1)(dui:D002318;dis:Cardiovascular Diseases;g:CYP17A1)(dui:D004067;dis:Digestive System Neoplasms;g:CYP17A1)(dui:D014652;dis:Vascular Diseases;g:CYP17A1)(dui:D019636;dis:Neurodegenerative Diseases;g:CYP17A1)(dui:D006973;dis:Hypertension;g:CYP17A1)(dui:D009069;dis:Movement Disorders;g:CYP17A1)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:CYP17A1)(dui:D001523;dis:Mental Disorders;g:CYP17A1)(dui:D002277;dis:Carcinoma;g:CYP17A1)(dui:D010300;dis:Parkinson Disease;g:CYP17A1)(dui:D001480;dis:Basal Ganglia Diseases;g:CYP17A1)(dui:D020734;dis:Parkinsonian Disorders;g:CYP17A1)(dui:D000230;dis:Adenocarcinoma;g:CYP17A1)(dui:D008113;dis:Liver Neoplasms;g:CYP17A1)(dui:D007247;dis:Infertility, Female;g:CYP17A1)(dui:D020018;dis:Sexual Dysfunctions, Psychological;g:CYP17A1)(dui:D006528;dis:Carcinoma, Hepatocellular;g:CYP17A1)(dui:D007006;dis:Hypogonadism;g:CYP17A1)(dui:D007248;dis:Infertility, Male;g:CYP17A1)(dui:D010900;dis:Pituitary Diseases;g:CYP17A1)(dui:D005234;dis:Fatty Liver;g:CYP17A1)(dui:D007018;dis:Hypopituitarism;g:CYP17A1)(dui:D008103;dis:Liver Cirrhosis;g:CYP17A1)(dui:D014883;dis:Water-Electrolyte Imbalance;g:CYP17A1)(dui:D006947;dis:Hyperkalemia;g:CYP17A1)(dui:D006974;dis:Hypertension, Malignant;g:CYP17A1)(dui:D007027;dis:Hypothalamic Diseases;g:CYP17A1)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:CYP17A1)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:CYP17A1)	Stanolone:Dexamethasone:Ketoconazole:Nabiximols:Abiraterone:Medical Cannabis:Cannabidiol:Clomifene:Aldosterone:NADH:Spironolactone:Aminophenazone:Dexamethasone acetate:Progesterone:Prasterone	GO:0019825:GO:0042448:GO:0008202:GO:0005783:GO:0006694:GO:0043025:GO:0042446:GO:0020037:GO:0005789:GO:0006704:GO:0007548:GO:0006702:GO:0005506:GO:0004508:GO:0047442:GO:0055114:GO:0030424	609300	PF00067	-0.04														M	
chr10:102837224	SNV	G	1	G/A	PASS	5.714786366718549e-107	1062.43		400	G=184,A=216	G=0.46,A=0.54	54.00	46.0	heterozygous	1	0.443	1		CYP17A1	NM_000102.4	CYP17A1:exonic:NM_000102.4	synonymous	CAT	1	p.His46=	c.138C>T				A	GMAF=0.3949:AMAF=0.3645:EMAF=0.4105	0.02		Benign	3751500	rs6162		(dui:D004700;dis:Endocrine System Diseases;g:CYP17A1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP17A1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP17A1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP17A1)(dui:D006058;dis:Gonadal Disorders;g:CYP17A1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP17A1)(dui:D008659;dis:Metabolic Diseases;g:CYP17A1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP17A1)(dui:D000013;dis:Congenital Abnormalities;g:CYP17A1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP17A1)(dui:D012734;dis:Disorders of Sex Development;g:CYP17A1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP17A1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP17A1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP17A1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP17A1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP17A1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP17A1)(dui:D009369;dis:Neoplasms;g:CYP17A1)(dui:D009371;dis:Neoplasms by Site;g:CYP17A1)(dui:D004066;dis:Digestive System Diseases;g:CYP17A1)(dui:D008107;dis:Liver Diseases;g:CYP17A1)(dui:D009422;dis:Nervous System Diseases;g:CYP17A1)(dui:D005831;dis:Genital Diseases, Female;g:CYP17A1)(dui:D005832;dis:Genital Diseases, Male;g:CYP17A1)(dui:D002493;dis:Central Nervous System Diseases;g:CYP17A1)(dui:D001927;dis:Brain Diseases;g:CYP17A1)(dui:D007246;dis:Infertility;g:CYP17A1)(dui:D014565;dis:Urogenital Neoplasms;g:CYP17A1)(dui:D010049;dis:Ovarian Diseases;g:CYP17A1)(dui:D000291;dis:Adnexal Diseases;g:CYP17A1)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CYP17A1)(dui:D011469;dis:Prostatic Diseases;g:CYP17A1)(dui:D012871;dis:Skin Diseases;g:CYP17A1)(dui:D001941;dis:Breast Diseases;g:CYP17A1)(dui:D003560;dis:Cysts;g:CYP17A1)(dui:D010048;dis:Ovarian Cysts;g:CYP17A1)(dui:D001943;dis:Breast Neoplasms;g:CYP17A1)(dui:D005834;dis:Genital Neoplasms, Male;g:CYP17A1)(dui:D009370;dis:Neoplasms by Histologic Type;g:CYP17A1)(dui:D011471;dis:Prostatic Neoplasms;g:CYP17A1)(dui:D002318;dis:Cardiovascular Diseases;g:CYP17A1)(dui:D004067;dis:Digestive System Neoplasms;g:CYP17A1)(dui:D014652;dis:Vascular Diseases;g:CYP17A1)(dui:D019636;dis:Neurodegenerative Diseases;g:CYP17A1)(dui:D006973;dis:Hypertension;g:CYP17A1)(dui:D009069;dis:Movement Disorders;g:CYP17A1)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:CYP17A1)(dui:D001523;dis:Mental Disorders;g:CYP17A1)(dui:D002277;dis:Carcinoma;g:CYP17A1)(dui:D010300;dis:Parkinson Disease;g:CYP17A1)(dui:D001480;dis:Basal Ganglia Diseases;g:CYP17A1)(dui:D020734;dis:Parkinsonian Disorders;g:CYP17A1)(dui:D000230;dis:Adenocarcinoma;g:CYP17A1)(dui:D008113;dis:Liver Neoplasms;g:CYP17A1)(dui:D007247;dis:Infertility, Female;g:CYP17A1)(dui:D020018;dis:Sexual Dysfunctions, Psychological;g:CYP17A1)(dui:D006528;dis:Carcinoma, Hepatocellular;g:CYP17A1)(dui:D007006;dis:Hypogonadism;g:CYP17A1)(dui:D007248;dis:Infertility, Male;g:CYP17A1)(dui:D010900;dis:Pituitary Diseases;g:CYP17A1)(dui:D005234;dis:Fatty Liver;g:CYP17A1)(dui:D007018;dis:Hypopituitarism;g:CYP17A1)(dui:D008103;dis:Liver Cirrhosis;g:CYP17A1)(dui:D014883;dis:Water-Electrolyte Imbalance;g:CYP17A1)(dui:D006947;dis:Hyperkalemia;g:CYP17A1)(dui:D006974;dis:Hypertension, Malignant;g:CYP17A1)(dui:D007027;dis:Hypothalamic Diseases;g:CYP17A1)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:CYP17A1)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:CYP17A1)	Stanolone:Dexamethasone:Ketoconazole:Nabiximols:Abiraterone:Medical Cannabis:Cannabidiol:Clomifene:Aldosterone:NADH:Spironolactone:Aminophenazone:Dexamethasone acetate:Progesterone:Prasterone	GO:0019825:GO:0042448:GO:0008202:GO:0005783:GO:0006694:GO:0043025:GO:0042446:GO:0020037:GO:0005789:GO:0006704:GO:0007548:GO:0006702:GO:0005506:GO:0004508:GO:0047442:GO:0055114:GO:0030424	609300	PF00067	-0.11														M	
chr10:102837395	SNV	A	1	A/G	PASS	3.7731146335839097e-79	784.233		400	A=213,G=187	A=0.5325,G=0.4675	46.75	53.25	heterozygous	1	0.41	1		CYP17A1	NM_000102.4	CYP17A1:utr_5:NM_000102.4	unknown		1	p.?	c.-34T>C				G	GMAF=0.3823:AMAF=0.3608:EMAF=0.3934			Benign		rs743572		(dui:D004700;dis:Endocrine System Diseases;g:CYP17A1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CYP17A1)(dui:D052776;dis:Female Urogenital Diseases;g:CYP17A1)(dui:D052801;dis:Male Urogenital Diseases;g:CYP17A1)(dui:D006058;dis:Gonadal Disorders;g:CYP17A1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CYP17A1)(dui:D008659;dis:Metabolic Diseases;g:CYP17A1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CYP17A1)(dui:D000013;dis:Congenital Abnormalities;g:CYP17A1)(dui:D014564;dis:Urogenital Abnormalities;g:CYP17A1)(dui:D012734;dis:Disorders of Sex Development;g:CYP17A1)(dui:D047808;dis:Adrenogenital Syndrome;g:CYP17A1)(dui:D000307;dis:Adrenal Gland Diseases;g:CYP17A1)(dui:D030342;dis:Genetic Diseases, Inborn;g:CYP17A1)(dui:D000312;dis:Adrenal Hyperplasia, Congenital;g:CYP17A1)(dui:D008661;dis:Metabolism, Inborn Errors;g:CYP17A1)(dui:D043202;dis:Steroid Metabolism, Inborn Errors;g:CYP17A1)(dui:D009369;dis:Neoplasms;g:CYP17A1)(dui:D009371;dis:Neoplasms by Site;g:CYP17A1)(dui:D004066;dis:Digestive System Diseases;g:CYP17A1)(dui:D008107;dis:Liver Diseases;g:CYP17A1)(dui:D009422;dis:Nervous System Diseases;g:CYP17A1)(dui:D005831;dis:Genital Diseases, Female;g:CYP17A1)(dui:D005832;dis:Genital Diseases, Male;g:CYP17A1)(dui:D002493;dis:Central Nervous System Diseases;g:CYP17A1)(dui:D001927;dis:Brain Diseases;g:CYP17A1)(dui:D007246;dis:Infertility;g:CYP17A1)(dui:D014565;dis:Urogenital Neoplasms;g:CYP17A1)(dui:D010049;dis:Ovarian Diseases;g:CYP17A1)(dui:D000291;dis:Adnexal Diseases;g:CYP17A1)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CYP17A1)(dui:D011469;dis:Prostatic Diseases;g:CYP17A1)(dui:D012871;dis:Skin Diseases;g:CYP17A1)(dui:D001941;dis:Breast Diseases;g:CYP17A1)(dui:D003560;dis:Cysts;g:CYP17A1)(dui:D010048;dis:Ovarian Cysts;g:CYP17A1)(dui:D001943;dis:Breast Neoplasms;g:CYP17A1)(dui:D005834;dis:Genital Neoplasms, Male;g:CYP17A1)(dui:D009370;dis:Neoplasms by Histologic Type;g:CYP17A1)(dui:D011471;dis:Prostatic Neoplasms;g:CYP17A1)(dui:D002318;dis:Cardiovascular Diseases;g:CYP17A1)(dui:D004067;dis:Digestive System Neoplasms;g:CYP17A1)(dui:D014652;dis:Vascular Diseases;g:CYP17A1)(dui:D019636;dis:Neurodegenerative Diseases;g:CYP17A1)(dui:D006973;dis:Hypertension;g:CYP17A1)(dui:D009069;dis:Movement Disorders;g:CYP17A1)(dui:D009375;dis:Neoplasms, Glandular and Epithelial;g:CYP17A1)(dui:D001523;dis:Mental Disorders;g:CYP17A1)(dui:D002277;dis:Carcinoma;g:CYP17A1)(dui:D010300;dis:Parkinson Disease;g:CYP17A1)(dui:D001480;dis:Basal Ganglia Diseases;g:CYP17A1)(dui:D020734;dis:Parkinsonian Disorders;g:CYP17A1)(dui:D000230;dis:Adenocarcinoma;g:CYP17A1)(dui:D008113;dis:Liver Neoplasms;g:CYP17A1)(dui:D007247;dis:Infertility, Female;g:CYP17A1)(dui:D020018;dis:Sexual Dysfunctions, Psychological;g:CYP17A1)(dui:D006528;dis:Carcinoma, Hepatocellular;g:CYP17A1)(dui:D007006;dis:Hypogonadism;g:CYP17A1)(dui:D007248;dis:Infertility, Male;g:CYP17A1)(dui:D010900;dis:Pituitary Diseases;g:CYP17A1)(dui:D005234;dis:Fatty Liver;g:CYP17A1)(dui:D007018;dis:Hypopituitarism;g:CYP17A1)(dui:D008103;dis:Liver Cirrhosis;g:CYP17A1)(dui:D014883;dis:Water-Electrolyte Imbalance;g:CYP17A1)(dui:D006947;dis:Hyperkalemia;g:CYP17A1)(dui:D006974;dis:Hypertension, Malignant;g:CYP17A1)(dui:D007027;dis:Hypothalamic Diseases;g:CYP17A1)(dui:D008106;dis:Liver Cirrhosis, Experimental;g:CYP17A1)(dui:D065626;dis:Non-alcoholic Fatty Liver Disease;g:CYP17A1)	Stanolone:Dexamethasone:Ketoconazole:Nabiximols:Abiraterone:Medical Cannabis:Cannabidiol:Clomifene:Aldosterone:NADH:Spironolactone:Aminophenazone:Dexamethasone acetate:Progesterone:Prasterone	GO:0019825:GO:0042448:GO:0008202:GO:0005783:GO:0006694:GO:0043025:GO:0042446:GO:0020037:GO:0005789:GO:0006704:GO:0007548:GO:0006702:GO:0005506:GO:0004508:GO:0047442:GO:0055114:GO:0030424	609300	PF00067	-0.52														M	
chr10:123041039	INDEL	AT	1	A/A	PASS	1.0543868963912496e-195	1949.77		359	AT=0,A=359	AT=0.0,A=1.0	100.00	0.0	homozygous	1	0.035	6		ACADSB	NM_001609.4	ACADSB:intronic:NM_001609.4	unknown			p.?	c.511-169delT				A						rs1589741386:rs11300559		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADSB)(dui:NBS3;dis:Secondary Conditions;g:ACADSB)(dui:NBS18;dis:2-Methylbutyrylglycinuria;g:ACADSB)(dui:NBS4;dis:Organic Acid Condition;g:ACADSB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADSB)(dui:D008659;dis:Metabolic Diseases;g:ACADSB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADSB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADSB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADSB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACADSB)(dui:D001523;dis:Mental Disorders;g:ACADSB)(dui:D065886;dis:Neurodevelopmental Disorders;g:ACADSB)(dui:D002659;dis:Child Development Disorders, Pervasive;g:ACADSB)(dui:D001321;dis:Autistic Disorder;g:ACADSB)	Valproic acid:Isoleucine	GO:0003853:GO:0042802:GO:0009083:GO:0005759:GO:0050660:GO:0016937:GO:0005739:GO:0102035:GO:0006550:GO:0055114:GO:0006631	600301		-0.13,0.0														M	
chr10:123041337	SNV	C	1	T/T	PASS	0.0	3993.52		399	C=0,T=399	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.228	1		ACADSB	NM_001609.4	ACADSB:exonic:NM_001609.4	synonymous	CAT	5	p.His213=	c.639C>T				T	GMAF=0.2281:AMAF=0.2156:EMAF=0.2345	0.02		Benign	3997809	rs1140591		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADSB)(dui:NBS3;dis:Secondary Conditions;g:ACADSB)(dui:NBS18;dis:2-Methylbutyrylglycinuria;g:ACADSB)(dui:NBS4;dis:Organic Acid Condition;g:ACADSB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADSB)(dui:D008659;dis:Metabolic Diseases;g:ACADSB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADSB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADSB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADSB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACADSB)(dui:D001523;dis:Mental Disorders;g:ACADSB)(dui:D065886;dis:Neurodevelopmental Disorders;g:ACADSB)(dui:D002659;dis:Child Development Disorders, Pervasive;g:ACADSB)(dui:D001321;dis:Autistic Disorder;g:ACADSB)	Valproic acid:Isoleucine	GO:0003853:GO:0042802:GO:0009083:GO:0005759:GO:0050660:GO:0016937:GO:0005739:GO:0102035:GO:0006550:GO:0055114:GO:0006631	600301		-1.56														M	
chr11:5226496	SNV	G	1	G/A	PASS	2.3944181728633653e-70	696.208		400	G=223,A=177	G=0.5575,A=0.4425	44.25	55.75	heterozygous	1	0.099	1		HBB	NM_000518.5	HBB:intronic:NM_000518.5	unknown			p.?	c.315+81C>T				A				Benign		rs7946748		(dui:D006425;dis:Hemic and Lymphatic Diseases;g:HBB)(dui:D006402;dis:Hematologic Diseases;g:HBB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HBB)(dui:D030342;dis:Genetic Diseases, Inborn;g:HBB)(dui:D000740;dis:Anemia;g:HBB)(dui:D000743;dis:Anemia, Hemolytic;g:HBB)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:HBB)(dui:D006453;dis:Hemoglobinopathies;g:HBB)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HBB)(dui:NBS13;dis:Hemoglobin Disorder;g:HBB)(dui:NBS2;dis:Core Conditions;g:HBB)(dui:NBS67;dis:Hb SS-disease (sickle cell anemia);g:HBB)(dui:NBS68;dis:Hb beta zero-thalassemia;g:HBB)(dui:D013789;dis:Thalassemia;g:HBB)(dui:D017086;dis:beta-Thalassemia;g:HBB)(dui:D000755;dis:Anemia, Sickle Cell;g:HBB)(dui:D017085;dis:alpha-Thalassemia;g:HBB)(dui:D055538;dis:delta-Thalassemia;g:HBB)(dui:D006450;dis:Hemoglobin SC Disease;g:HBB)(dui:D001855;dis:Bone Marrow Diseases;g:HBB)(dui:D009196;dis:Myeloproliferative Disorders;g:HBB)(dui:D006445;dis:Hemoglobin C Disease;g:HBB)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:HBB)(dui:D012871;dis:Skin Diseases;g:HBB)(dui:D011086;dis:Polycythemia;g:HBB)(dui:D008708;dis:Methemoglobinemia;g:HBB)(dui:D017486;dis:Acneiform Eruptions;g:HBB)(dui:D054506;dis:Chloracne;g:HBB)(dui:D011087;dis:Polycythemia Vera;g:HBB)	2,6-dicarboxynaphthalene:Sodium ferric gluconate complex:Oxygen:Zinc chloride:4-Carboxycinnamic Acid:2-[(2-methoxy-5-methylphenoxy)methyl]pyridine:2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID:Ferric pyrophosphate citrate:Pentaerythritol tetranitrate:Efaproxiral:Zinc sulfate, unspecified form:Zinc:Sebacic acid:Trimesic acid:Zinc acetate:Copper:Ferric pyrophosphate:Iron Dextran:4-[(5-methoxy-2-methylphenoxy)methyl]pyridine:Nitrous acid	GO:0045429:GO:0015671:GO:0030492:GO:0007596:GO:0005576:GO:1904813:GO:0070062:GO:0031838:GO:0072562:GO:0005829:GO:0015701:GO:0070527:GO:0019825:GO:0030185:GO:1904724:GO:0043177:GO:0043312:GO:0042542:GO:0005344:GO:0006898:GO:0008217:GO:0020037:GO:0042744:GO:0005833:GO:0004601:GO:0005615:GO:0005515:GO:0070293:GO:0046872:GO:0071682:GO:0098869:GO:0010942:GO:0031721:GO:0031720	141900	PF00042	-0.45														M	
chr11:5226503	SNV	A	1	A/C	PASS	5.701642722807478e-107	1062.44		400	A=184,C=216	A=0.46,C=0.54	54.00	46.0	heterozygous	1	0.369	1		HBB	NM_000518.5	HBB:intronic:NM_000518.5	unknown			p.?	c.315+74T>G				C				Benign		rs7480526		(dui:D006425;dis:Hemic and Lymphatic Diseases;g:HBB)(dui:D006402;dis:Hematologic Diseases;g:HBB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HBB)(dui:D030342;dis:Genetic Diseases, Inborn;g:HBB)(dui:D000740;dis:Anemia;g:HBB)(dui:D000743;dis:Anemia, Hemolytic;g:HBB)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:HBB)(dui:D006453;dis:Hemoglobinopathies;g:HBB)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HBB)(dui:NBS13;dis:Hemoglobin Disorder;g:HBB)(dui:NBS2;dis:Core Conditions;g:HBB)(dui:NBS67;dis:Hb SS-disease (sickle cell anemia);g:HBB)(dui:NBS68;dis:Hb beta zero-thalassemia;g:HBB)(dui:D013789;dis:Thalassemia;g:HBB)(dui:D017086;dis:beta-Thalassemia;g:HBB)(dui:D000755;dis:Anemia, Sickle Cell;g:HBB)(dui:D017085;dis:alpha-Thalassemia;g:HBB)(dui:D055538;dis:delta-Thalassemia;g:HBB)(dui:D006450;dis:Hemoglobin SC Disease;g:HBB)(dui:D001855;dis:Bone Marrow Diseases;g:HBB)(dui:D009196;dis:Myeloproliferative Disorders;g:HBB)(dui:D006445;dis:Hemoglobin C Disease;g:HBB)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:HBB)(dui:D012871;dis:Skin Diseases;g:HBB)(dui:D011086;dis:Polycythemia;g:HBB)(dui:D008708;dis:Methemoglobinemia;g:HBB)(dui:D017486;dis:Acneiform Eruptions;g:HBB)(dui:D054506;dis:Chloracne;g:HBB)(dui:D011087;dis:Polycythemia Vera;g:HBB)	2,6-dicarboxynaphthalene:Sodium ferric gluconate complex:Oxygen:Zinc chloride:4-Carboxycinnamic Acid:2-[(2-methoxy-5-methylphenoxy)methyl]pyridine:2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID:Ferric pyrophosphate citrate:Pentaerythritol tetranitrate:Efaproxiral:Zinc sulfate, unspecified form:Zinc:Sebacic acid:Trimesic acid:Zinc acetate:Copper:Ferric pyrophosphate:Iron Dextran:4-[(5-methoxy-2-methylphenoxy)methyl]pyridine:Nitrous acid	GO:0045429:GO:0015671:GO:0030492:GO:0007596:GO:0005576:GO:1904813:GO:0070062:GO:0031838:GO:0072562:GO:0005829:GO:0015701:GO:0070527:GO:0019825:GO:0030185:GO:1904724:GO:0043177:GO:0043312:GO:0042542:GO:0005344:GO:0006898:GO:0008217:GO:0020037:GO:0042744:GO:0005833:GO:0004601:GO:0005615:GO:0005515:GO:0070293:GO:0046872:GO:0071682:GO:0098869:GO:0010942:GO:0031721:GO:0031720	141900	PF00042	0.17														M	
chr11:5226561	SNV	C	1	C/G	PASS	3.8779303087618206e-97	964.114		398	C=192,G=206	C=0.4824,G=0.5176	51.76	48.24	heterozygous	1	0.28	1		HBB	NM_000518.5	HBB:intronic:NM_000518.5	unknown			p.?	c.315+16G>C				G	GMAF=0.1491:AMAF=0.1297:EMAF=0.159			Benign/Likely benign		rs10768683		(dui:D006425;dis:Hemic and Lymphatic Diseases;g:HBB)(dui:D006402;dis:Hematologic Diseases;g:HBB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HBB)(dui:D030342;dis:Genetic Diseases, Inborn;g:HBB)(dui:D000740;dis:Anemia;g:HBB)(dui:D000743;dis:Anemia, Hemolytic;g:HBB)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:HBB)(dui:D006453;dis:Hemoglobinopathies;g:HBB)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HBB)(dui:NBS13;dis:Hemoglobin Disorder;g:HBB)(dui:NBS2;dis:Core Conditions;g:HBB)(dui:NBS67;dis:Hb SS-disease (sickle cell anemia);g:HBB)(dui:NBS68;dis:Hb beta zero-thalassemia;g:HBB)(dui:D013789;dis:Thalassemia;g:HBB)(dui:D017086;dis:beta-Thalassemia;g:HBB)(dui:D000755;dis:Anemia, Sickle Cell;g:HBB)(dui:D017085;dis:alpha-Thalassemia;g:HBB)(dui:D055538;dis:delta-Thalassemia;g:HBB)(dui:D006450;dis:Hemoglobin SC Disease;g:HBB)(dui:D001855;dis:Bone Marrow Diseases;g:HBB)(dui:D009196;dis:Myeloproliferative Disorders;g:HBB)(dui:D006445;dis:Hemoglobin C Disease;g:HBB)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:HBB)(dui:D012871;dis:Skin Diseases;g:HBB)(dui:D011086;dis:Polycythemia;g:HBB)(dui:D008708;dis:Methemoglobinemia;g:HBB)(dui:D017486;dis:Acneiform Eruptions;g:HBB)(dui:D054506;dis:Chloracne;g:HBB)(dui:D011087;dis:Polycythemia Vera;g:HBB)	2,6-dicarboxynaphthalene:Sodium ferric gluconate complex:Oxygen:Zinc chloride:4-Carboxycinnamic Acid:2-[(2-methoxy-5-methylphenoxy)methyl]pyridine:2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID:Ferric pyrophosphate citrate:Pentaerythritol tetranitrate:Efaproxiral:Zinc sulfate, unspecified form:Zinc:Sebacic acid:Trimesic acid:Zinc acetate:Copper:Ferric pyrophosphate:Iron Dextran:4-[(5-methoxy-2-methylphenoxy)methyl]pyridine:Nitrous acid	GO:0045429:GO:0015671:GO:0030492:GO:0007596:GO:0005576:GO:1904813:GO:0070062:GO:0031838:GO:0072562:GO:0005829:GO:0015701:GO:0070527:GO:0019825:GO:0030185:GO:1904724:GO:0043177:GO:0043312:GO:0042542:GO:0005344:GO:0006898:GO:0008217:GO:0020037:GO:0042744:GO:0005833:GO:0004601:GO:0005615:GO:0005515:GO:0070293:GO:0046872:GO:0071682:GO:0098869:GO:0010942:GO:0031721:GO:0031720	141900	PF00042	-3.19														M	
chr11:5227013	SNV	A	1	A/G	PASS	7.90678627999818e-85	841.02		399	A=206,G=193	A=0.5163,G=0.4837	48.37	51.63	heterozygous	1	0.286	1		HBB	NM_000518.5	HBB:exonic:NM_000518.5	synonymous	CAC	1	p.His3=	c.9T>C				G	GMAF=0.1513:AMAF=0.1361:EMAF=0.1591	0.1		Benign	6484194	rs713040:rs63750898:rs63750407		(dui:D006425;dis:Hemic and Lymphatic Diseases;g:HBB)(dui:D006402;dis:Hematologic Diseases;g:HBB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:HBB)(dui:D030342;dis:Genetic Diseases, Inborn;g:HBB)(dui:D000740;dis:Anemia;g:HBB)(dui:D000743;dis:Anemia, Hemolytic;g:HBB)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:HBB)(dui:D006453;dis:Hemoglobinopathies;g:HBB)(dui:NBS1;dis:Recommended Newborn Screening Panels;g:HBB)(dui:NBS13;dis:Hemoglobin Disorder;g:HBB)(dui:NBS2;dis:Core Conditions;g:HBB)(dui:NBS67;dis:Hb SS-disease (sickle cell anemia);g:HBB)(dui:NBS68;dis:Hb beta zero-thalassemia;g:HBB)(dui:D013789;dis:Thalassemia;g:HBB)(dui:D017086;dis:beta-Thalassemia;g:HBB)(dui:D000755;dis:Anemia, Sickle Cell;g:HBB)(dui:D017085;dis:alpha-Thalassemia;g:HBB)(dui:D055538;dis:delta-Thalassemia;g:HBB)(dui:D006450;dis:Hemoglobin SC Disease;g:HBB)(dui:D001855;dis:Bone Marrow Diseases;g:HBB)(dui:D009196;dis:Myeloproliferative Disorders;g:HBB)(dui:D006445;dis:Hemoglobin C Disease;g:HBB)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:HBB)(dui:D012871;dis:Skin Diseases;g:HBB)(dui:D011086;dis:Polycythemia;g:HBB)(dui:D008708;dis:Methemoglobinemia;g:HBB)(dui:D017486;dis:Acneiform Eruptions;g:HBB)(dui:D054506;dis:Chloracne;g:HBB)(dui:D011087;dis:Polycythemia Vera;g:HBB)	2,6-dicarboxynaphthalene:Sodium ferric gluconate complex:Oxygen:Zinc chloride:4-Carboxycinnamic Acid:2-[(2-methoxy-5-methylphenoxy)methyl]pyridine:2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID:Ferric pyrophosphate citrate:Pentaerythritol tetranitrate:Efaproxiral:Zinc sulfate, unspecified form:Zinc:Sebacic acid:Trimesic acid:Zinc acetate:Copper:Ferric pyrophosphate:Iron Dextran:4-[(5-methoxy-2-methylphenoxy)methyl]pyridine:Nitrous acid	GO:0045429:GO:0015671:GO:0030492:GO:0007596:GO:0005576:GO:1904813:GO:0070062:GO:0031838:GO:0072562:GO:0005829:GO:0015701:GO:0070527:GO:0019825:GO:0030185:GO:1904724:GO:0043177:GO:0043312:GO:0042542:GO:0005344:GO:0006898:GO:0008217:GO:0020037:GO:0042744:GO:0005833:GO:0004601:GO:0005615:GO:0005515:GO:0070293:GO:0046872:GO:0071682:GO:0098869:GO:0010942:GO:0031721:GO:0031720	141900	PF00042	-0.89														M	
chr11:68760132	SNV	G	1	A/A	PASS	3.013006024186017e-308	3075.21		349	G=1,A=348	G=0.0029,A=0.9971	99.71	0.29000000000000625	homozygous	1	0.338	5		CPT1A	NM_001876.4	CPT1A:intronic:NM_001876.4	unknown			p.?	c.2142+93C>T				A						rs3019598		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CPT1A)(dui:NBS3;dis:Secondary Conditions;g:CPT1A)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:CPT1A)(dui:NBS27;dis:Carnitine palmitoyltransferase I deficiency;g:CPT1A)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CPT1A)(dui:D008659;dis:Metabolic Diseases;g:CPT1A)(dui:D044882;dis:Glucose Metabolism Disorders;g:CPT1A)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CPT1A)(dui:D030342;dis:Genetic Diseases, Inborn;g:CPT1A)(dui:D008661;dis:Metabolism, Inborn Errors;g:CPT1A)(dui:D052439;dis:Lipid Metabolism Disorders;g:CPT1A)(dui:D007003;dis:Hypoglycemia;g:CPT1A)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:CPT1A)(dui:D004700;dis:Endocrine System Diseases;g:CPT1A)(dui:D003920;dis:Diabetes Mellitus;g:CPT1A)(dui:D003924;dis:Diabetes Mellitus, Type 2;g:CPT1A)(dui:D009369;dis:Neoplasms;g:CPT1A)(dui:D052801;dis:Male Urogenital Diseases;g:CPT1A)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CPT1A)(dui:D014570;dis:Urologic Diseases;g:CPT1A)(dui:D052776;dis:Female Urogenital Diseases;g:CPT1A)(dui:D007674;dis:Kidney Diseases;g:CPT1A)(dui:D051437;dis:Renal Insufficiency;g:CPT1A)(dui:D051436;dis:Renal Insufficiency, Chronic;g:CPT1A)(dui:D007676;dis:Kidney Failure, Chronic;g:CPT1A)(dui:D009371;dis:Neoplasms by Site;g:CPT1A)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CPT1A)(dui:D012871;dis:Skin Diseases;g:CPT1A)(dui:D001941;dis:Breast Diseases;g:CPT1A)(dui:D001943;dis:Breast Neoplasms;g:CPT1A)(dui:D003921;dis:Diabetes Mellitus, Experimental;g:CPT1A)	Glyburide:Perhexiline:Levocarnitine	GO:0006641:GO:0006006:GO:0009437:GO:0042755:GO:0045471:GO:0050796:GO:0006635:GO:0071398:GO:0042802:GO:0032000:GO:0004095:GO:0014070:GO:0005741:GO:0006853:GO:0007623:GO:0006631:GO:0030855:GO:0031307:GO:0001676:GO:1990698:GO:0042493:GO:0005739:GO:0016020:GO:0019216:GO:0010883	600528	PF00755:PF16484	-0.34														M	
chr11:68781872	SNV	A	1	G/G	PASS	0.0	3605.79		400	A=14,G=386	A=0.035,G=0.965	96.50	3.5	homozygous	1	0.107	3		CPT1A	NM_001876.4	CPT1A:exonic:NM_001876.4	synonymous	TTC	11	p.Phe417=	c.1251T>C				G	GMAF=0.088:AMAF=0.153:EMAF=0.0547			Benign		rs755361411:rs2228502		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CPT1A)(dui:NBS3;dis:Secondary Conditions;g:CPT1A)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:CPT1A)(dui:NBS27;dis:Carnitine palmitoyltransferase I deficiency;g:CPT1A)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CPT1A)(dui:D008659;dis:Metabolic Diseases;g:CPT1A)(dui:D044882;dis:Glucose Metabolism Disorders;g:CPT1A)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CPT1A)(dui:D030342;dis:Genetic Diseases, Inborn;g:CPT1A)(dui:D008661;dis:Metabolism, Inborn Errors;g:CPT1A)(dui:D052439;dis:Lipid Metabolism Disorders;g:CPT1A)(dui:D007003;dis:Hypoglycemia;g:CPT1A)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:CPT1A)(dui:D004700;dis:Endocrine System Diseases;g:CPT1A)(dui:D003920;dis:Diabetes Mellitus;g:CPT1A)(dui:D003924;dis:Diabetes Mellitus, Type 2;g:CPT1A)(dui:D009369;dis:Neoplasms;g:CPT1A)(dui:D052801;dis:Male Urogenital Diseases;g:CPT1A)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CPT1A)(dui:D014570;dis:Urologic Diseases;g:CPT1A)(dui:D052776;dis:Female Urogenital Diseases;g:CPT1A)(dui:D007674;dis:Kidney Diseases;g:CPT1A)(dui:D051437;dis:Renal Insufficiency;g:CPT1A)(dui:D051436;dis:Renal Insufficiency, Chronic;g:CPT1A)(dui:D007676;dis:Kidney Failure, Chronic;g:CPT1A)(dui:D009371;dis:Neoplasms by Site;g:CPT1A)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CPT1A)(dui:D012871;dis:Skin Diseases;g:CPT1A)(dui:D001941;dis:Breast Diseases;g:CPT1A)(dui:D001943;dis:Breast Neoplasms;g:CPT1A)(dui:D003921;dis:Diabetes Mellitus, Experimental;g:CPT1A)	Glyburide:Perhexiline:Levocarnitine	GO:0006641:GO:0006006:GO:0009437:GO:0042755:GO:0045471:GO:0050796:GO:0006635:GO:0071398:GO:0042802:GO:0032000:GO:0004095:GO:0014070:GO:0005741:GO:0006853:GO:0007623:GO:0006631:GO:0030855:GO:0031307:GO:0001676:GO:1990698:GO:0042493:GO:0005739:GO:0016020:GO:0019216:GO:0010883	600528	PF00755:PF16484	0.3														M	
chr11:68793312	SNV	C	1	C/T	PASS	3.6441815078885976e-88	874.384		395	C=200,T=195	C=0.5063,T=0.4937	49.37	50.63	heterozygous	1	0.038	1		CPT1A	NM_001876.4	CPT1A:intronic:NM_001876.4	unknown			p.?	c.967+3G>A				T	GMAF=0.0127:AMAF=0.0068:EMAF=0.0157			Benign		rs75677837		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CPT1A)(dui:NBS3;dis:Secondary Conditions;g:CPT1A)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:CPT1A)(dui:NBS27;dis:Carnitine palmitoyltransferase I deficiency;g:CPT1A)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CPT1A)(dui:D008659;dis:Metabolic Diseases;g:CPT1A)(dui:D044882;dis:Glucose Metabolism Disorders;g:CPT1A)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CPT1A)(dui:D030342;dis:Genetic Diseases, Inborn;g:CPT1A)(dui:D008661;dis:Metabolism, Inborn Errors;g:CPT1A)(dui:D052439;dis:Lipid Metabolism Disorders;g:CPT1A)(dui:D007003;dis:Hypoglycemia;g:CPT1A)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:CPT1A)(dui:D004700;dis:Endocrine System Diseases;g:CPT1A)(dui:D003920;dis:Diabetes Mellitus;g:CPT1A)(dui:D003924;dis:Diabetes Mellitus, Type 2;g:CPT1A)(dui:D009369;dis:Neoplasms;g:CPT1A)(dui:D052801;dis:Male Urogenital Diseases;g:CPT1A)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CPT1A)(dui:D014570;dis:Urologic Diseases;g:CPT1A)(dui:D052776;dis:Female Urogenital Diseases;g:CPT1A)(dui:D007674;dis:Kidney Diseases;g:CPT1A)(dui:D051437;dis:Renal Insufficiency;g:CPT1A)(dui:D051436;dis:Renal Insufficiency, Chronic;g:CPT1A)(dui:D007676;dis:Kidney Failure, Chronic;g:CPT1A)(dui:D009371;dis:Neoplasms by Site;g:CPT1A)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CPT1A)(dui:D012871;dis:Skin Diseases;g:CPT1A)(dui:D001941;dis:Breast Diseases;g:CPT1A)(dui:D001943;dis:Breast Neoplasms;g:CPT1A)(dui:D003921;dis:Diabetes Mellitus, Experimental;g:CPT1A)	Glyburide:Perhexiline:Levocarnitine	GO:0006641:GO:0006006:GO:0009437:GO:0042755:GO:0045471:GO:0050796:GO:0006635:GO:0071398:GO:0042802:GO:0032000:GO:0004095:GO:0014070:GO:0005741:GO:0006853:GO:0007623:GO:0006631:GO:0030855:GO:0031307:GO:0001676:GO:1990698:GO:0042493:GO:0005739:GO:0016020:GO:0019216:GO:0010883	600528	PF00755:PF16484	3.19														M	
chr11:68799181	MNV	AAA	3	GCT/GCT	PASS	1.0641920249497412e-09	89.7298		9	AAA=0,GCT=9	AAA=0.0,GCT=1.0	100.00	0.0	0	1	0.436:0.281:0.157	5		CPT1A	NM_001876.4	CPT1A:intronic:NM_001876.4	unknown			p.?	c.693+35_693+37delinsAGC				GCT						rs61887062:rs373853770:rs61887064:rs200844352:rs67266031:rs1302471537:rs61887063:rs1555230749:rs371123694:rs753779449:rs776600347		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:CPT1A)(dui:NBS3;dis:Secondary Conditions;g:CPT1A)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:CPT1A)(dui:NBS27;dis:Carnitine palmitoyltransferase I deficiency;g:CPT1A)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:CPT1A)(dui:D008659;dis:Metabolic Diseases;g:CPT1A)(dui:D044882;dis:Glucose Metabolism Disorders;g:CPT1A)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:CPT1A)(dui:D030342;dis:Genetic Diseases, Inborn;g:CPT1A)(dui:D008661;dis:Metabolism, Inborn Errors;g:CPT1A)(dui:D052439;dis:Lipid Metabolism Disorders;g:CPT1A)(dui:D007003;dis:Hypoglycemia;g:CPT1A)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:CPT1A)(dui:D004700;dis:Endocrine System Diseases;g:CPT1A)(dui:D003920;dis:Diabetes Mellitus;g:CPT1A)(dui:D003924;dis:Diabetes Mellitus, Type 2;g:CPT1A)(dui:D009369;dis:Neoplasms;g:CPT1A)(dui:D052801;dis:Male Urogenital Diseases;g:CPT1A)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:CPT1A)(dui:D014570;dis:Urologic Diseases;g:CPT1A)(dui:D052776;dis:Female Urogenital Diseases;g:CPT1A)(dui:D007674;dis:Kidney Diseases;g:CPT1A)(dui:D051437;dis:Renal Insufficiency;g:CPT1A)(dui:D051436;dis:Renal Insufficiency, Chronic;g:CPT1A)(dui:D007676;dis:Kidney Failure, Chronic;g:CPT1A)(dui:D009371;dis:Neoplasms by Site;g:CPT1A)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:CPT1A)(dui:D012871;dis:Skin Diseases;g:CPT1A)(dui:D001941;dis:Breast Diseases;g:CPT1A)(dui:D001943;dis:Breast Neoplasms;g:CPT1A)(dui:D003921;dis:Diabetes Mellitus, Experimental;g:CPT1A)	Glyburide:Perhexiline:Levocarnitine	GO:0006641:GO:0006006:GO:0009437:GO:0042755:GO:0045471:GO:0050796:GO:0006635:GO:0071398:GO:0042802:GO:0032000:GO:0004095:GO:0014070:GO:0005741:GO:0006853:GO:0007623:GO:0006631:GO:0030855:GO:0031307:GO:0001676:GO:1990698:GO:0042493:GO:0005739:GO:0016020:GO:0019216:GO:0010883	600528	PF00755:PF16484	0.35,0.91,0.14														M	
chr11:108121585	SNV	C	1	C/G	PASS	6.452083809019614e-97	961.903		400	C=194,G=206	C=0.485,G=0.515	51.50	48.5	heterozygous	1	0.095	2		ACAT1	NM_000019.4	ACAT1:utr_5:NM_000019.4	unknown		1	p.?	c.-22C>G				G	GMAF=0.1296:AMAF=0.0849:EMAF=0.1527			Benign		rs3741054		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACAT1)(dui:NBS2;dis:Core Conditions;g:ACAT1)(dui:NBS48;dis:beta-Ketothiolase deficiency;g:ACAT1)(dui:NBS9;dis:Organic Acid Condition;g:ACAT1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACAT1)(dui:D008659;dis:Metabolic Diseases;g:ACAT1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACAT1)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACAT1)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACAT1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACAT1)(dui:D052801;dis:Male Urogenital Diseases;g:ACAT1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:ACAT1)(dui:D014570;dis:Urologic Diseases;g:ACAT1)(dui:D052776;dis:Female Urogenital Diseases;g:ACAT1)(dui:D007674;dis:Kidney Diseases;g:ACAT1)(dui:D051437;dis:Renal Insufficiency;g:ACAT1)(dui:D051436;dis:Renal Insufficiency, Chronic;g:ACAT1)(dui:D007676;dis:Kidney Failure, Chronic;g:ACAT1)(dui:D009422;dis:Nervous System Diseases;g:ACAT1)(dui:D002493;dis:Central Nervous System Diseases;g:ACAT1)(dui:D001927;dis:Brain Diseases;g:ACAT1)(dui:D009461;dis:Neurologic Manifestations;g:ACAT1)(dui:D012640;dis:Seizures;g:ACAT1)(dui:D004827;dis:Epilepsy;g:ACAT1)	Nabiximols:Sulfasalazine:Medical Cannabis:Cannabidiol	GO:0006085:GO:0042594:GO:0046952:GO:0046356:GO:0046951:GO:0003985:GO:0006635:GO:0070062:GO:0003988:GO:0001889:GO:0016453:GO:0072229:GO:0042802:GO:0009083:GO:1902860:GO:0006550:GO:1902224:GO:0007420:GO:0014070:GO:0009725:GO:0060612:GO:0030955:GO:0005759:GO:0005739:GO:0015937:GO:0034435:GO:0015936:GO:0019899	607809	PF02803:PF00108:PF00109	-1.57														M	
chr11:108121598	SNV	T	1	T/A	PASS	2.775875603534323e-79	785.566		395	T=209,A=186	T=0.5291,A=0.4709	47.09	52.91	heterozygous	1	0.314	1		ACAT1	NM_000019.4	ACAT1:utr_5:NM_000019.4	unknown		1	p.?	c.-9T>A				A	GMAF=0.1976:AMAF=0.0792:EMAF=0.2582			Benign		rs3741055:rs34512802		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACAT1)(dui:NBS2;dis:Core Conditions;g:ACAT1)(dui:NBS48;dis:beta-Ketothiolase deficiency;g:ACAT1)(dui:NBS9;dis:Organic Acid Condition;g:ACAT1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACAT1)(dui:D008659;dis:Metabolic Diseases;g:ACAT1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACAT1)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACAT1)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACAT1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACAT1)(dui:D052801;dis:Male Urogenital Diseases;g:ACAT1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:ACAT1)(dui:D014570;dis:Urologic Diseases;g:ACAT1)(dui:D052776;dis:Female Urogenital Diseases;g:ACAT1)(dui:D007674;dis:Kidney Diseases;g:ACAT1)(dui:D051437;dis:Renal Insufficiency;g:ACAT1)(dui:D051436;dis:Renal Insufficiency, Chronic;g:ACAT1)(dui:D007676;dis:Kidney Failure, Chronic;g:ACAT1)(dui:D009422;dis:Nervous System Diseases;g:ACAT1)(dui:D002493;dis:Central Nervous System Diseases;g:ACAT1)(dui:D001927;dis:Brain Diseases;g:ACAT1)(dui:D009461;dis:Neurologic Manifestations;g:ACAT1)(dui:D012640;dis:Seizures;g:ACAT1)(dui:D004827;dis:Epilepsy;g:ACAT1)	Nabiximols:Sulfasalazine:Medical Cannabis:Cannabidiol	GO:0006085:GO:0042594:GO:0046952:GO:0046356:GO:0046951:GO:0003985:GO:0006635:GO:0070062:GO:0003988:GO:0001889:GO:0016453:GO:0072229:GO:0042802:GO:0009083:GO:1902860:GO:0006550:GO:1902224:GO:0007420:GO:0014070:GO:0009725:GO:0060612:GO:0030955:GO:0005759:GO:0005739:GO:0015937:GO:0034435:GO:0015936:GO:0019899	607809	PF02803:PF00108:PF00109	-1.31														M	
chr11:108121619	SNV	G	1	G/C	PASS	1.0282530348811046e-79	789.879		400	G=212,C=188	G=0.53,C=0.47	47.00	53.0	heterozygous	1	0.332	2		ACAT1	NM_000019.4	ACAT1:exonic:NM_000019.4	missense	CCG	1	p.Ala5Pro	c.13G>C	0.01	0.61	27.0	C	GMAF=0.2097:AMAF=0.1224:EMAF=0.2544	0.24		Benign	3752118	rs3741056:rs1591350265		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACAT1)(dui:NBS2;dis:Core Conditions;g:ACAT1)(dui:NBS48;dis:beta-Ketothiolase deficiency;g:ACAT1)(dui:NBS9;dis:Organic Acid Condition;g:ACAT1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACAT1)(dui:D008659;dis:Metabolic Diseases;g:ACAT1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACAT1)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACAT1)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACAT1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACAT1)(dui:D052801;dis:Male Urogenital Diseases;g:ACAT1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:ACAT1)(dui:D014570;dis:Urologic Diseases;g:ACAT1)(dui:D052776;dis:Female Urogenital Diseases;g:ACAT1)(dui:D007674;dis:Kidney Diseases;g:ACAT1)(dui:D051437;dis:Renal Insufficiency;g:ACAT1)(dui:D051436;dis:Renal Insufficiency, Chronic;g:ACAT1)(dui:D007676;dis:Kidney Failure, Chronic;g:ACAT1)(dui:D009422;dis:Nervous System Diseases;g:ACAT1)(dui:D002493;dis:Central Nervous System Diseases;g:ACAT1)(dui:D001927;dis:Brain Diseases;g:ACAT1)(dui:D009461;dis:Neurologic Manifestations;g:ACAT1)(dui:D012640;dis:Seizures;g:ACAT1)(dui:D004827;dis:Epilepsy;g:ACAT1)	Nabiximols:Sulfasalazine:Medical Cannabis:Cannabidiol	GO:0006085:GO:0042594:GO:0046952:GO:0046356:GO:0046951:GO:0003985:GO:0006635:GO:0070062:GO:0003988:GO:0001889:GO:0016453:GO:0072229:GO:0042802:GO:0009083:GO:1902860:GO:0006550:GO:1902224:GO:0007420:GO:0014070:GO:0009725:GO:0060612:GO:0030955:GO:0005759:GO:0005739:GO:0015937:GO:0034435:GO:0015936:GO:0019899	607809	PF02803:PF00108:PF00109	-0.17														M	
chr11:108138933	SNV	C	1	C/A	PASS	3.38298443797595e-90	894.707		400	C=201,A=199	C=0.5025,A=0.4975	49.75	50.25	heterozygous	1	0.127	2		ACAT1	NM_000019.4	ACAT1:exonic:NM_000019.4	synonymous	TCA	6	p.Ser157=	c.471C>A				A	GMAF=0.1818:AMAF=0.1958:EMAF=0.1746	0.83		Benign	1350699	rs1591367422:rs35188041		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACAT1)(dui:NBS2;dis:Core Conditions;g:ACAT1)(dui:NBS48;dis:beta-Ketothiolase deficiency;g:ACAT1)(dui:NBS9;dis:Organic Acid Condition;g:ACAT1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACAT1)(dui:D008659;dis:Metabolic Diseases;g:ACAT1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACAT1)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACAT1)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACAT1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACAT1)(dui:D052801;dis:Male Urogenital Diseases;g:ACAT1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:ACAT1)(dui:D014570;dis:Urologic Diseases;g:ACAT1)(dui:D052776;dis:Female Urogenital Diseases;g:ACAT1)(dui:D007674;dis:Kidney Diseases;g:ACAT1)(dui:D051437;dis:Renal Insufficiency;g:ACAT1)(dui:D051436;dis:Renal Insufficiency, Chronic;g:ACAT1)(dui:D007676;dis:Kidney Failure, Chronic;g:ACAT1)(dui:D009422;dis:Nervous System Diseases;g:ACAT1)(dui:D002493;dis:Central Nervous System Diseases;g:ACAT1)(dui:D001927;dis:Brain Diseases;g:ACAT1)(dui:D009461;dis:Neurologic Manifestations;g:ACAT1)(dui:D012640;dis:Seizures;g:ACAT1)(dui:D004827;dis:Epilepsy;g:ACAT1)	Nabiximols:Sulfasalazine:Medical Cannabis:Cannabidiol	GO:0006085:GO:0042594:GO:0046952:GO:0046356:GO:0046951:GO:0003985:GO:0006635:GO:0070062:GO:0003988:GO:0001889:GO:0016453:GO:0072229:GO:0042802:GO:0009083:GO:1902860:GO:0006550:GO:1902224:GO:0007420:GO:0014070:GO:0009725:GO:0060612:GO:0030955:GO:0005759:GO:0005739:GO:0015937:GO:0034435:GO:0015936:GO:0019899	607809	PF02803:PF00108:PF00109	0.17														M	
chr11:108142366	SNV	A	1	A/G	PASS	3.688926481189995e-98	974.331		399	A=192,G=207	A=0.4812,G=0.5188	51.88	48.12	heterozygous	1	0.191	1		ACAT1	NM_000019.4	ACAT1:intronic:NM_000019.4	unknown			p.?	c.827-71A>G				G						rs10890818		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACAT1)(dui:NBS2;dis:Core Conditions;g:ACAT1)(dui:NBS48;dis:beta-Ketothiolase deficiency;g:ACAT1)(dui:NBS9;dis:Organic Acid Condition;g:ACAT1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACAT1)(dui:D008659;dis:Metabolic Diseases;g:ACAT1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACAT1)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACAT1)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACAT1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACAT1)(dui:D052801;dis:Male Urogenital Diseases;g:ACAT1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:ACAT1)(dui:D014570;dis:Urologic Diseases;g:ACAT1)(dui:D052776;dis:Female Urogenital Diseases;g:ACAT1)(dui:D007674;dis:Kidney Diseases;g:ACAT1)(dui:D051437;dis:Renal Insufficiency;g:ACAT1)(dui:D051436;dis:Renal Insufficiency, Chronic;g:ACAT1)(dui:D007676;dis:Kidney Failure, Chronic;g:ACAT1)(dui:D009422;dis:Nervous System Diseases;g:ACAT1)(dui:D002493;dis:Central Nervous System Diseases;g:ACAT1)(dui:D001927;dis:Brain Diseases;g:ACAT1)(dui:D009461;dis:Neurologic Manifestations;g:ACAT1)(dui:D012640;dis:Seizures;g:ACAT1)(dui:D004827;dis:Epilepsy;g:ACAT1)	Nabiximols:Sulfasalazine:Medical Cannabis:Cannabidiol	GO:0006085:GO:0042594:GO:0046952:GO:0046356:GO:0046951:GO:0003985:GO:0006635:GO:0070062:GO:0003988:GO:0001889:GO:0016453:GO:0072229:GO:0042802:GO:0009083:GO:1902860:GO:0006550:GO:1902224:GO:0007420:GO:0014070:GO:0009725:GO:0060612:GO:0030955:GO:0005759:GO:0005739:GO:0015937:GO:0034435:GO:0015936:GO:0019899	607809	PF02803:PF00108:PF00109	-0.34														M	
chr11:108144072	SNV	C	1	C/T	PASS	9.038575706601892e-81	800.439		274	C=119,T=155	C=0.4343,T=0.5657	56.57	43.43	heterozygous	1	0.308	1		ACAT1	NM_000019.4	ACAT1:intronic:NM_000019.4	unknown			p.?	c.1005+25C>T				T	GMAF=0.2437:AMAF=0.0902:EMAF=0.3222					rs10890819		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACAT1)(dui:NBS2;dis:Core Conditions;g:ACAT1)(dui:NBS48;dis:beta-Ketothiolase deficiency;g:ACAT1)(dui:NBS9;dis:Organic Acid Condition;g:ACAT1)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACAT1)(dui:D008659;dis:Metabolic Diseases;g:ACAT1)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACAT1)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACAT1)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACAT1)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ACAT1)(dui:D052801;dis:Male Urogenital Diseases;g:ACAT1)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:ACAT1)(dui:D014570;dis:Urologic Diseases;g:ACAT1)(dui:D052776;dis:Female Urogenital Diseases;g:ACAT1)(dui:D007674;dis:Kidney Diseases;g:ACAT1)(dui:D051437;dis:Renal Insufficiency;g:ACAT1)(dui:D051436;dis:Renal Insufficiency, Chronic;g:ACAT1)(dui:D007676;dis:Kidney Failure, Chronic;g:ACAT1)(dui:D009422;dis:Nervous System Diseases;g:ACAT1)(dui:D002493;dis:Central Nervous System Diseases;g:ACAT1)(dui:D001927;dis:Brain Diseases;g:ACAT1)(dui:D009461;dis:Neurologic Manifestations;g:ACAT1)(dui:D012640;dis:Seizures;g:ACAT1)(dui:D004827;dis:Epilepsy;g:ACAT1)	Nabiximols:Sulfasalazine:Medical Cannabis:Cannabidiol	GO:0006085:GO:0042594:GO:0046952:GO:0046356:GO:0046951:GO:0003985:GO:0006635:GO:0070062:GO:0003988:GO:0001889:GO:0016453:GO:0072229:GO:0042802:GO:0009083:GO:1902860:GO:0006550:GO:1902224:GO:0007420:GO:0014070:GO:0009725:GO:0060612:GO:0030955:GO:0005759:GO:0005739:GO:0015937:GO:0034435:GO:0015936:GO:0019899	607809	PF02803:PF00108:PF00109	-0.31														M	
chr12:56004670	SNV	G	1	C/C	PASS	0.0	4002.86		400	G=0,C=400	G=0.0,C=1.0	100.00	0.0	homozygous	1	0.237	2		SUOX	NM_001032387.2	SUOX:exonic:NM_001032387.2	synonymous	TCC	4	p.Ser427=	c.1281G>C				C	GMAF=0.2642:AMAF=0.3768:EMAF=0.0802			Benign		rs1565799723:rs773115		(dui:D009750;dis:Nutritional and Metabolic Diseases;g:SUOX)(dui:D008659;dis:Metabolic Diseases;g:SUOX)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:SUOX)(dui:D030342;dis:Genetic Diseases, Inborn;g:SUOX)(dui:D008661;dis:Metabolism, Inborn Errors;g:SUOX)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:SUOX)(dui:D007154;dis:Immune System Diseases;g:SUOX)(dui:D004700;dis:Endocrine System Diseases;g:SUOX)(dui:D001327;dis:Autoimmune Diseases;g:SUOX)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:SUOX)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:SUOX)(dui:D009140;dis:Musculoskeletal Diseases;g:SUOX)(dui:D009369;dis:Neoplasms;g:SUOX)(dui:D003240;dis:Connective Tissue Diseases;g:SUOX)(dui:D003560;dis:Cysts;g:SUOX)(dui:D006058;dis:Gonadal Disorders;g:SUOX)(dui:D007592;dis:Joint Diseases;g:SUOX)(dui:D012216;dis:Rheumatic Diseases;g:SUOX)(dui:D052776;dis:Female Urogenital Diseases;g:SUOX)(dui:D001168;dis:Arthritis;g:SUOX)(dui:D001172;dis:Arthritis, Rheumatoid;g:SUOX)(dui:D005831;dis:Genital Diseases, Female;g:SUOX)(dui:D010048;dis:Ovarian Cysts;g:SUOX)(dui:D010049;dis:Ovarian Diseases;g:SUOX)(dui:D000291;dis:Adnexal Diseases;g:SUOX)(dui:D011085;dis:Polycystic Ovary Syndrome;g:SUOX)	{[2-Amino-4-oxo-6,7-di(sulfanyl-κS)-3,5,5a,8,9a,10-hexahydro-4H-pyrano[3,2-g]pteridin-8-yl]methyl dihydrogenato(2-) phosphate}(dioxo)sulfanylmolybdenum	GO:0005758:GO:0005515:GO:0006790:GO:0070221:GO:0005759:GO:0005739:GO:0008482:GO:0030151:GO:0020037:GO:0043546	606887	PF00173:PF00174:PF03404	-1.35														M	
chr12:102843690	SNV	G	1	C/C	PASS	0.0	3984.83		398	G=0,C=398	G=0.0,C=1.0	100.00	0.0	homozygous	1	0.16	1		PAH	NM_001354304.2	PAH:exonic:NM_001354304.2	synonymous	CTG	12	p.Leu385=	c.1155C>G				C	GMAF=0.1728:AMAF=0.1959:EMAF=0.161			Benign		rs772897		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-0.1														M	
chr12:102846852	SNV	C	1	C/A	PASS	4.3141972732687535e-92	913.651		400	C=199,A=201	C=0.4975,A=0.5025	50.25	49.75	heterozygous	1	0.27	2		PAH	NM_001354304.2	PAH:intronic:NM_001354304.2	unknown			p.?	c.969+43G>T				A	GMAF=0.3666:AMAF=0.2685:EMAF=0.4169			Benign		rs1522306		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-1.11														M	
chr12:102852922	SNV	C	1	C/T	PASS	2.4768516757935576e-91	906.061		399	C=199,T=200	C=0.4987,T=0.5013	50.13	49.87	heterozygous	1	0.315	2		PAH	NM_001354304.2	PAH:exonic:NM_001354304.2	synonymous	GTA	8	p.Val245=	c.735G>A				T	GMAF=0.1815:AMAF=0.0556:EMAF=0.246	0.39		Benign,Likely pathogenic	5618696	rs1042503:rs796052017		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-0.25														M	
chr12:102855146	SNV	C	1	C/T	PASS	1.603245390690035e-88	877.95		399	C=202,T=197	C=0.5063,T=0.4937	49.37	50.63	heterozygous	1	0.454	1		PAH	NM_001354304.2	PAH:exonic:NM_001354304.2	synonymous	CAA	7	p.Gln232=	c.696G>A				T	GMAF=0.3465:AMAF=0.2317:EMAF=0.4052	0.02		Benign	7233325	rs1126758		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-2.59														M	
chr12:102855386	SNV	C	1	C/T	PASS	1.8625159474379088e-56	557.299		400	C=240,T=160	C=0.6,T=0.4	40.00	60.0	heterozygous	1	0.235	1		PAH	NM_001354304.2	PAH:intronic:NM_001354304.2	unknown			p.?	c.510-54G>A				T				Benign		rs2251905		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-4.26														M	
chr12:102877415	SNV	G	1	G/A	PASS	4.806179647259492e-72	713.182		400	G=221,A=179	G=0.5525,A=0.4475	44.75	55.25	heterozygous	1	0.294	2		PAH	NM_001354304.2	PAH:intronic:NM_001354304.2	unknown			p.?	c.441+47C>T				A	GMAF=0.3828:AMAF=0.2851:EMAF=0.4329			Benign		rs1718301		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-1.57														M	
chr12:102877572	SNV	G	1	G/A	PASS	1.8378074173641755e-99	987.357		398	G=190,A=208	G=0.4774,A=0.5226	52.26	47.74	heterozygous	1	0.317	1		PAH	NM_001354304.2	PAH:intronic:NM_001354304.2	unknown			p.?	c.353-22C>T				A	GMAF=0.1968:AMAF=0.13:EMAF=0.2309			Benign		rs2037639		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-0.22														M	
chr12:102912772	SNV	A	1	A/G	PASS	1.5420554834704421e-83	828.119		400	A=208,G=192	A=0.52,G=0.48	48.00	52.0	heterozygous	1	0.217	3		PAH	NM_001354304.2	PAH:intronic:NM_001354304.2	unknown			p.?	c.168+19T>C				G	GMAF=0.2069:AMAF=0.2916:EMAF=0.1635			Benign		rs17842947		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	2.01														M	
chr12:102917009	SNV	G	1	G/A	PASS	3.328894257585384e-71	704.777		400	G=222,A=178	G=0.555,A=0.445	44.50	55.5	heterozygous	1	0.364	2		PAH	NM_001354304.2	PAH:intronic:NM_001354304.2	unknown			p.?	c.60+62C>T				A	GMAF=0.3771:AMAF=0.487:EMAF=0.318			Benign		rs1522296		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PAH)(dui:NBS2;dis:Core Conditions;g:PAH)(dui:NBS11;dis:Amino Acid Disorder;g:PAH)(dui:NBS58;dis:Phenylketonuria;g:PAH)(dui:D009422;dis:Nervous System Diseases;g:PAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PAH)(dui:D008659;dis:Metabolic Diseases;g:PAH)(dui:D002493;dis:Central Nervous System Diseases;g:PAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:PAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:PAH)(dui:D001927;dis:Brain Diseases;g:PAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:PAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:PAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PAH)(dui:D010661;dis:Phenylketonurias;g:PAH)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:PAH)(dui:D011248;dis:Pregnancy Complications;g:PAH)(dui:D017042;dis:Phenylketonuria, Maternal;g:PAH)	Sapropterin:L-erythro-7,8-dihydrobiopterin:Quinonoid 7,8-Tetrahydrobiopterin:Phenylalanine:beta-2-Thienyl-L-alanine:Norepinephrine:Cupric sulfate:D-norleucine:Droxidopa		612349	PF00351:PF01842	-0.51														M	
chr12:120737096	SNV	T	1	T/C	PASS	5.240829125640209e-58	572.806		400	T=238,C=162	T=0.595,C=0.405	40.50	59.5	heterozygous	1	0.409	1		ACADS	NM_000017.4	ACADS:exonic:NM_000017.4	synonymous	CGC	3	p.Arg107=	c.321T>C				C	GMAF=0.4932:AMAF=0.3756:EMAF=0.4466	0.28		Benign	3765623	rs1064795254:rs3914		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-0.18														M	
chr12:120737807	SNV	G	1	G/A	PASS	4.157191206752116e-92	913.812		400	G=199,A=201	G=0.4975,A=0.5025	50.25	49.75	heterozygous	1	0.027	1		ACADS	NM_000017.4	ACADS:intronic:NM_000017.4	unknown			p.?	c.473-30G>A				A	GMAF=0.0222:AMAF=0.007:EMAF=0.03					rs117000908		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-0.99														M	
chr12:120738181	SNV	T	1	T/C	PASS	3.2025800946290125e-72	714.945		399	T=220,C=179	T=0.5514,C=0.4486	44.86	55.14	heterozygous	1	0.406	1		ACADS	NM_000017.4	ACADS:intronic:NM_000017.4	unknown			p.?	c.625-99T>C				C						rs555404		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-2.88														M	
chr12:120738876	SNV	C	1	C/T	PASS	2.904691407381891e-72	715.369		399	C=220,T=179	C=0.5514,T=0.4486	44.86	55.14	heterozygous	1	0.327	1		ACADS	NM_000017.4	ACADS:exonic:NM_000017.4	synonymous	CGT	8	p.Arg330=	c.990C>T				T	GMAF=0.408:AMAF=0.1235:EMAF=0.4462	0.02		Benign	4146720	rs796051906:rs1555244280:rs3915		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ACADS)(dui:NBS21;dis:Short-chain acyl-CoA dehydrogenase deficiency;g:ACADS)(dui:NBS3;dis:Secondary Conditions;g:ACADS)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ACADS)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ACADS)(dui:D008659;dis:Metabolic Diseases;g:ACADS)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ACADS)(dui:D030342;dis:Genetic Diseases, Inborn;g:ACADS)(dui:D008661;dis:Metabolism, Inborn Errors;g:ACADS)(dui:D052439;dis:Lipid Metabolism Disorders;g:ACADS)(dui:D008052;dis:Lipid Metabolism, Inborn Errors;g:ACADS)	Acetoacetyl-CoA:NADH:Flavin adenine dinucleotide	GO:0003995:GO:0005634:GO:0005813:GO:0006635:GO:0033539:GO:0005759:GO:0050660:GO:0004085:GO:0005739:GO:0046359:GO:0005654	606885	PF02771:PF02770:PF00441:PF08028	-1.49														M	
chr13:100111823	INDEL	TGT	2	TGT/T	PASS	2.666244668312505e-91	905.741		392	TGT=189,T=203	TGT=0.4821,T=0.5179	51.79	48.21	heterozygous	1		1		PCCA	NR_148031.2	PCCA:intronic_nc:NR_148031.2															rs770647056:rs201452244:rs60618091:rs757554291		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PCCA)(dui:NBS2;dis:Core Conditions;g:PCCA)(dui:NBS9;dis:Organic Acid Condition;g:PCCA)(dui:NBS42;dis:Propionic acidemia;g:PCCA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PCCA)(dui:D008659;dis:Metabolic Diseases;g:PCCA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PCCA)(dui:D030342;dis:Genetic Diseases, Inborn;g:PCCA)(dui:D008661;dis:Metabolism, Inborn Errors;g:PCCA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PCCA)(dui:D056693;dis:Propionic Acidemia;g:PCCA)(dui:D005128;dis:Eye Diseases;g:PCCA)(dui:D012030;dis:Refractive Errors;g:PCCA)	Biotin		232000	PF08443:PF07478:PF00364:PF02222:PF02786:PF02785:PF00289	2.51,-0.28,2.55														M	
chr13:100111931	INDEL	TATTT	4	TATTT/T	PASS	8.912509381337514e-103	1020.5		390	TATTT=181,T=209	TATTT=0.4641,T=0.5359	53.59	46.41	heterozygous	1	0.077	1		PCCA	NR_148031.2	PCCA:intronic_nc:NR_148031.2															rs201261215:rs762246120:rs147037340		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PCCA)(dui:NBS2;dis:Core Conditions;g:PCCA)(dui:NBS9;dis:Organic Acid Condition;g:PCCA)(dui:NBS42;dis:Propionic acidemia;g:PCCA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PCCA)(dui:D008659;dis:Metabolic Diseases;g:PCCA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PCCA)(dui:D030342;dis:Genetic Diseases, Inborn;g:PCCA)(dui:D008661;dis:Metabolism, Inborn Errors;g:PCCA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PCCA)(dui:D056693;dis:Propionic Acidemia;g:PCCA)(dui:D005128;dis:Eye Diseases;g:PCCA)(dui:D012030;dis:Refractive Errors;g:PCCA)	Biotin		232000	PF08443:PF07478:PF00364:PF02222:PF02786:PF02785:PF00289	-0.12,-0.79,0.07,0.17,1.2														M	
chr13:100268802	SNV	A	1	G/G	PASS	0.0	3626.55		400	A=10,G=390	A=0.025,G=0.975	97.50	2.5	homozygous	1	0.084	1		PCCA	NR_148031.2	PCCA:intronic_nc:NR_148031.2										GMAF=0.0825:AMAF=0.2419:EMAF=8.0E-4			Benign		rs4306370		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PCCA)(dui:NBS2;dis:Core Conditions;g:PCCA)(dui:NBS9;dis:Organic Acid Condition;g:PCCA)(dui:NBS42;dis:Propionic acidemia;g:PCCA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PCCA)(dui:D008659;dis:Metabolic Diseases;g:PCCA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PCCA)(dui:D030342;dis:Genetic Diseases, Inborn;g:PCCA)(dui:D008661;dis:Metabolism, Inborn Errors;g:PCCA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PCCA)(dui:D056693;dis:Propionic Acidemia;g:PCCA)(dui:D005128;dis:Eye Diseases;g:PCCA)(dui:D012030;dis:Refractive Errors;g:PCCA)	Biotin		232000	PF08443:PF07478:PF00364:PF02222:PF02786:PF02785:PF00289	-0.76														M	
chr13:100368441	SNV	A	1	A/G	PASS	1.3188639580261043e-75	748.798		396	A=214,G=182	A=0.5404,G=0.4596	45.96	54.04	heterozygous	1	0.447	1		PCCA	NR_148031.2	PCCA:intronic_nc:NR_148031.2										GMAF=0.3177:AMAF=0.4921:EMAF=0.2284			Benign		rs9518061		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:PCCA)(dui:NBS2;dis:Core Conditions;g:PCCA)(dui:NBS9;dis:Organic Acid Condition;g:PCCA)(dui:NBS42;dis:Propionic acidemia;g:PCCA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:PCCA)(dui:D008659;dis:Metabolic Diseases;g:PCCA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:PCCA)(dui:D030342;dis:Genetic Diseases, Inborn;g:PCCA)(dui:D008661;dis:Metabolism, Inborn Errors;g:PCCA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:PCCA)(dui:D056693;dis:Propionic Acidemia;g:PCCA)(dui:D005128;dis:Eye Diseases;g:PCCA)(dui:D012030;dis:Refractive Errors;g:PCCA)	Biotin		232000	PF08443:PF07478:PF00364:PF02222:PF02786:PF02785:PF00289	2.28														M	
chr15:40407739	SNV	T	1	T/C	PASS	1.2787922629358252e-74	738.932		400	T=214,C=186	T=0.535,C=0.465	46.50	53.5	heterozygous	1	0.352	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2										GMAF=0.4044:AMAF=0.485:EMAF=0.3478			Benign		rs2289331		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		-1.6														M	
chr15:40407823	SNV	C	1	C/T	PASS	1.3899526312133554e-119	1188.57		400	C=172,T=228	C=0.43,T=0.57	57.00	43.0	heterozygous	1	0.473	2		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2															rs10518693:rs1566932254:rs1219352520		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.04														M	
chr15:40411410	SNV	A	1	G/G	PASS	0.0	3954.36		395	A=0,G=395	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.022	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2													Benign		rs4924466		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.1														M	
chr15:40412906	SNV	A	1	A/G	PASS	1.7770514423145472e-64	637.503		400	A=230,G=170	A=0.575,G=0.425	42.50	57.5	heterozygous	1	0.317	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2															rs2289330		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.42														M	
chr15:40412960	SNV	T	1	T/C	PASS	1.89365125489666e-69	687.227		400	T=224,C=176	T=0.56,C=0.44	44.00	56.0	heterozygous	1	0.466	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2										GMAF=0.3293:AMAF=0.2031:EMAF=0.394			Benign		rs2289329		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.94														M	
chr15:40416223	SNV	A	1	A/G	PASS	3.517223773787025e-95	944.538		398	A=194,G=204	A=0.4874,G=0.5126	51.26	48.74	heterozygous	1	0.368	1		IVD	NR_148925.2	IVD:intronic_nc:NR_148925.2										GMAF=0.4227:AMAF=0.4324:EMAF=0.3485			Benign		rs11070270		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:IVD)(dui:NBS2;dis:Core Conditions;g:IVD)(dui:NBS9;dis:Organic Acid Condition;g:IVD)(dui:NBS44;dis:Isovaleric acidemia;g:IVD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:IVD)(dui:D030342;dis:Genetic Diseases, Inborn;g:IVD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:IVD)(dui:D008659;dis:Metabolic Diseases;g:IVD)(dui:D008661;dis:Metabolism, Inborn Errors;g:IVD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:IVD)(dui:D012140;dis:Respiratory Tract Diseases;g:IVD)(dui:D008171;dis:Lung Diseases;g:IVD)(dui:D017563;dis:Lung Diseases, Interstitial;g:IVD)	Coenzyme A persulfide:Flavin adenine dinucleotide		607036		0.49														M	
chr15:80152950	SNV	G	1	G/C	PASS	9.266164374937348e-77	760.331		293	G=135,C=158	G=0.4608,C=0.5392	53.92	46.08	heterozygous	1	0.186	5		FAH	NM_000137.4	FAH:upstream:NM_000137.4	unknown			p.?	c.-105G>C				C				Benign		rs112474268		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-2.77														M	
chr15:80153172	INDEL	GGAGTGGAGTGGAGTGGAGT	19	GGAGTGGAGTGGAGTGGAGT/G	PASS	2.772043237577736e-89	885.572		257	GGAGTGGAGTGGAGTGGAGT=100,G=157	GGAGTGGAGTGGAGTGGAGT=0.3891,G=0.6109	61.09	38.91	heterozygous	1	0.031	3		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.81+38_81+56delGAGTGGAGTGGAGTGGAGT				G						rs57837512:rs1434937359:rs1555440095:rs558321563:rs756381638:rs752679360:rs1186087842:rs1555440100:rs554422109:rs753734814:rs1355859470:rs777902403:rs767638459:rs762924131:rs1595888602:rs1595888601:rs757176902		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	0.14,0.14,-1.81,0.78,-0.07,3.12,1.98,-0.67,1.26,-0.7,1.29,-0.07,0.16,-0.13,-1.18,0.08,-0.13,0.08,1.37,0.71														M	
chr15:80153209	INDEL	AGTGGA	5	AGTGGA/A	PASS	0.0009592680945759316	30.1806		349	AGTGGA=302,A=47	AGTGGA=0.8653,A=0.1347	13.47	86.53	heterozygous	1	0.0	1		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.81+75_81+79delGTGGA				A						rs1567112946:rs534184772:rs1361931262:rs1316986199:rs867498731:rs1341663234		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-1.35,0.39,0.16,0.21,0.17,-0.94														M	
chr15:80158047	SNV	G	1	A/A	PASS	0.0	3948.95		399	G=1,A=398	G=0.0025,A=0.9975	99.75	0.25	homozygous	1	0.493	1		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.82-13G>A				A	GMAF=0.4463:AMAF=0.3221:EMAF=0.49			Benign		rs1370275		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-4.7														M	
chr15:80159733	SNV	T	1	C/C	PASS	4.0644332916519454e-144	1433.91		166	T=8,C=158	T=0.0482,C=0.9518	95.18	4.819999999999993	homozygous	1	0.367	6		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.193-23T>C				C	GMAF=0.3974:AMAF=0.3865:EMAF=0.4029			Benign		rs1370274		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	0.14														M	
chr15:80159926	SNV	G	1	A/A	PASS	8.053784411990775e-295	2940.94		306	G=3,A=303	G=0.0098,A=0.9902	99.02	0.980000000000004	homozygous	1	0.36	2		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.314+49G>A				A	GMAF=0.3919:AMAF=0.3684:EMAF=0.404			Benign		rs1370273:rs1404883356		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-0.57														M	
chr15:80162365	SNV	G	1	G/A	PASS	3.848575404157336e-86	854.147		399	G=204,A=195	G=0.5113,A=0.4887	48.87	51.13	heterozygous	1	0.089	1		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.455+29G>A				A	GMAF=0.0033:AMAF=0.0054:EMAF=0.0022			Benign		rs2278204		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	0.2														M	
chr15:80168182	SNV	A	1	A/G	PASS	2.2620385397696293e-87	866.455		400	A=204,G=196	A=0.51,G=0.49	49.00	51.0	heterozygous	1	0.221	1		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.553+33A>G				G	GMAF=0.273:AMAF=0.2453:EMAF=0.2871			Benign		rs1545119		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	0.21														M	
chr15:80175284	SNV	G	1	G/T	PASS	1.069054879222649e-115	1149.71		400	G=175,T=225	G=0.4375,T=0.5625	56.25	43.75	heterozygous	1	0.447	3		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.913+193G>T				T						rs1863768		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-0.01														M	
chr15:80180089	SNV	C	1	C/A	PASS	5.84924752541185e-97	962.329		400	C=194,A=206	C=0.485,A=0.515	51.50	48.5	heterozygous	1	0.33	2		FAH	NM_000137.4	FAH:intronic:NM_000137.4	unknown			p.?	c.961-35C>A				A	GMAF=0.406:AMAF=0.4737:EMAF=0.3713			Benign		rs2043691		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:FAH)(dui:NBS2;dis:Core Conditions;g:FAH)(dui:NBS11;dis:Amino Acid Disorder;g:FAH)(dui:NBS59;dis:Tyrosinemia type I;g:FAH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:FAH)(dui:D008659;dis:Metabolic Diseases;g:FAH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:FAH)(dui:D030342;dis:Genetic Diseases, Inborn;g:FAH)(dui:D008661;dis:Metabolism, Inborn Errors;g:FAH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:FAH)(dui:D009422;dis:Nervous System Diseases;g:FAH)(dui:D002493;dis:Central Nervous System Diseases;g:FAH)(dui:D001927;dis:Brain Diseases;g:FAH)(dui:D001928;dis:Brain Diseases, Metabolic;g:FAH)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:FAH)(dui:D020176;dis:Tyrosinemias;g:FAH)	Fumaric Acid:4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid:Acetoacetic acid	GO:0006527:GO:0005515:GO:0006559:GO:0070062:GO:0046872:GO:1902000:GO:0005829:GO:0006572:GO:0004334	613871	PF01557:PF09298	-1.01														M	
chr16:71570009	SNV	C	1	C/A	PASS	7.046930689671453e-92	911.52		391	C=193,A=198	C=0.4936,A=0.5064	50.64	49.36	heterozygous	1	0.433	5		TAT|TAT-AS1	NM_000353.3|NR_103851.1	TAT:intronic:NM_000353.3|TAT-AS1:intronic_nc:NR_103851.1	unknown|	|	|	p.?|	c.1042-72G>T|	|	|	|	A|						rs172650:rs1413052063		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TAT)(dui:NBS3;dis:Secondary Conditions;g:TAT)(dui:NBS6;dis:Amino Acid Disorder;g:TAT)(dui:NBS37;dis:Tyrosinemia type II;g:TAT)(dui:NBS38;dis:Tyrosinemia type III;g:TAT)(dui:D009422;dis:Nervous System Diseases;g:TAT)(dui:D002493;dis:Central Nervous System Diseases;g:TAT)(dui:D001927;dis:Brain Diseases;g:TAT)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:TAT)(dui:D008659;dis:Metabolic Diseases;g:TAT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TAT)(dui:D030342;dis:Genetic Diseases, Inborn;g:TAT)(dui:D008661;dis:Metabolism, Inborn Errors;g:TAT)(dui:D001928;dis:Brain Diseases, Metabolic;g:TAT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:TAT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:TAT)(dui:D020176;dis:Tyrosinemias;g:TAT)	Pyridoxal phosphate:Tyrosine:Glutamic acid:Phenylalanine	GO:0030170:GO:0042802:GO:0046689:GO:0006572:GO:0009058:GO:0005575:GO:0006103:GO:0006979:GO:0006536:GO:0005515:GO:0006559:GO:0004838:GO:0005739:GO:0051384:GO:0005829:GO:0016597	613018	PF07706:PF00155:PF00266	0.63														M	
chr16:71573481	SNV	T	1	T/G	PASS	2.543314105987938e-77	765.946		400	T=215,G=185	T=0.5375,G=0.4625	46.25	53.75	heterozygous	1	0.414	1		TAT	NM_000353.3	TAT:intronic:NM_000353.3	unknown			p.?	c.408+58A>C				G	GMAF=0.3121:AMAF=0.229:EMAF=0.3482					rs2432520		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:TAT)(dui:NBS3;dis:Secondary Conditions;g:TAT)(dui:NBS6;dis:Amino Acid Disorder;g:TAT)(dui:NBS37;dis:Tyrosinemia type II;g:TAT)(dui:NBS38;dis:Tyrosinemia type III;g:TAT)(dui:D009422;dis:Nervous System Diseases;g:TAT)(dui:D002493;dis:Central Nervous System Diseases;g:TAT)(dui:D001927;dis:Brain Diseases;g:TAT)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:TAT)(dui:D008659;dis:Metabolic Diseases;g:TAT)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:TAT)(dui:D030342;dis:Genetic Diseases, Inborn;g:TAT)(dui:D008661;dis:Metabolism, Inborn Errors;g:TAT)(dui:D001928;dis:Brain Diseases, Metabolic;g:TAT)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:TAT)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:TAT)(dui:D020176;dis:Tyrosinemias;g:TAT)	Pyridoxal phosphate:Tyrosine:Glutamic acid:Phenylalanine	GO:0030170:GO:0042802:GO:0046689:GO:0006572:GO:0009058:GO:0005575:GO:0006103:GO:0006979:GO:0006536:GO:0005515:GO:0006559:GO:0004838:GO:0005739:GO:0051384:GO:0005829:GO:0016597	613018	PF07706:PF00155:PF00266	0.9														M	
chr19:12891586	SNV	G	1	G/C	PASS	4.129524052369182e-92	913.841		400	G=199,C=201	G=0.4975,C=0.5025	50.25	49.75	heterozygous	1	0.253	2		GCDH	NR_102317.1	GCDH:exonic_nc:NR_102317.1			3							GMAF=0.3233:AMAF=0.2298:EMAF=0.3639					rs1799918		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:GCDH)(dui:NBS2;dis:Core Conditions;g:GCDH)(dui:NBS9;dis:Organic Acid Condition;g:GCDH)(dui:NBS49;dis:Glutaric acidemia type I;g:GCDH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:GCDH)(dui:D008659;dis:Metabolic Diseases;g:GCDH)(dui:D009422;dis:Nervous System Diseases;g:GCDH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:GCDH)(dui:D002493;dis:Central Nervous System Diseases;g:GCDH)(dui:D030342;dis:Genetic Diseases, Inborn;g:GCDH)(dui:D008661;dis:Metabolism, Inborn Errors;g:GCDH)(dui:D001927;dis:Brain Diseases;g:GCDH)(dui:D001928;dis:Brain Diseases, Metabolic;g:GCDH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:GCDH)	S-4-Nitrobutyryl-CoA:Flavin adenine dinucleotide		608801	PF02771:PF02770:PF00441:PF08028	0.59														M	
chr19:12897793	SNV	G	1	G/T	PASS	2.250090572279361e-67	666.478		398	G=225,T=173	G=0.5653,T=0.4347	43.47	56.53	heterozygous	1	0.25	7		GCDH|SYCE2	NR_102317.1|NM_001105578.2	GCDH:exonic_nc:NR_102317.1|SYCE2:downstream:NM_001105578.2	|unknown	|	10|	|p.?	|c.*1548C>A	|	|	|	|T	GMAF=0.3071:AMAF=0.2072:EMAF=0.3583	0.09		Benign	2816924:6039891:3756351	rs1060218:rs1486220652		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:GCDH)(dui:NBS2;dis:Core Conditions;g:GCDH)(dui:NBS9;dis:Organic Acid Condition;g:GCDH)(dui:NBS49;dis:Glutaric acidemia type I;g:GCDH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:GCDH)(dui:D008659;dis:Metabolic Diseases;g:GCDH)(dui:D009422;dis:Nervous System Diseases;g:GCDH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:GCDH)(dui:D002493;dis:Central Nervous System Diseases;g:GCDH)(dui:D030342;dis:Genetic Diseases, Inborn;g:GCDH)(dui:D008661;dis:Metabolism, Inborn Errors;g:GCDH)(dui:D001927;dis:Brain Diseases;g:GCDH)(dui:D001928;dis:Brain Diseases, Metabolic;g:GCDH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:GCDH)	S-4-Nitrobutyryl-CoA:Flavin adenine dinucleotide	GO:0051301:GO:0005515:GO:0007130:GO:0000801:GO:0005654	611487:608801	PF02771:PF02770:PF00441:PF08028	-1.11														M	
chr19:12899706	SNV	A	1	G/G	PASS	0.0	3982.01		398	A=0,G=398	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.28	1		GCDH|SYCE2	NR_102317.1|NM_001105578.2	GCDH:exonic_nc:NR_102317.1|SYCE2:intronic:NM_001105578.2	|unknown	|	11|	|p.?	|c.612+298T>C	|	|	|	|G	GMAF=0.3611:AMAF=0.1756:EMAF=0.4546	0.11		Benign	7218541	rs8012		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:GCDH)(dui:NBS2;dis:Core Conditions;g:GCDH)(dui:NBS9;dis:Organic Acid Condition;g:GCDH)(dui:NBS49;dis:Glutaric acidemia type I;g:GCDH)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:GCDH)(dui:D008659;dis:Metabolic Diseases;g:GCDH)(dui:D009422;dis:Nervous System Diseases;g:GCDH)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:GCDH)(dui:D002493;dis:Central Nervous System Diseases;g:GCDH)(dui:D030342;dis:Genetic Diseases, Inborn;g:GCDH)(dui:D008661;dis:Metabolism, Inborn Errors;g:GCDH)(dui:D001927;dis:Brain Diseases;g:GCDH)(dui:D001928;dis:Brain Diseases, Metabolic;g:GCDH)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:GCDH)	S-4-Nitrobutyryl-CoA:Flavin adenine dinucleotide	GO:0051301:GO:0005515:GO:0007130:GO:0000801:GO:0005654	611487:608801	PF02771:PF02770:PF01442:PF00441:PF08028	0.32														M	
chr19:41397766	SNV	A	1	G/G	PASS	0.0	3968.0		400	A=1,G=399	A=0.0025,G=0.9975	99.75	0.25	homozygous	1	0.418	3		EXOSC5|BCKDHA	NM_020158.4|NM_001164783.2	EXOSC5:upstream:NM_020158.4|BCKDHA:upstream:NM_001164783.2	unknown|unknown	|	|	p.?|p.?	c.-438T>C|c.-62A>G	|	|	|	G|G						rs892044		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)(dui:D009369;dis:Neoplasms;g:EXOSC5)(dui:D009371;dis:Neoplasms by Site;g:EXOSC5)(dui:D004066;dis:Digestive System Diseases;g:EXOSC5)(dui:D004067;dis:Digestive System Neoplasms;g:EXOSC5)(dui:D005767;dis:Gastrointestinal Diseases;g:EXOSC5)(dui:D005770;dis:Gastrointestinal Neoplasms;g:EXOSC5)(dui:D013272;dis:Stomach Diseases;g:EXOSC5)(dui:D013274;dis:Stomach Neoplasms;g:EXOSC5)		GO:0034475:GO:0043928:GO:0045006:GO:0043488:GO:0006364:GO:0005730:GO:0000178:GO:0005654:GO:0003863:GO:0071051:GO:0003723:GO:0005947:GO:0003826:GO:0016075:GO:0005829:GO:0051607:GO:0034427:GO:0016831:GO:0090503:GO:0009083:GO:0004532:GO:0000177:GO:0000176:GO:0000175:GO:0005515:GO:0005759:GO:0046872:GO:0005737:GO:0005739:GO:0035327:GO:0071028:GO:0055114	606492:608348		0.08														M	
chr19:41397770	SNV	A	1	G/G	PASS	0.0	3997.33		400	A=0,G=400	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.02	1		EXOSC5|BCKDHA	NM_020158.4|NM_001164783.2	EXOSC5:upstream:NM_020158.4|BCKDHA:upstream:NM_001164783.2	unknown|unknown	|	|	p.?|p.?	c.-442T>C|c.-58A>G	|	|	|	G|G						rs892043		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)(dui:D009369;dis:Neoplasms;g:EXOSC5)(dui:D009371;dis:Neoplasms by Site;g:EXOSC5)(dui:D004066;dis:Digestive System Diseases;g:EXOSC5)(dui:D004067;dis:Digestive System Neoplasms;g:EXOSC5)(dui:D005767;dis:Gastrointestinal Diseases;g:EXOSC5)(dui:D005770;dis:Gastrointestinal Neoplasms;g:EXOSC5)(dui:D013272;dis:Stomach Diseases;g:EXOSC5)(dui:D013274;dis:Stomach Neoplasms;g:EXOSC5)		GO:0034475:GO:0043928:GO:0045006:GO:0043488:GO:0006364:GO:0005730:GO:0000178:GO:0005654:GO:0003863:GO:0071051:GO:0003723:GO:0005947:GO:0003826:GO:0016075:GO:0005829:GO:0051607:GO:0034427:GO:0016831:GO:0090503:GO:0009083:GO:0004532:GO:0000177:GO:0000176:GO:0000175:GO:0005515:GO:0005759:GO:0046872:GO:0005737:GO:0005739:GO:0035327:GO:0071028:GO:0055114	606492:608348		0.12														M	
chr19:41410927	SNV	C	1	C/T	PASS	2.787404520323769e-83	825.548		400	C=208,T=192	C=0.52,T=0.48	48.00	52.0	heterozygous	1	0.001	2		BCKDHA	NM_001164783.2	BCKDHA:exonic:NM_001164783.2	missense	CTG	3	p.Pro98Leu	c.293C>T	0.0	0.835	98.0	T				Uncertain significance		rs532803527		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	5.65														M	
chr19:41414039	SNV	A	1	C/C	PASS	0.0	3993.3		399	A=0,C=399	A=0.0,C=1.0	100.00	0.0	homozygous	1	0.384	1		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.376-10A>C				C	GMAF=0.3239:AMAF=0.1902:EMAF=0.3924	0.01		Benign	4000746	rs3213861		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	-0.51														M	
chr19:41422431	SNV	T	1	C/C	PASS	0.0	3998.15		400	T=0,C=400	T=0.0,C=1.0	100.00	0.0	homozygous	1	0.382	1		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.853+61T>C				C						rs284651		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	-2.12														M	
chr19:41422747	SNV	C	1	T/T	PASS	0.0	3975.58		400	C=0,T=400	C=0.0,T=1.0	100.00	0.0	homozygous	1	0.384	2		BCKDHA	NM_001164783.2	BCKDHA:exonic:NM_001164783.2	synonymous	TTT	7	p.Phe323=	c.969C>T				T	GMAF=0.3239:AMAF=0.1902:EMAF=0.3924	0.92		Benign	3933055	rs284652:rs112312448		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	2.87														M	
chr19:41422796	SNV	C	1	T/T	PASS	0.0	3457.09		389	C=16,T=373	C=0.0411,T=0.9589	95.89	4.109999999999999	homozygous	1	0.257	5		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.992+26C>T				T	GMAF=0.3824:AMAF=0.264:EMAF=0.4431			Benign/Likely benign		rs284653		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	-0.25														M	
chr19:41422819	SNV	G	1	A/A	PASS	0.0	4003.29		400	G=0,A=400	G=0.0,A=1.0	100.00	0.0	homozygous	1	0.414	1		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.992+49G>A				A	GMAF=0.3565:AMAF=0.2855:EMAF=0.3929			Benign/Likely benign		rs284654		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	-1.91														M	
chr19:41422860	SNV	C	1	T/T	PASS	0.0	3876.04		400	C=4,T=396	C=0.01,T=0.99	99.00	1.0	homozygous	1	0.386	2		BCKDHA	NM_001164783.2	BCKDHA:intronic:NM_001164783.2	unknown			p.?	c.992+90C>T				T						rs284655		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0003863:GO:0005515:GO:0009083:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0055114:GO:0016831	608348	PF00676	0.58														M	
chr19:41424491	SNV	A	1	G/G	PASS	0.0	3967.01		400	A=1,G=399	A=0.0025,G=0.9975	99.75	0.25	homozygous	1	0.383	1		BCKDHA|B3GNT8	NM_001164783.2|NM_198540.2	BCKDHA:exonic:NM_001164783.2|B3GNT8:downstream:NM_198540.2	synonymous|unknown	CTG|	9|	p.Leu406=|p.?	c.1218A>G|c.*1094T>C	|	|	|	G|G	GMAF=0.323:AMAF=0.1895:EMAF=0.3914	0.15		Benign	7239888	rs4674		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:BCKDHA)(dui:NBS2;dis:Core Conditions;g:BCKDHA)(dui:NBS11;dis:Amino Acid Disorder;g:BCKDHA)(dui:NBS56;dis:Maple syrup urine disease;g:BCKDHA)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:BCKDHA)(dui:D008659;dis:Metabolic Diseases;g:BCKDHA)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:BCKDHA)(dui:D030342;dis:Genetic Diseases, Inborn;g:BCKDHA)(dui:D009422;dis:Nervous System Diseases;g:BCKDHA)(dui:D002493;dis:Central Nervous System Diseases;g:BCKDHA)(dui:D001927;dis:Brain Diseases;g:BCKDHA)(dui:D001928;dis:Brain Diseases, Metabolic;g:BCKDHA)(dui:D008661;dis:Metabolism, Inborn Errors;g:BCKDHA)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:BCKDHA)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:BCKDHA)(dui:D008375;dis:Maple Syrup Urine Disease;g:BCKDHA)		GO:0009083:GO:0016758:GO:0008375:GO:0006486:GO:0008532:GO:0000139:GO:0005794:GO:0008376:GO:0003863:GO:0005515:GO:0070062:GO:0005947:GO:0005759:GO:0046872:GO:0003826:GO:0005739:GO:0016262:GO:0016021:GO:0055114:GO:0016266:GO:0030311:GO:0016831	615357:608348	PF00676	0.76														M	
chr19:45529477	INDEL	CAG	2	CAG/C	PASS	4.812824218676037e-87	863.176		393	CAG=199,C=194	CAG=0.5064,C=0.4936	49.36	50.64	heterozygous	1	0.148	1		OPA3												GMAF=0.1345:AMAF=0.1308:EMAF=0.1363					rs1599947393:rs149252540:rs1599947386		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:OPA3)(dui:NBS3;dis:Secondary Conditions;g:OPA3)(dui:NBS4;dis:Organic Acid Condition;g:OPA3)(dui:NBS19;dis:3-Methylglutaconic aciduria;g:OPA3)(dui:D009422;dis:Nervous System Diseases;g:OPA3)(dui:D005128;dis:Eye Diseases;g:OPA3)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:OPA3)(dui:D030342;dis:Genetic Diseases, Inborn;g:OPA3)(dui:D003389;dis:Cranial Nerve Diseases;g:OPA3)(dui:D009901;dis:Optic Nerve Diseases;g:OPA3)(dui:D019636;dis:Neurodegenerative Diseases;g:OPA3)(dui:D009896;dis:Optic Atrophy;g:OPA3)(dui:D020271;dis:Heredodegenerative Disorders, Nervous System;g:OPA3)(dui:D015785;dis:Eye Diseases, Hereditary;g:OPA3)(dui:D015418;dis:Optic Atrophies, Hereditary;g:OPA3)(dui:D007905;dis:Lens Diseases;g:OPA3)(dui:D002386;dis:Cataract;g:OPA3)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:OPA3)(dui:D008659;dis:Metabolic Diseases;g:OPA3)(dui:D009461;dis:Neurologic Manifestations;g:OPA3)(dui:D000013;dis:Congenital Abnormalities;g:OPA3)(dui:D002493;dis:Central Nervous System Diseases;g:OPA3)(dui:D009421;dis:Nervous System Malformations;g:OPA3)(dui:D009468;dis:Neuromuscular Diseases;g:OPA3)(dui:D008661;dis:Metabolism, Inborn Errors;g:OPA3)(dui:D009069;dis:Movement Disorders;g:OPA3)(dui:D010523;dis:Peripheral Nervous System Diseases;g:OPA3)(dui:D015417;dis:Hereditary Sensory and Motor Neuropathy;g:OPA3)(dui:D020820;dis:Dyskinesias;g:OPA3)(dui:D002819;dis:Chorea;g:OPA3)(dui:D011115;dis:Polyneuropathies;g:OPA3)(dui:D015419;dis:Spastic Paraplegia, Hereditary;g:OPA3)			606580		-0.36,-0.32,4.25														M	
chr19:45553823	SNV	A	1	G/G	PASS	0.0	4003.3		400	A=0,G=400	A=0.0,G=1.0	100.00	0.0	homozygous	1	0.233	1		OPA3	NM_025136.4	OPA3:exonic:NM_025136.4	synonymous	GCC	2	p.Ala77=	c.231T>C				G	GMAF=0.3174:AMAF=0.2398:EMAF=0.3572	0.09		Benign	439792	rs3826860		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:OPA3)(dui:NBS3;dis:Secondary Conditions;g:OPA3)(dui:NBS4;dis:Organic Acid Condition;g:OPA3)(dui:NBS19;dis:3-Methylglutaconic aciduria;g:OPA3)(dui:D009422;dis:Nervous System Diseases;g:OPA3)(dui:D005128;dis:Eye Diseases;g:OPA3)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:OPA3)(dui:D030342;dis:Genetic Diseases, Inborn;g:OPA3)(dui:D003389;dis:Cranial Nerve Diseases;g:OPA3)(dui:D009901;dis:Optic Nerve Diseases;g:OPA3)(dui:D019636;dis:Neurodegenerative Diseases;g:OPA3)(dui:D009896;dis:Optic Atrophy;g:OPA3)(dui:D020271;dis:Heredodegenerative Disorders, Nervous System;g:OPA3)(dui:D015785;dis:Eye Diseases, Hereditary;g:OPA3)(dui:D015418;dis:Optic Atrophies, Hereditary;g:OPA3)(dui:D007905;dis:Lens Diseases;g:OPA3)(dui:D002386;dis:Cataract;g:OPA3)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:OPA3)(dui:D008659;dis:Metabolic Diseases;g:OPA3)(dui:D009461;dis:Neurologic Manifestations;g:OPA3)(dui:D000013;dis:Congenital Abnormalities;g:OPA3)(dui:D002493;dis:Central Nervous System Diseases;g:OPA3)(dui:D009421;dis:Nervous System Malformations;g:OPA3)(dui:D009468;dis:Neuromuscular Diseases;g:OPA3)(dui:D008661;dis:Metabolism, Inborn Errors;g:OPA3)(dui:D009069;dis:Movement Disorders;g:OPA3)(dui:D010523;dis:Peripheral Nervous System Diseases;g:OPA3)(dui:D015417;dis:Hereditary Sensory and Motor Neuropathy;g:OPA3)(dui:D020820;dis:Dyskinesias;g:OPA3)(dui:D002819;dis:Chorea;g:OPA3)(dui:D011115;dis:Polyneuropathies;g:OPA3)(dui:D015419;dis:Spastic Paraplegia, Hereditary;g:OPA3)		GO:0070584:GO:0005739:GO:0050905:GO:0045444:GO:0007601:GO:0019216:GO:0040008:GO:0050896:GO:0060348	606580	PF07047	-0.93														M	
chr19:45584554	SNV	C	1	C/G	PASS	3.6466996889423397e-81	804.381		399	C=210,G=189	C=0.5263,G=0.4737	47.37	52.63	heterozygous	1	0.023	4		OPA3	NM_025136.4	OPA3:intronic:NM_025136.4	unknown			p.?	c.142+69G>C				G						rs62111684		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:OPA3)(dui:NBS3;dis:Secondary Conditions;g:OPA3)(dui:NBS4;dis:Organic Acid Condition;g:OPA3)(dui:NBS19;dis:3-Methylglutaconic aciduria;g:OPA3)(dui:D009422;dis:Nervous System Diseases;g:OPA3)(dui:D005128;dis:Eye Diseases;g:OPA3)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:OPA3)(dui:D030342;dis:Genetic Diseases, Inborn;g:OPA3)(dui:D003389;dis:Cranial Nerve Diseases;g:OPA3)(dui:D009901;dis:Optic Nerve Diseases;g:OPA3)(dui:D019636;dis:Neurodegenerative Diseases;g:OPA3)(dui:D009896;dis:Optic Atrophy;g:OPA3)(dui:D020271;dis:Heredodegenerative Disorders, Nervous System;g:OPA3)(dui:D015785;dis:Eye Diseases, Hereditary;g:OPA3)(dui:D015418;dis:Optic Atrophies, Hereditary;g:OPA3)(dui:D007905;dis:Lens Diseases;g:OPA3)(dui:D002386;dis:Cataract;g:OPA3)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:OPA3)(dui:D008659;dis:Metabolic Diseases;g:OPA3)(dui:D009461;dis:Neurologic Manifestations;g:OPA3)(dui:D000013;dis:Congenital Abnormalities;g:OPA3)(dui:D002493;dis:Central Nervous System Diseases;g:OPA3)(dui:D009421;dis:Nervous System Malformations;g:OPA3)(dui:D009468;dis:Neuromuscular Diseases;g:OPA3)(dui:D008661;dis:Metabolism, Inborn Errors;g:OPA3)(dui:D009069;dis:Movement Disorders;g:OPA3)(dui:D010523;dis:Peripheral Nervous System Diseases;g:OPA3)(dui:D015417;dis:Hereditary Sensory and Motor Neuropathy;g:OPA3)(dui:D020820;dis:Dyskinesias;g:OPA3)(dui:D002819;dis:Chorea;g:OPA3)(dui:D011115;dis:Polyneuropathies;g:OPA3)(dui:D015419;dis:Spastic Paraplegia, Hereditary;g:OPA3)		GO:0070584:GO:0005739:GO:0050905:GO:0045444:GO:0007601:GO:0019216:GO:0040008:GO:0050896:GO:0060348	606580	PF07047	1.45														M	
chr19:51354484	SNV	G	1	G/A	PASS	2.3550492838960093e-110	1096.28		399	G=180,A=219	G=0.4511,A=0.5489	54.89	45.11	heterozygous	1	0.077	4		ETFB	NM_001985.3	ETFB:intronic:NM_001985.3	unknown			p.?	c.58-176C>T				A	GMAF=0.0605:AMAF=0.0445:EMAF=0.0687			Benign		rs79338777		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:ETFB)(dui:NBS3;dis:Secondary Conditions;g:ETFB)(dui:NBS5;dis:Fatty Acid Oxidation Disorder;g:ETFB)(dui:NBS24;dis:Glutaric acidemia type II;g:ETFB)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:ETFB)(dui:D008659;dis:Metabolic Diseases;g:ETFB)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:ETFB)(dui:D030342;dis:Genetic Diseases, Inborn;g:ETFB)(dui:D008661;dis:Metabolism, Inborn Errors;g:ETFB)(dui:D028361;dis:Mitochondrial Diseases;g:ETFB)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:ETFB)(dui:D054069;dis:Multiple Acyl Coenzyme A Dehydrogenase Deficiency;g:ETFB)		GO:0033539:GO:0005515:GO:0005759:GO:0009055:GO:0005739:GO:0022904	130410	PF01012	-2.72														M	
chrX:38367350	SNV	A	1	G/G	PASS	0.0	3700.5		399	A=10,G=389	A=0.0251,G=0.9749	97.49	2.510000000000005	homozygous	1	0.184	6		OTC	NM_000531.6	OTC:exonic:NM_000531.6	missense	AGA	2	p.Lys46Arg	c.137A>G	0.13	0.185	26.0	G	GMAF=0.2903:AMAF=0.3765:EMAF=0.2413	0.95:0.94		Benign	3759494:3766934	rs1800321		(dui:ACMG59;dis:ACMG Recommendations...;g:OTC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:OTC)(dui:D008659;dis:Metabolic Diseases;g:OTC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:OTC)(dui:D009422;dis:Nervous System Diseases;g:OTC)(dui:D030342;dis:Genetic Diseases, Inborn;g:OTC)(dui:D002493;dis:Central Nervous System Diseases;g:OTC)(dui:D001927;dis:Brain Diseases;g:OTC)(dui:D008661;dis:Metabolism, Inborn Errors;g:OTC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:OTC)(dui:D001928;dis:Brain Diseases, Metabolic;g:OTC)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:OTC)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:OTC)(dui:D040181;dis:Genetic Diseases, X-Linked;g:OTC)(dui:D020163;dis:Ornithine Carbamoyltransferase Deficiency Disease;g:OTC)(dui:D004066;dis:Digestive System Diseases;g:OTC)(dui:D008107;dis:Liver Diseases;g:OTC)	N-(Phosphonoacetyl)-L-Ornithine:Norvaline:Citrulline:Ornithine	GO:0042802:GO:0010043:GO:0007494:GO:0006593:GO:0005543:GO:0042301:GO:0097272:GO:0004585:GO:0005743:GO:0055081:GO:0032868:GO:0005759:GO:0019240:GO:0000050:GO:0001889:GO:0042493:GO:0043231:GO:0005739:GO:0042450:GO:0070781:GO:0016597	300461	PF02729:PF00185	7.43														M	
chrX:38381334	SNV	T	1	A/A	PASS	1.9620045039256622e-53	527.073		64	T=4,A=60	T=0.0625,A=0.9375	93.75	6.25	homozygous	1	0.077	10		OTC	NM_000531.6	OTC:intronic:NM_000531.6	unknown			p.?	c.299-8T>A				A	GMAF=0.1565:AMAF=0.035:EMAF=0.2257			Benign		rs73196229:rs374145788		(dui:ACMG59;dis:ACMG Recommendations...;g:OTC)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:OTC)(dui:D008659;dis:Metabolic Diseases;g:OTC)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:OTC)(dui:D009422;dis:Nervous System Diseases;g:OTC)(dui:D030342;dis:Genetic Diseases, Inborn;g:OTC)(dui:D002493;dis:Central Nervous System Diseases;g:OTC)(dui:D001927;dis:Brain Diseases;g:OTC)(dui:D008661;dis:Metabolism, Inborn Errors;g:OTC)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:OTC)(dui:D001928;dis:Brain Diseases, Metabolic;g:OTC)(dui:D020739;dis:Brain Diseases, Metabolic, Inborn;g:OTC)(dui:D056806;dis:Urea Cycle Disorders, Inborn;g:OTC)(dui:D040181;dis:Genetic Diseases, X-Linked;g:OTC)(dui:D020163;dis:Ornithine Carbamoyltransferase Deficiency Disease;g:OTC)(dui:D004066;dis:Digestive System Diseases;g:OTC)(dui:D008107;dis:Liver Diseases;g:OTC)	N-(Phosphonoacetyl)-L-Ornithine:Norvaline:Citrulline:Ornithine	GO:0042802:GO:0010043:GO:0007494:GO:0006593:GO:0005543:GO:0042301:GO:0097272:GO:0004585:GO:0005743:GO:0055081:GO:0032868:GO:0005759:GO:0019240:GO:0000050:GO:0001889:GO:0042493:GO:0043231:GO:0005739:GO:0042450:GO:0070781:GO:0016597	300461	PF02729:PF00185	-0.1														M	
chrX:154532293	SNV	G	1	A/A	PASS	4.2461956394629914e-197	1963.72		206	G=3,A=203	G=0.0146,A=0.9854	98.54	1.4599999999999937	hemizygous	1		2		G6PD	NM_001042351.3	G6PD:intronic:NM_001042351.3	unknown			p.?	c.1365-13C>T				A	GMAF=0.3923:AMAF=0.1523:EMAF=0.1327					rs2071429		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:G6PD)(dui:NBS3;dis:Secondary Conditions;g:G6PD)(dui:NBS39;dis:Hb carrier other than C,D,E,S,O-Arab;g:G6PD)(dui:NBS7;dis:Hemoglobin Disorder;g:G6PD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:G6PD)(dui:D030342;dis:Genetic Diseases, Inborn;g:G6PD)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:G6PD)(dui:D006402;dis:Hematologic Diseases;g:G6PD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:G6PD)(dui:D000740;dis:Anemia;g:G6PD)(dui:D008659;dis:Metabolic Diseases;g:G6PD)(dui:D000743;dis:Anemia, Hemolytic;g:G6PD)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:G6PD)(dui:D008661;dis:Metabolism, Inborn Errors;g:G6PD)(dui:D005955;dis:Glucosephosphate Dehydrogenase Deficiency;g:G6PD)(dui:D040181;dis:Genetic Diseases, X-Linked;g:G6PD)(dui:D002239;dis:Carbohydrate Metabolism, Inborn Errors;g:G6PD)(dui:D052801;dis:Male Urogenital Diseases;g:G6PD)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:G6PD)(dui:D014570;dis:Urologic Diseases;g:G6PD)(dui:D052776;dis:Female Urogenital Diseases;g:G6PD)(dui:D007674;dis:Kidney Diseases;g:G6PD)(dui:D004066;dis:Digestive System Diseases;g:G6PD)(dui:D002318;dis:Cardiovascular Diseases;g:G6PD)(dui:D014652;dis:Vascular Diseases;g:G6PD)(dui:D008107;dis:Liver Diseases;g:G6PD)(dui:D007154;dis:Immune System Diseases;g:G6PD)(dui:D007153;dis:Immunologic Deficiency Syndromes;g:G6PD)(dui:D007960;dis:Leukocyte Disorders;g:G6PD)(dui:D010585;dis:Phagocyte Bactericidal Dysfunction;g:G6PD)(dui:D009422;dis:Nervous System Diseases;g:G6PD)(dui:D002493;dis:Central Nervous System Diseases;g:G6PD)(dui:D001927;dis:Brain Diseases;g:G6PD)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:G6PD)(dui:D012871;dis:Skin Diseases;g:G6PD)(dui:D004700;dis:Endocrine System Diseases;g:G6PD)(dui:D044882;dis:Glucose Metabolism Disorders;g:G6PD)(dui:D005236;dis:Favism;g:G6PD)(dui:D000746;dis:Anemia, Hemolytic, Congenital Nonspherocytic;g:G6PD)(dui:D003920;dis:Diabetes Mellitus;g:G6PD)(dui:D002561;dis:Cerebrovascular Disorders;g:G6PD)(dui:D001928;dis:Brain Diseases, Metabolic;g:G6PD)(dui:D009748;dis:Nutrition Disorders;g:G6PD)(dui:D006105;dis:Granulomatous Disease, Chronic;g:G6PD)(dui:D052439;dis:Lipid Metabolism Disorders;g:G6PD)(dui:D002545;dis:Brain Ischemia;g:G6PD)(dui:D003872;dis:Dermatitis;g:G6PD)(dui:D017443;dis:Skin Diseases, Eczematous;g:G6PD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:G6PD)(dui:D003877;dis:Dermatitis, Contact;g:G6PD)(dui:D006946;dis:Hyperinsulinism;g:G6PD)(dui:D050171;dis:Dyslipidemias;g:G6PD)(dui:D051437;dis:Renal Insufficiency;g:G6PD)(dui:D006949;dis:Hyperlipidemias;g:G6PD)(dui:D007333;dis:Insulin Resistance;g:G6PD)(dui:D058186;dis:Acute Kidney Injury;g:G6PD)	Nicotinamide adenine dinucleotide phosphate:Glycolic acid:16-Bromoepiandrosterone:Artenimol	GO:0032094:GO:0010041:GO:0009051:GO:0061052:GO:0034451:GO:0006740:GO:0006006:GO:0043523:GO:0004345:GO:0009898:GO:0043249:GO:1904879:GO:0045471:GO:0070062:GO:0043231:GO:0006739:GO:0019322:GO:0005829:GO:0010734:GO:2000378:GO:0042802:GO:0042803:GO:0006098:GO:0006695:GO:0014070:GO:0021762:GO:0005536:GO:0005634:GO:0050661:GO:0051156:GO:0005515:GO:0005737:GO:0006749:GO:0006629:GO:0016020:GO:0034599:GO:0055114:GO:0046390	305900	PF00479:PF02781	-0.82														M	
chrX:154532439	SNV	A	1	G/G	PASS	0.0	4000.84		400	A=0,G=400	A=0.0,G=1.0	100.00	0.0	hemizygous	1		1		G6PD	NM_001042351.3	G6PD:exonic:NM_001042351.3	synonymous	TAC	11	p.Tyr437=	c.1311T>C				G	GMAF=0.1667:AMAF=0.2605:EMAF=0.1133			Benign		rs2230037		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:G6PD)(dui:NBS3;dis:Secondary Conditions;g:G6PD)(dui:NBS39;dis:Hb carrier other than C,D,E,S,O-Arab;g:G6PD)(dui:NBS7;dis:Hemoglobin Disorder;g:G6PD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:G6PD)(dui:D030342;dis:Genetic Diseases, Inborn;g:G6PD)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:G6PD)(dui:D006402;dis:Hematologic Diseases;g:G6PD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:G6PD)(dui:D000740;dis:Anemia;g:G6PD)(dui:D008659;dis:Metabolic Diseases;g:G6PD)(dui:D000743;dis:Anemia, Hemolytic;g:G6PD)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:G6PD)(dui:D008661;dis:Metabolism, Inborn Errors;g:G6PD)(dui:D005955;dis:Glucosephosphate Dehydrogenase Deficiency;g:G6PD)(dui:D040181;dis:Genetic Diseases, X-Linked;g:G6PD)(dui:D002239;dis:Carbohydrate Metabolism, Inborn Errors;g:G6PD)(dui:D052801;dis:Male Urogenital Diseases;g:G6PD)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:G6PD)(dui:D014570;dis:Urologic Diseases;g:G6PD)(dui:D052776;dis:Female Urogenital Diseases;g:G6PD)(dui:D007674;dis:Kidney Diseases;g:G6PD)(dui:D004066;dis:Digestive System Diseases;g:G6PD)(dui:D002318;dis:Cardiovascular Diseases;g:G6PD)(dui:D014652;dis:Vascular Diseases;g:G6PD)(dui:D008107;dis:Liver Diseases;g:G6PD)(dui:D007154;dis:Immune System Diseases;g:G6PD)(dui:D007153;dis:Immunologic Deficiency Syndromes;g:G6PD)(dui:D007960;dis:Leukocyte Disorders;g:G6PD)(dui:D010585;dis:Phagocyte Bactericidal Dysfunction;g:G6PD)(dui:D009422;dis:Nervous System Diseases;g:G6PD)(dui:D002493;dis:Central Nervous System Diseases;g:G6PD)(dui:D001927;dis:Brain Diseases;g:G6PD)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:G6PD)(dui:D012871;dis:Skin Diseases;g:G6PD)(dui:D004700;dis:Endocrine System Diseases;g:G6PD)(dui:D044882;dis:Glucose Metabolism Disorders;g:G6PD)(dui:D005236;dis:Favism;g:G6PD)(dui:D000746;dis:Anemia, Hemolytic, Congenital Nonspherocytic;g:G6PD)(dui:D003920;dis:Diabetes Mellitus;g:G6PD)(dui:D002561;dis:Cerebrovascular Disorders;g:G6PD)(dui:D001928;dis:Brain Diseases, Metabolic;g:G6PD)(dui:D009748;dis:Nutrition Disorders;g:G6PD)(dui:D006105;dis:Granulomatous Disease, Chronic;g:G6PD)(dui:D052439;dis:Lipid Metabolism Disorders;g:G6PD)(dui:D002545;dis:Brain Ischemia;g:G6PD)(dui:D003872;dis:Dermatitis;g:G6PD)(dui:D017443;dis:Skin Diseases, Eczematous;g:G6PD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:G6PD)(dui:D003877;dis:Dermatitis, Contact;g:G6PD)(dui:D006946;dis:Hyperinsulinism;g:G6PD)(dui:D050171;dis:Dyslipidemias;g:G6PD)(dui:D051437;dis:Renal Insufficiency;g:G6PD)(dui:D006949;dis:Hyperlipidemias;g:G6PD)(dui:D007333;dis:Insulin Resistance;g:G6PD)(dui:D058186;dis:Acute Kidney Injury;g:G6PD)	Nicotinamide adenine dinucleotide phosphate:Glycolic acid:16-Bromoepiandrosterone:Artenimol	GO:0032094:GO:0010041:GO:0009051:GO:0061052:GO:0034451:GO:0006740:GO:0006006:GO:0043523:GO:0004345:GO:0009898:GO:0043249:GO:1904879:GO:0045471:GO:0070062:GO:0043231:GO:0006739:GO:0019322:GO:0005829:GO:0010734:GO:2000378:GO:0042802:GO:0042803:GO:0006098:GO:0006695:GO:0014070:GO:0021762:GO:0005536:GO:0005634:GO:0050661:GO:0051156:GO:0005515:GO:0005737:GO:0006749:GO:0006629:GO:0016020:GO:0034599:GO:0055114:GO:0046390	305900	PF00479:PF02781	-2.64														M	
chrX:154533044	SNV	C	1	T/T	PASS	0.0	3975.03		400	C=0,T=400	C=0.0,T=1.0	100.00	0.0	hemizygous	1	0.002	1		G6PD	NM_001042351.3	G6PD:exonic:NM_001042351.3	missense	AAG	9	p.Glu317Lys	c.949G>A	0.05	0.837	56.0	T		0.92		Conflicting interpretations of pathogenicity	9230996	rs137852339		(dui:NBS1;dis:Recommended Newborn Screening Panels;g:G6PD)(dui:NBS3;dis:Secondary Conditions;g:G6PD)(dui:NBS39;dis:Hb carrier other than C,D,E,S,O-Arab;g:G6PD)(dui:NBS7;dis:Hemoglobin Disorder;g:G6PD)(dui:D009358;dis:Congenital, Hereditary, and Neonatal Diseases and Abnormalities;g:G6PD)(dui:D030342;dis:Genetic Diseases, Inborn;g:G6PD)(dui:D006425;dis:Hemic and Lymphatic Diseases;g:G6PD)(dui:D006402;dis:Hematologic Diseases;g:G6PD)(dui:D009750;dis:Nutritional and Metabolic Diseases;g:G6PD)(dui:D000740;dis:Anemia;g:G6PD)(dui:D008659;dis:Metabolic Diseases;g:G6PD)(dui:D000743;dis:Anemia, Hemolytic;g:G6PD)(dui:D000745;dis:Anemia, Hemolytic, Congenital;g:G6PD)(dui:D008661;dis:Metabolism, Inborn Errors;g:G6PD)(dui:D005955;dis:Glucosephosphate Dehydrogenase Deficiency;g:G6PD)(dui:D040181;dis:Genetic Diseases, X-Linked;g:G6PD)(dui:D002239;dis:Carbohydrate Metabolism, Inborn Errors;g:G6PD)(dui:D052801;dis:Male Urogenital Diseases;g:G6PD)(dui:D005261;dis:Female Urogenital Diseases and Pregnancy Complications;g:G6PD)(dui:D014570;dis:Urologic Diseases;g:G6PD)(dui:D052776;dis:Female Urogenital Diseases;g:G6PD)(dui:D007674;dis:Kidney Diseases;g:G6PD)(dui:D004066;dis:Digestive System Diseases;g:G6PD)(dui:D002318;dis:Cardiovascular Diseases;g:G6PD)(dui:D014652;dis:Vascular Diseases;g:G6PD)(dui:D008107;dis:Liver Diseases;g:G6PD)(dui:D007154;dis:Immune System Diseases;g:G6PD)(dui:D007153;dis:Immunologic Deficiency Syndromes;g:G6PD)(dui:D007960;dis:Leukocyte Disorders;g:G6PD)(dui:D010585;dis:Phagocyte Bactericidal Dysfunction;g:G6PD)(dui:D009422;dis:Nervous System Diseases;g:G6PD)(dui:D002493;dis:Central Nervous System Diseases;g:G6PD)(dui:D001927;dis:Brain Diseases;g:G6PD)(dui:D017437;dis:Skin and Connective Tissue Diseases;g:G6PD)(dui:D012871;dis:Skin Diseases;g:G6PD)(dui:D004700;dis:Endocrine System Diseases;g:G6PD)(dui:D044882;dis:Glucose Metabolism Disorders;g:G6PD)(dui:D005236;dis:Favism;g:G6PD)(dui:D000746;dis:Anemia, Hemolytic, Congenital Nonspherocytic;g:G6PD)(dui:D003920;dis:Diabetes Mellitus;g:G6PD)(dui:D002561;dis:Cerebrovascular Disorders;g:G6PD)(dui:D001928;dis:Brain Diseases, Metabolic;g:G6PD)(dui:D009748;dis:Nutrition Disorders;g:G6PD)(dui:D006105;dis:Granulomatous Disease, Chronic;g:G6PD)(dui:D052439;dis:Lipid Metabolism Disorders;g:G6PD)(dui:D002545;dis:Brain Ischemia;g:G6PD)(dui:D003872;dis:Dermatitis;g:G6PD)(dui:D017443;dis:Skin Diseases, Eczematous;g:G6PD)(dui:D000592;dis:Amino Acid Metabolism, Inborn Errors;g:G6PD)(dui:D003877;dis:Dermatitis, Contact;g:G6PD)(dui:D006946;dis:Hyperinsulinism;g:G6PD)(dui:D050171;dis:Dyslipidemias;g:G6PD)(dui:D051437;dis:Renal Insufficiency;g:G6PD)(dui:D006949;dis:Hyperlipidemias;g:G6PD)(dui:D007333;dis:Insulin Resistance;g:G6PD)(dui:D058186;dis:Acute Kidney Injury;g:G6PD)	Nicotinamide adenine dinucleotide phosphate:Glycolic acid:16-Bromoepiandrosterone:Artenimol	GO:0032094:GO:0010041:GO:0009051:GO:0061052:GO:0034451:GO:0006740:GO:0006006:GO:0043523:GO:0004345:GO:0009898:GO:0043249:GO:1904879:GO:0045471:GO:0070062:GO:0043231:GO:0006739:GO:0019322:GO:0005829:GO:0010734:GO:2000378:GO:0042802:GO:0042803:GO:0006098:GO:0006695:GO:0014070:GO:0021762:GO:0005536:GO:0005634:GO:0050661:GO:0051156:GO:0005515:GO:0005737:GO:0006749:GO:0006629:GO:0016020:GO:0034599:GO:0055114:GO:0046390	305900	PF00479:PF02781	2.83														M	
